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ABSTRACT
Federal legislation designed to transform the U.S. healthcare system and the emergence
of mobile technology are among the common drivers that have contributed to a data explosion,
with industry analysts and stakeholders proclaiming this decade the big data decade in healthcare
(Horowitz, 2012). But a precise definition of big data is hazy (Dumbill, 2013). Instead, the
healthcare industry mainly relies on metaphors, buzzwords, and slogans that fail to provide
information about big data’s content, value, or purposes for existence (Burns, 2011). Bollier and
Firestone (2010) even suggests “big data does not really exist in healthcare” (p. 29). While
federal policymakers and other healthcare stakeholders struggle with the adoption of Meaningful
Use Standards, International Classification of Diseases-10 (ICD-10), and electronic health record
interoperability standards, big data in healthcare remains a widely misunderstood phenomenon.
Borgman (2012) found by “studying how data are created, handled, and managed in multidisciplinary collaborations, we can inform science policy and practice” (p. 12).
Through the narratives of nine leaders representing three key stakeholder classes in the
healthcare ecosystem: government, providers and consumers, this phenomenological research
study explored a fundamental question: Within and across the narratives of three key healthcare
stakeholder classes, what are the important categories of meaning or current themes about big
data in healthcare? This research is significant because it: (1) produces new thematic insights
about the meaning of big data in healthcare through narrative inquiry; (2) offers an agile
framework of big data that can be deployed across all industries; and, (3) makes a unique
contribution to scholarly qualitative literature about the phenomena of big data in healthcare for
future research on topics including the diffusion and spread of health information across
networks, mixed methods studies about big data, standards development, and health policy.
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CHAPTER I. INTRODUCTION

Big data is a phenomenon of data usage closely linked to the "Information Age" (Heudecker,
2013). The term is common to many industries, in which 15 of the U.S. economy’s 17 sectors,
companies with more than one thousand employees, store on average more data than is contained
in the U.S. Library of Congress (Brown, Chui, & Manyika, 2011). With the advent of health
information technology (HIT), namely electronic health records (EHRs), big data in healthcare
has emerged as a “natural resource” that could potentially revolutionize how we deliver
personalized medicine and improve the health of populations. Consider the following vignette
which describes a vision of the future of health and healthcare, fueled by big data:
At the level of the healthcare consumer, “big data” facilitated health
improvement by applying massive computational utilities and the profound
knowledge of systems biology to rich data clouds around each person. The
billions of bits in each cloud came from inexpensive microfluidic devices enabling
nearly continuous testing of blood for circulating proteins with bio-monitoring
devices that could interface with personal simulations to predict future wellbeing.
By collecting a person’s genetic code, zip code and everything in between, these
systems offered the capacity to predict when people were likely to get a major
disease and to die. Personal avatars (digital health coaches) helped people
recognize and leverage the extent to which their health was shaped by social,
psychological, and behavioral factors. Most cancers were effectively preempted
and managed by 2030. Former Type I and II diabetics now faced happier and
longer lives due to the ability to grow and transplant pancreatic islet cells from
pluripotent stem cells. Healthier communities, more effective personal healthcare
and more sophisticated self-care decreased the demand for physician services and
hospital care. In the eyes of many, the revolutionary transformation in both health
and healthcare in the decades leading to 2032 was inevitable given the rapid
diffusion of knowledge to an engaged population with a deeply held aspiration to
be healthy.1
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Institute for Alternative Futures. Health and Health Care in 2032: Report from the RWJF Futures Symposium, June
20-21. Alexandria, VA: Institute for Alternative Futures; 2012. http://www.altfutures.org/pubs/RWJF/IAFHealthandHealthCare2032.pdf

2
The aforementioned vignette is not merely a pipedream – it is a likely reality. But a major
roadblock persists: the definition of big data is hazy (Dumbill, 2013) and remains a buzzword
(Davenport, Barth, & Bean, 2012). While big data in healthcare fervently grows weekly by some
unknown order of magnitude, the difficulties and realities of sharing, linking, visualizing, and
using big data in healthcare are magnified.

Research Question

This study addressed an important research question:

Q1: Within and across the narratives of three key healthcare stakeholder classes, what
are the important categories of meaning or current themes about big data in healthcare?

While not usually a focal source of data for public policymaking, my intuition lead me to
believe that ‘stories,’ or narratives, from the perspective of those who live the experience would
yield rich, in-depth descriptions of the big data phenomenon in healthcare. In large part, this
study was inspired by the science of epidemiology which studies the origin, patterns, and spread
of an epidemic. Eysenbach (2002) coined the research discipline, infodemiology, which
“identifies areas where there is a knowledge translation gap between best evidence (what some
experts know) and practice (what most people do or believe)” (p. 763) about the distribution of
information and misinformation on the internet. In “An Epidemiology of Big Data,” this study
aimed to determine the practical meaning about big data and fill the translation gap between
what some experts know about big data offered through the wealth of ‘grey literature’ and what
healthcare leaders believe through their cohesive ‘lived experiences’ of the big data phenomena.
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Healthcare at a Glance
Recent estimates released from the Office of the Actuary at the Centers for Medicare and
Medicaid Services (CMS) project that aggregate healthcare spending in the United States will
grow at an average annual rate of 5.8 percent for 2012–22, or 1.0 percentage point faster than the
expected growth in the gross domestic product (GDP). The healthcare share of GDP by 2022 is
projected to rise to 19.9 percent from its 2011 level of 17.9 percent (CMS, 2012). Not to be
confused with the life sciences, translational bioinformatics (Butte & Shah, 2011) or biomedical
sciences, which produced the groundbreaking Human Genome Project that propelled the life
sciences to the forefront of big data by generating approximately one terabase (trillion bases) of
sequence data per month (Hey, Tansley, & Tolle, 2009), healthcare (or heath care) differs from
other commodities because it is typically provided in a series of separate but related delivery
episodes (Hornbrook, Hurtado, & Johnson, 1985; Lameire, Joffe, & Wiedemann, 1999) and can
be thought of as a bundle of attributes (e.g., diagnosis, treatment, prevention of disease, illness,
injury, appointments, technology, insurance) that vary in cost as well as importance to the buyer
(Weisbrod, 1991). The bottom line in healthcare is cost savings, which have been extremely
difficult to achieve in the absence of a major health system transformation.
The healthcare system possesses a large and growing elderly population that threatens to
push the pace of upward spiraling healthcare price increases even higher than their already
faster-than-inflation rates. Expensive medical treatments, end-of-life care, health inequities, new
technologies, fraud and waste are just some of the intended and unintended expenditures that
wreak havoc on healthcare delivery system budgets. Unchecked healthcare inflation creates everlarger federal budget deficits, and pushes up the embarrassingly large number of Americans
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without adequate health insurance. Brown (2011) estimates potential “savings from big data in
the sector could be upwards of $450 billion annually” (p. 2). This unprecedented potential for
cost reductions within the healthcare system has captured the government’s imagination and
attention, as over $200 million in new federal commitments were announced in an effort to
improve the nation’s ability to manage, understand, and act on big data (Re, Nter, & Mill, 2012).
Big data’s role in healthcare cost reduction is vital. To understand big data in healthcare, big data
in a general context must first be understood.

Big Data in a General Context
Big data is not a new concept or idea; however, there is no clear definition for big data
(Zaslavsky, Perera, & Georgakopoulos, 2013). The term "big data" originated as a tag for a class
of technology with roots in high-performance computing, as pioneered by Google in the early
2000s (Hopkins & Evelson, 2012). A representative search of the term big data from Google
yields a multitude of references : Big data BANKS (Kates, 1969); Big data BASES (Boehm,
1975); Big data FILTER (Ernst, 1976); Big data POOL (Porth, Badke, & Mieth, 1982); Big data
SETS (Kinnstaetter, Lohmann, Schwider, & Streibl, 1988). One of the earliest references to big
data was found in a dissertation that used the term big data as a subject key. The dissertation
topic considered the problem of the optimal hardware architecture for advanced data
management systems (Neches, 1983).
Every day, we create 2.5 quintillion bytes of data — so much that 90% of the data in the
world today has been created in the last two years alone. This data comes from everywhere:
sensors used to gather climate information, posts to social media sites, digital pictures and
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videos, purchase transaction records, and cell phone GPS signals to name a few. This data is big
data (Davenport & Jarvenpaa, 2008). Big data is routinely referenced in many industries
including banking, defense, and oceanography, whose information technology and computational
methods are mature and robust. Consumer retail has been a commonly cited industry that has
taken advantage of big data’s benefits. Large retailers like Target and Wal-Mart have used big
data to develop business intelligence on consumer shopping patterns and behavior. By assigning
a unique identifier to each customer that uses a credit card, fills out a survey, or provides their
phone number, retailers are able to employ sophisticated statistical models to create targeted
marketing campaigns.

The volume of stored information in the world is growing so fast that scientists have had
to create orders of magnitude of data, including zettabyte and yottabyte, to describe the flood of
data (Kuner, Cate, Millard, & Svantesson, 2012). The digital world is expected to hold a
collective 2.7 zettabytes of data by year-end, an amount roughly equivalent to 700 billion DVDs
(Hardy, 2012). As hardware and software advance, the capacities of large computational
resources provide us with the only practical and reliable sense of what “big” means. This is
particularly characteristic in an emerging digital information economy, where clickstream data
give precisely targeted and real-time insights into consumer behavior. Our purchases, searches,
and online activities are being tracked to improve everything from websites to social movements
intended to democratize entire countries.

Earlier mainstream notions of big data were limited to a few organizations such as
Google, Yahoo, and Microsoft, which did not produce scholarly communications but did
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produce reputable, credible marketing whitepapers found in the grey literature. Big data as a
marketing and services tool has emerged as a profitable growth opportunity for many firms
across industries. But there is a dearth of scholarly articles on big data, particularly in healthcare,
as it has not been widely studied in academic circles; hence, many of the attempts to define big
data are found in grey literature, including conference proceedings, briefing documents and
sophisticated marketing materials that target buyers of services and goods. The following big
data definitions sampled from mostly grey and some scholarly literature show just how wideranging and troublesome it is to adopt a definition of the term “big data:”


“Big Data” is a science of fielding algorithms that enable machines to recognize complex
patterns in data. It fuses machine learning with a very deep understanding of computer
science and algorithms and that, of course, is key to being able to take machine learning and
deploy it in a very scalable way (Paredes, 2012).



“Big Data” exceeds the processing capacity of conventional database systems. The data is too
big, moves too fast, or doesn’t fit the strictures of your database architectures. To gain value
from this data, you must choose an alternative way to process it (Dumbill, 2013).



“Big Data” is the ability to mine and integrate data, extracting new knowledge from it to
inform and change the way providers, even patients, think about healthcare (Roney, 2012).



“Big Data” is not a precise term; rather, it’s a characterization of the never-ending
accumulation of all kinds of data, most of it unstructured. It describes data sets that are
growing exponentially and that are too large, too raw, or too unstructured for analysis using
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relational database techniques. Whether terabytes or petabytes, the precise amount is less the
issue than where the data ends up and how it is used (EMC2, 2012).


“Big Data” is the ability to collect, process, and interpret massive amounts of information.
One of the biggest potential areas of application for society is healthcare (Rooney, 2012).



“Big Data” is a bubble just filled with hot air – at least for now. Everyone is talking about it
but when you dig a bit deep with a pointed question, very quickly you discover that it has
nothing much to do with the Big Data (Shah, 2013).



“Big Data” are datasets whose size is beyond the ability of typical database software tools to
capture, store, manage, and analyze (Manyika et al., 2011).



“Big Data” is techniques and technologies that make handling data at extreme scale
affordable (Hopkins & Evelson, 2012).



“Big Data” is more data than our current systems and resources can handle (Fogarty 2012).



“Big data” is an explosion of available information, a byproduct of the digital revolution (I.
Thomas, 2013).



“Big data” does not really exist in healthcare settings (Bollier & Firestone, 2010).



“Big Data” n: the belief that any sufficiently large pile of s--- contains a pony (Arbesman,
2013).

Recent trends suggest big data is a philosophy: an organizational culture that embraces the
complexities of integrating, analyzing and transforming vast amounts of data into a valued
organizational asset. Young (2012) suggests “big data is only applicable to life and biomedical
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sciences research and not capable of adding value to the bedside delivery of healthcare, where
patient encounters are counted - not petabytes” (p. 8).

Big Data in Healthcare
It is an impossible task to accurately count the number of patient encounters and
transactions because of the current fragmentation of the care delivery system and the abundance
of information technology platforms that do not interact. Big data in healthcare is slowly
changing with the advent of system development approaches, wireless grids, and semantic web
technologies that are highly compatible with widely distributed systems. The expansion of digital
technology is capable of synthesizing data sources from other industries including housing,
transportation, and social services to create an explosion of data in every aspect of an
individual’s personal health profile.
Big data will enable the notion of personalized medicine, which provides physicians with
a comprehensive understanding of a person's health and genomic makeup, rather than relying on
a superficial understanding of other patients' histories (Horowitz, 2012). Underlying the data’s
sheer volume are valuable relationships among datasets and social networks, implying that data
integration can expose new information that was not discoverable in the past.
What has changed dramatically in the last twenty years is that computers have become
more mobile, creating a robust mobile health (mHealth) industry where it is commonplace, if not
necessary, for clinicians to carry handheld devices into exam rooms. Millions of smartphones,
tablets, and other portable devices are generating and consuming data of increasing variety.
Clinicians continue in 2013 to adopt mobile computing devices at a rapid rate, with nearly ninety
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percent expected to use smartphones in 2014 and almost as many using tablets.2 Microsoft’s
Google Glass is gaining a reputation as a potential disruptive innovation. The wearable device is
now deployed during certain surgical procedures and outpatient visits and is not as impersonal
and distracting as a handheld device. The masses of small, mobile devices represent enormous
computational capacity; albeit each individual physician typically generates or consumes a
modest amount of data.
Big data is a challenge for industries such as defense, transportation, and banking. For
healthcare it is even more formidable largely because patient data records cannot be so easily
collected and freely shared; there are all sorts of technical, ethical, and public policy barriers to
making such liquid data – liquid (Bollier & Firestone, 2010). Healthcare data remain in silos,
fragmented and distributed across thousands of physician offices, hospitals, and clinicallyintegrated delivery systems that themselves are composed of autonomous units (L. R. Burns et
al., 2002). The real revolution is not in the machines that calculate the data but in the data itself
and how we use it (Mayer-Schönberger & Cukier, 2013).
Healthcare’s Big Data Drivers
Bringing intelligent healthcare informatics to bear on the national problems of improving
healthcare (Robertson, Dehart, Tolle, & Heckerman, 2009), reducing healthcare costs, and
improving quality and health outcomes relies on an ability to take raw data and transform it into
information that becomes knowledge for decision making. This is what fundamentally drives big
data in healthcare. The next section provides a brief, but important acknowledgement of three
Data taken from Epocrates’ Mobile Trends Report based on a survey of 1,063 clinicians in May 2013. Internet
Source: http://www.healthdatamanagement.com.
2
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significant drivers beyond cost reduction pressures of big data in healthcare: health information
technology, federal healthcare legislation, and healthcare consumers.

Health Information Technology (HIT)
The advent of health information technology (HIT) is expected to improve the
management, analysis, and deployment of a tremendous amount of granular-level, patientcentered data. For instance, a possible transition to International Classification of Disease –
Version 10 (ICD-10) will require physicians across all clinical specialties to transition from
20,000 codes under ICD-9 to 155,000 under ICD-10 – an almost eight-fold expansion.3 In an
information-rich healthcare industry, basic HIT interoperability is still a daunting problem. Even
with HITECH legislation that encourages widespread adoption of HIT across all healthcare
settings including physician practices, hospitals, and laboratories, there are different scales of
data, both structured and unstructured, that do not have the ability to connect on a single
platform. Much of medical knowledge and information remains in paper form. And even where
data is digitized, it often resides in disparate datasets and repositories in diverse formats.
It is expected that through the adoption of HIT an extraordinary amount of structured and
unstructured data will be generated, requiring a new level of computational strength and
synthesis. As such, this data can be used as information to create knowledge to inform healthcare
providers, consumers, and policymakers alike about topics ranging from highly complex
questions at the point of care to pandemic forecasting.

3

McKesson. Source: http://sites.mckesson.com/achievehit/files/ICD-10_FAQs_McKesson.pdf
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With EHRs slowly filtering into physician practices, it is the data - and lots of it - that has
healthcare thought leaders and visionaries anticipating the threshold moment of “Healthcare
Singularity” (Buchan, 2009), when healthcare knowledge becomes instantaneous (remember the
2032 vignette?). When data was once considered tedious to manage and costly to store big data
is now considered an asset to both individuals and organizations. Although the potential of new
laws that promote information technology interoperability across stakeholder classes and
consumer demand for “liberated” data on the health of communities are exciting, the spread and
diffusion of medical knowledge is slow (Porter & Teisberg, 2006).

Federal Healthcare Legislation
Healthcare is a highly regulated field, with various laws guiding how healthcare data is
used and reported (Sullivan, 2011). Healthcare legislation designed to reform an inefficient
healthcare “system of systems” has been at the forefront of presidential political agendas for
decades. Over the past ten years, several major bodies of healthcare legislation have been
enacted to provide Medicare beneficiaries with Part D drug plans, which closes the metaphorical
“donut-hole” prescription coverage gap that describes the variance between initial drug coverage
limits and catastrophic drug coverage thresholds; the Health Insurance Portability and
Accountability Act (HIPAA) has standardized the exchange of essentially all healthcare
transactions between physicians, hospitals and their business partners while also providing
guidance on patient privacy and systems security; and, the Patient Protection & Affordable Care
Act (Affordable Care Act), which is the most sweeping body of legislation since Medicare was
introduced over 45 years ago, will introduce, among many patient protections, innovative
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payment and coordinated care models designed to provide high quality healthcare at lower costs,
rules against insurers dropping patients because of pre-existing conditions, and eliminates
lifetime limits on medical expenses. The Affordable Care Act identified a host of old
(administrative) and new (streaming) datasets (Figure 1) that must be collected, managed, and
reported by healthcare stakeholders.

Figure 1.A sample of structured and unstructured datasets collected under healthcare reform.
Source: Patient Protection & Affordable Care Act 2010

Though the new healthcare landscape promises to provide high quality, cost effective
care to millions of new beneficiaries through federally-mandated Health Insurance Marketplaces
and to people with preexisting health conditions, the deluge of data will certainly test the
system’s ability to collect, store, and analyze big data. Still, there is skepticism that federal
policies thus far have blunted big data’s potential in the public sector (Konkel, 2013).
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Although the government has a long history of making biomedical science data available
to the public, the Obama Administration’s Open Government Initiative has motivated federal
agencies to make a wider variety of data available to “citizen scientists” at www.data.gov. This
website has the potential to create a secondary market for visionaries, researchers, and
entrepreneurs to create new tools and knowledge for many stakeholders including healthcare
consumers who lately have been inclined to provide open access to their personal health records.

Consumers of Health and Healthcare
A new healthcare information economy has materialized. Healthcare consumers now
demand a new scale of data liquidity enabled by EHRs, laboratory information systems,
medication-management systems which are interoperable with their personally controlled health
records (PCHR) where they independently decide (Mandl & Kohane, 2008) when and with
whom they share their individually identified health information.4 Healthcare consumers must
now become researchers, or “citizen scientists.” However, beyond initiatives like Blue Button®
Connector, which provides a limited number of Medicare beneficiaries access to historical
claims data, access to the tools and information on par to the sophistication and rigor of that
afforded to policymakers and providers allowing, them to better manage their own healthcare in
the new health information economy is at best, scant. While some healthcare consumers so
happen to be highly skilled data scientists, the masses do not have the necessary technical skills

4

The Health Insurance Portability & Accountability Act (HIPAA) which includes provisions for protection of
individually identifiable health information (formerly protected health information (PHI)) does not apply to patients who
wish to share their own health information.
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or even the requisite health literacy (and e-health literacy) skills to harness big data for basic
healthcare decision making.
Healthcare is growing rapidly in terms of the quantity and quality of data that is collected
on a daily basis. The problem is that this data is growing faster than the consumers can use it. As
the world’s population increases, the health and healthcare data problem will be exacerbated.
Healthcare consumers are facing the challenge of not only selecting the best care for themselves
and their families, but doing it in a cost effective manner based on the best available healthcare
information and clinical evidence-base.
The once skeptical healthcare patient engagement movement is slowly gaining
momentum with the advent of technological innovations such as wireless grids, semantic web
applications, and social networking approaches that revolutionize the way healthcare consumers
collaborate, identify potential collaborators or friends, communicate with each other, and identify
information that is relevant for them (Eysenbach, 2008). These tools will produce better ways for
consumers to take charge engaging with physicians, government, and other healthcare
stakeholders to reduce wasteful spending and improve population health.
Big data also enables personalized medicine, which provides physicians with a
comprehensive understanding of an individual's health, environmental, and genomic makeup,
rather than relying on a superficial understanding of other patients' histories (Horowitz, 2012). In
order for healthcare consumers to be effective participants in a reformed healthcare landscape,
they require information from trusted, third-party sources. The Health 2.0 movement makes a
uniform attempt to provide collaborative approaches to engaging healthcare consumers through
credible information. For instance, Dr. Gunther Eysenbach coined the term “apomediation,”
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which encompasses a socio-technological information seeking strategy where people rely less on
a traditional intermediary, such as a pharmacist giving relevant information to a patient. The
difference between an intermediary and an apomediary is that an intermediary stands “in
between” the consumer and information. In contrast, apomediation means that there are agents
(e.g., people, tools) that “stand by” to guide a consumer to high quality information and services
without being a prerequisite to obtain that information or service in the first place. While these
distinctions are not absolute (in practice, there may be a mix of both, with people moving back
and forth between apomediation and intermediation models), it has been hypothesized that they
influence how people judge credibility (Eysenbach, 2008).

Who are the key healthcare stakeholders?
From Congress who drafts healthcare legislation to patients who require evidence-based
information to inform their treatment decisions, there are many stakeholders with an interest in
the delivery of h. The Agency for Healthcare Quality and Research (2014) defines healthcare
stakeholders, “as persons or groups that have a vested interest in a clinical decision and the
evidence that supports that decision. Healthcare stakeholders include: patients, caregivers,
clinicians, researchers, advocacy groups, professional societies, employers, and policymakers”
(p. 11).
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Figure 2. The many classes of healthcare stakeholders of the reformed healthcare ecosystem
It is a highly complex task to understand the interrelationship between many healthcare
stakeholders of the ecosystem (Figure2). At a very basic level, an episode of care is initiated
when a patient (stakeholder) initiates and follows through on a scheduled appointment to interact
with a provider (stakeholder) for clinical consultation and treatment of an ailment or illness. This
simple scenario does not even take into account whether the patient has employer-based
insurance or is a beneficiary of a public healthcare entitlement program, such as Medicaid or
Medicare. The scope of events that precede and succeed a single patient encounter entails
synchronization of care coordination, data collection and analysis, information generation and
exchange, and knowledge in the form of policies, procedures, evidence-based medicine, and
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provider report cards – underpinned by HIT. The point being, a single patient episode, regardless
of its level of complexity, requires collaboration and exchange of information from as few as two
to a multitude of additional healthcare stakeholders.

Data Sharing
Data sharing is complex and inconsistent within and across the many classes of
healthcare stakeholders and are frequently hampered by the lack of foolproof de-identification
for patient privacy, as data reside in many discrete data systems. The lines in Figure 2 depicts
information technology interoperability where all stakeholders share their big data in a common
data repository, creating massive amounts of data for healthcare decision making, shared
knowledge for learning systems, and consumer choices. While such data repositories may exist
locally or regionally, no such national data warehouse exists.
This issue alone impedes opportunities for data mining and analysis that would enable
precise predictive and preventive medicine (Robertson et al., 2009). The use of EHRs is
producing more data-in-depth healthcare environments in which substantially more data are
captured and transferred digitally, flooding stakeholders with data, generating an urgent need for
new techniques and tools that can intelligently and automatically assist in transforming (Fayyad
et al, 1996) big data into better information for decision making.
An analysis of healthcare stakeholder classifications typically included federal, state, and
local policymakers who create rules and regulations, consumers who demand healthcare
services, and providers who supply healthcare services either at a cost or through charitable care.
These three key healthcare stakeholders are central to achieving the industry adopted Triple Aim
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of improving the experience of care, improving the health of populations, and reducing per capita
costs of health (Berwick, Nolan, & Whittington, 2008). Grossmann (2010), in an Institute of
Medicine series wrote, “by providing greater insight to patients, providers and policymaker[s] …
data hold the potential to help transform the U.S. healthcare system” (p. 69).

Figure 3. Information flow along the healthcare information value chain
These core health system classes are situated at the center and both ends of the healthcare
value chain: government (producers), providers (deliverers) and consumers (users) (Figure 3).
The implementation of EHRs has contributed to a data rich healthcare environment in
which substantially more data are now captured and transferred digitally, generating an urgent
need for new analytical techniques and information management tools that can intelligently and
automatically assist in transforming (Fayyad et al., 1996) big data into better information for
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decision making. Yet, the three stakeholder classes that are the focus of this study have different
goals and hopes for big data (Feldman, Martin, & Skotnes, 2012). An assessment of the
readiness of the three key stakeholder classes was explored:


Government: As the largest producer of open source data for public use, government is a
key contributor to the generation of information needed to achieve cost efficiencies in
healthcare. Through government supported data initiatives like Healthdata.gov, providers,
consumers and other healthcare stakeholders can have reasonable access to raw data for
making choices about treatments (Clancy, 2006). Yet, government leaders struggle with
the sheer volume of data they seek to manage.5 They lack a systematic approach to
classifying and sharing quality, cost, and outcome data with other interested participants
of the delivery of healthcare. Also, what is the proper and practical role for government
in the face of a deluge of digital data (Kuner et al., 2012)?



Providers: They most frequently use data for healthcare delivery, value-based purchasing,
and EHR reporting incentives. However, they often lack sufficient data aggregation
and analysis tools to capture data and turn it into usable knowledge. The general
perception is physicians are not prepared to use big data at the point-of-care for decisionmaking.



Consumers: Consumers produce the bulk of big data. There is often an abundance of
information available, but much of it is irrelevant to the decision-making process. Little
is actually known about what kinds of data and information consumers need to

5

Tech America Foundation Report (2012) Demystifying Big Data: A practical guide to transforming the business of
government. http://www-304.ibm.com/industries/publicsector/fileserve?contentid=239170
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make decisions (Edgman-Levitan & Cleary, 1996). Currently, consumers have more
mobility, live longer lives and, healthcare is more shared than ever before. Consumers
have little control within the contour of big data in an undefined, unregulated data
environment. Ethical issues such as privacy, trust, and informed consent loom as major
big data barriers.
Collectively, triangulating the perceptions of these three “key” healthcare stakeholder classes
represent an optimal starting point to understand the phenomenology of big data in healthcare.
This research study is about discovering the important categories of “meaning about” big data in
healthcare verses the “meaning that” which many theoretical frameworks, including Grounded
Theory, Information Diffusion Theory, or Dewey’s Theory of Experiential Learning seek to
ground or test research data. However, a short discussion of information sharing provides the
necessary breath to understand big data in the context of healthcare. Value chain analysis in
healthcare provides an intriguing framework that encompasses the vertical and horizontal
integration of the strategic relationships and information sharing among healthcare stakeholders.
In the next section, I introduce an aspirational value chain framework: An epidemiology of big
data.
An Epidemiology of Big Data
Value chain analysis originally sought to examine the operations of a manufacturing
enterprise by looking at the value or cost of inputs in terms of the value or price of outputs. In a
typical value chain, money, products, services, information, or other goods are multilaterally
exchanged between two or more participants. L. R. Burns et al. (2002) describes the value chain
as “a virtual network designed to help move a produce (information) from the producer
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(government) through an intermediary purchaser (provider), and eventually down to the
consumer. However, in healthcare, a value chain framework “represents more aspiration than
reality” (p. 11) because of its many “broken links.” Similarly, in epidemiology the “chain of
infection” posits that for an infection to develop, each link of the chain must be connected.
Breaking any chain of the link can stop the transmission of the infection. Analogous to the
epidemiological chain of infection, in healthcare, information generated by big data might
typically spread among healthcare stakeholders, at least in theory. When a link in the value chain
that characterizes big data and information sharing in healthcare is broken, evidence-based
medicine is unachievable.
To express the origin, incidence, spread and control of information derived from big data
shared between healthcare stakeholders, a notional and aspirational value chain framework, “an
epidemiology of big data,” is potentially an important aspect of the big data “contagion” in the
healthcare ecosystem. In the context of big data analyzed into information for knowledge, such a
notional framework suggests that big data in healthcare evolves into information that is
multilaterally spread among healthcare stakeholders, creating commodity value each time big
data is exchanged and is “kinetically energized” by the “invisible hand” of efficient organization
which is embodied in metadata (Zeng & Qin, 2008).
An epidemiology of big data is not a construct of an IT system. Information derived
from organized structured and unstructured data (big data) whose value is presumably increased
(or decreased) through standardized multilateral knowledge and information exchange among
and between all healthcare stakeholders, creating value add and ultimately healthcare intelligence
for policymaking, decision-making, and care delivery (Table 1). In short, data’s value needs to
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be considered in terms of all the possible ways it can be “spread” by members along the
healthcare information value chain, not simply how it is used for its initial use (MayerSchönberger & Cukier, 2013; Porter & Teisberg, 2006).
STAKEHOLDERS

GOALS

CONCERNS

Consumers

• Understandable Clinical
Information
• Improved Data mobility
• Improved decision making
Better care coordination
• Performance based
payments
• Reduced administrative
paperwork
• Improved care
coordination
• Business Intelligence for
ACOs
• Program Integrity
• Quality Measures
• Better health outcomes
• Lower healthcare costs

• Access to care
• Affordable care
• Security and privacy of
personal data
• Trustworthiness
• Additional regulations and
paperwork requirements
• Increased uncompensated
care
• Data Quality
• Malpractice

Providers

Government

• Budget for infrastructure
change
• Prioritizing resources
• Value-Based Purchasing

Table 1. Information Goals and Concerns of Key Healthcare Stakeholders
Collectively, little is known about how much key healthcare stakeholders really know
about the magnitude of big data challenges and whether consumers are even aware of big data,
much less how to leverage it for their own benefit. To support this claim, I immersed myself in
an extended review of the literature which provided contextual background and supported
identification and refinement of the research question and research problem (Ridley, 2009).
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CHAPTER II. LITERATURE REVIEW

This chapter describes the processes I used to conduct the literature review and identifies
results and emergent themes derived from scholarly and grey literature. This information served
as a backdrop to the data collected from the in-depth interviews. The literature review is
foundational for an phenomenological research study; the literature does not guide and direct the
study but serves as an aid once patterns or categories have been identified (Creswell, 2009). The
preliminary literature review that began January 2011 underwent several revisions through
March 2013. A modified systematic literature review (Frehywot et al., 2013; Mays, Pope, &
Popay, 2005) was used to provide structure. In this research study, An Epidemiology of Big Data,
an extensive reference list of scholarly (87) and grey (1,380) literature was reviewed and
assessed for validity and usability.
The questions, context, and content of healthcare management and policy are generally
broader and more diffuse than those of the clinical world (J. L. Bellamy, Bledsoe, & Traube,
2006), requiring the use of ‘grey literature’ in this study. Web of Science/MEDLINE alone
cannot be used to effectively gather data about social science and humanities citations (Hutton,
2009). The broad function of the literature review for policy relevant research is to help decision
makers see and conceptualize the breadth of issues and broad models that can inform decision
making about a policy problem. Reviews can involve a policy problem that has remained
unchanged for years or it can involve a policy problem that is likely to emerge in the future.
Increasingly, health policy decision makers and professionals are turning to research-based
evidence to support decisions about policy and practice (Bell 2006).
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Lomas (2005) concluded that historically, “policymakers are less commonly seen as a
target audience for systematic reviews” (S1:36). Such rigorous literature reviews are relegated to
clinical research. This approach is changing; the discipline of “systematic-type” reviews has
filtered into policymaking, though not in the format or approach found in comprehensive
systematic reviews.
Mays (2005) found “there is no single agreed upon approach” (p. 1) to policy-related
systematic reviews. But in answering policy questions, policymakers and managers will often
need to draw on diverse sources of evidence – not only quantitative and qualitative research, but
also other evidence such as expert opinion and explicit value judgments (Mays et al., 2005).

A Dearth of Scholarly Literature
While the grey literature on big data has exploded with vendors adding the term “big
data” to marketing materials just to drive hype (Hopkins, 2011), there is a shortage of scholarly
works, and therefore, we are no closer to defining the term for stakeholders to make sense of its
true potential and application. In a Google search (09 Sept 2013), the term “big data” generated
over 9.1 million hits. Most of the literature addressed big data collected and synthesized for
providers while touching on big data in government including its policy implications (Konkel,
2013) and its funding prowess (Leinweber, 2011; Re et al., 2012). Consumer-related big data
research is almost nonexistent, as little is actually known about what kinds of data and
information consumers need to make decisions (Edgman-Levitan & Cleary, 1996).
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Modified Systematic Literature Review Approach
The modified systematic literature review for gathering, summarizing, and synthesizing
published and unpublished research is narrower than state-of-the-evidence reviews, but broader
than traditional systematic reviews and may include not only published and unpublished
research, but also published and unpublished non-research literature (Benzies et al, 2006). A
systematic review essentially summarizes the best available research on a specific question by
using transparent procedures to find, evaluate and synthesize the results of relevant study
questions. The methodological approach to modified systematic reviews found in Mays et al
(2005, p.9) study was adapted for this proposed course of research (Table 2).
COMPONENT

RESULT

Explicit research question

Within and across the narratives of three key
healthcare stakeholder classes, what are the important
categories of meaning or current themes about big data
in healthcare?
Explicit search strategy
Search Web of Science/MEDLINE and Scopus on the
search string: "big data"[All Fields] AND
"healthcare"[All Fields]. Limitations are animal science
related articles and the availability of free articles and
citations.
Explicit statement about what
Continue to refine selection criteria that contain “big
types of research evidence
data” and “healthcare” in peer-reviewed journal
were included and excluded
articles, systematic reviews, government supported
research, and meta-analysis. Also the discovery of new
themes and keywords are the objective.
Critical examination of the
Examine relevancy to research question as reviewed in
quality of the studies included
journals and authors frequently appearing in searches;
in the review
examine relevancy of citations.
Critical and transparent process Assess applicability to the “delivery of healthcare" and
of interpretation of the findings identify a proven method of qualitative content
of the review:
analysis.
Table 2. Five components of the modified systematic literature review
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Where peer review is a key part of the systematic literature review process (Thyer &
Myers, 2011), in this modified approach, I chose to forgo this important activity due to time
constraints. I instead relied mainly on the credibility of the journal’s peer review process.
Peer-reviewed scholarly literature that met the aforementioned criteria was identified by
electronically searching the following resource databases: Web of Science/MEDLINE (Syracuse
University Library) and Scopus.6 Google Scholar was used to identify additional sources of
scholarly and grey literature when Web of Science/MEDLINE or Scopus did not produce links to
full text articles. Hutton (2006) found that “considering Web of Science, Google Scholar, Google
and Web link information, through a varied approach to gather citations produces unique,
relevant instances of the use of grey literature” (p. 12). Target literature included books
(electronic and print) and scholarly articles on the primary search string and Boolean operator:
"big data"[All Fields] AND "healthcare"[All Fields]. This approach was used to restrict the
search to potential articles of interest and covered all possible combinations. Other key indicators
were added as the literature review was refined. The term “large data sets” was often found in the
literature but was not used in this study so to maintain consistency with the study term, “big
data.”
Investigator-led systematic reviews appear to be a clear method of progressively focusing
and refining analyses so that policymakers (Lavis et al., 2005; Tranfield, Denyer, & Smart,
2003), providers and consumers will find the resulting information both persuasive and usable.

6

At the time, PubMed was searched; however, no requisite citations were found.
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Systematic Review Challenges
As an emerging scholar-practitioner in healthcare, there are material challenges of
employing a “less than summative systematic review” as found in Cochrane Collaboration
Studies in epidemiological and economic research on clinical care. The first challenge is to
minimize bias (Benzies et al., 2006). Systematic reviews provide specific methodological
requirements, explicitness, and transparency in regard to the specific research question (Lomas,
2005) that helps to mitigate researcher bias. Another major challenge that persists with
systematic reviews is to gain credibility (Lomas, 2005) among academic researchers, who firmly
embrace the rigidity of gold standard scholarly methodological approaches. As with grey
literature, scholar-practitioners must weigh whether the advantages outweigh the challenges of
employing such methods. The intent with this research is to mitigate all bias by adopting an
approach that is replicable and proven to researchers and policymakers in the discipline.

Grey Literature Approach
In credible, scholarly research, the use of grey literature should only be used in two
contexts. First, grey literature could be used to supplement and triangulate information from
empirical scholarly literature that meets the gold standard for evidence. A second way of treating
grey literature is to trace the experience of a community and its policymakers with a particular
policy problem (Bell, 2006). This research study utilized both approaches where applicable, with
the goal of supplementing the scholarly literature found in the modified systematic literature
review. The prevalence of the term big data in conference proceedings, corporate marketing
materials, newspapers, and blogs provided needed breadth and depth to frame and understand the
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definition, growth, and uses of big data in the absence of scholarly citations in peer-reviewed
journals related to the subject. Grey literature was searched using Google and Google Scholar
databases and was limited to consultancy reports, government briefings, conference proceedings,
web articles, white papers, dissertations, newspapers and blogs from major corporations that are
known to produce high quality industry sector documents.
While not customarily the target of Cochrane Collaboration-style research, increasingly,
health policy decision makers and other allied health professionals are turning to research-based
evidence to support decisions about policy and practice. Decisions about whether to include grey
literature in a state-of-the-evidence review are complex (Bell, 2006). To reduce the complexities
of using grey literature, the following criteria were used to evaluate the grey literature cited in
this study:


Source of the Report: Grey literature was from reputable consulting firms that conduct
extensive industry studies in big data, from IBM, McKinsey, Forrester, Deloitte, SAS,
Becker’s Hospital Review and Microsoft will be included.



Transparency of Methods: Data and other types of information about where the report came
from, how it was analyzed, and how the final report was compiled were accessible.



Currency: Consultancy reports, government briefings, conference proceedings, web articles,
white papers, dissertations, newspapers and blogs were sourced between January 2010 and
April 2013.7

7

Source: http://guides.library.upenn.edu/content.php?pid=286667&sid=2454523
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Article Selection Criteria
A two-step process to select literature was used. First, an independent screen of titles,
keywords and abstracts (when available) of search results was carried out to ascertain if a
document met the general inclusion criteria. Subsequently, an independent assessment was
conducted of the full text file of each source based on the predetermined inclusion and exclusion
criteria. This review was limited to published references that directly described (1) big data in a
broad context to capture wide variations in its definition and application across industries and (2)
big data with a specific magnitude, to capture the specificity of themes in the healthcare-related
literature. Additional constraints included removing citation only references, and veterinaryrelated (e.g., animal science) research.
Aggregate results from the systematic review and the grey literature searches were
entered into a Thomson Reuters Endnote x6 Reference Manager ® bibliographic management
database and sorted by themes and important categories described in the following section.

Preliminary Literature Search
A preliminary literature search was conducted through Web of Science/MEDLINE and
was used exclusively to initiate the modified systematic literature review approach to capture the
scholarly literature. A secondary search was conducted in Scopus to find reputable articles from
additional peer-reviewed journals in which the full-text of the article was available. An analysis
was conducted of duplicate documents and relevance. Where no full text or abstract was
available, I searched Google Scholar and found many of the PDF and HTML files used in this
dissertation thesis. Google was searched to find select grey literature based on the inclusion
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criteria (consultancy reports, government briefings, conference proceedings, web articles, white
papers, dissertations, newspapers, and blogs from major corporations that are known to produce
high quality industry sector documents). Initial searches on the three databases led to an
inclusion of documents procured from U.S. Federal Government administered websites.

Results from the Literature Review
The literature search began with use of the following search terms and Boolean operator:
"big data"[All Fields] AND "healthcare"[All Fields]. Through the Web of Science/MEDLINE
database, 87 documents were found in peer-reviewed healthcare management related journals
(69). Government research support, reviews, letters, and editorials (18) constituted the balance of
the documents found. Prevalent research areas were computer science (25), medical informatics
(19), and healthcare science services (17). However, the most unanticipated research area that
tied for second (19) was information science/library science. Journal articles specifically focused
on research or life science disciplines including bioinformatics, genetics, biology, and
engineering, or non-health related disciplines, including computer science and information
science. Other areas of inquiry on big data are found in the energy and aerospace industries.
Because of the paucity of results, a second search was performed with the key indicator
of "big data"[All Fields] only, using the Web of Science/MEDLINE database. The return was
significantly larger, yielding 562 articles in various journals, including Sensors, National
Academy of Science and Journal of Animal Science. The journals on computer science had a
wealth of information on big data. Also conference proceedings were rich in usable information.
During the literature review, the term “big data” was still trending in healthcare. A review of my
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results from the Web of Science/MEDLINE search found no author who emerged as a thought
leader on the big data phenomena. The following argument table (Table 3) justified the
fundamental reasoning for conducting this study.
ARGUMENT STEPS

RELEVANT REFERENCES

Big Data is exploding in healthcare

(Cukier, 2010; Dumbill, 2013; Feldman et al.,
2012; Lomas, 2005; Villars, Olofson, & Eastwood,
2011)
(Porter & Teisberg, 2006; Young, 2012)

Big Data has been slow to adapt in
healthcare
Big data in healthcare requires a
clear definition and subsequent
taxonomy
Stakeholders are central to the
healthcare information value chain
Dialogue between policymaker
social scientist, and consumer
(healthcare information value
chain) must grow
Metadata is fundamental to big
data, interoperability, and
information exchange in healthcare
Drawing together published
literature, ‘grey’ literature, decision
maker’s experience, and
researcher’s knowledge and
experience make the best practice
and policy decisions
Data scientist and trusted
apomediation are necessary; data
scientist profession consists of
many titles, some of which have
existed for years in healthcare

(Brown et al., 2011; Brynjolfsson & McAfee,
2011)
(L. R. Burns et al., 2002; Gorman, 1995)
(L. R. Burns et al., 2002; Dumbill, 2013;
Leinweber, 2011; Lomas, 2005; Porter & Teisberg,
2006; Roper, Winkenwerder, Hackbarth, &
Krakauer, 1988)
(Burns, 2011; Gantz & Reinsel, 2011; Parsons et
al., 2011; Pavolotsky, 2012)
(Lavis et al., 2005)

(Brown et al., 2011; Chen, Chiang, & Storey,
2012; Davenport & Patil, 2012; Eysenbach, 2008)

Table 3. Argument chart to conduct phenomenological study
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The initial search was organized into four themes: “Big Data,” “Drivers,”
“Methods_LitReview,” and “Methods_Qualitative.” As I conducted a deeper analysis of the
literature through citation analysis to discern themes, additional categories emerged, including
“Stakeholders,” “Data Scientist,” “Privacy,” “Ethics,” ”Narrative Medicine” and “Metadata.”
These categories shaped the refinement and development of a credible research question.
The process of arriving to a very clear and concise research question was an iterative process that
took skill and time. The literature presented a compelling case to conduct this research.
Most articles included in this study mentioned big data in the context of healthcare
delivery.8 In some cases, the general application of big data across industries where the term has
matured was used for definitional purposes. Additionally, bibliographies of all documents
retained (peer-reviewed and grey literature) were reviewed as part of a “snowballing” technique
to find further relevant resources, including other documents and applicable websites. In all, over
200 documents are included in the review.

Analyzing the Evidence
There is a strong correlation between the categories of “Big Data,” “Information
Sharing,” and “Stakeholders.” This seems like a logical relationship, but patients within the
consumer stakeholder class were often left out of the information value chain; I believe there is
great potential for further study on this topic. The notion that “modern medicine is an
information science” (Hood & Friend, 2011; Litvin, Cavanaugh, Callanan, & Tenner, 2008) is

8

The term “healthcare” was often used as part of a reference list of industries where big data is or could be used. The

context of the article was not directly related to healthcare. These articles were eliminated.
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intriguing and is viewed or articulated in different ways: “personalized medicine, informationbased medicine.”
The master codes that synthesize across categories are:


Big data (large data sets)



Information Sharing



Metadata



Stakeholders (focusing on “patient” as the stakeholder)
The initial categories/columns helped me to organize the main points of each article and

provide a map which I used to look back to either further study the work of the authors cited or
find literature where I found potential gaps. As I scanned the literature a second and third time, I
found some additional codes:


Computation & Analytics



Data quality



Knowledge management



Privacy (HIPAA)



Data Scientists

Observations from the Literature Review and Emergent Themes
The modified systematic review of the literature on “big data” and “healthcare” produced the
following initial cohesive observations:
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There is a dearth of scholarly research on big data in healthcare. This is significant because
of the exponential growth in healthcare data types, the volume of data, and the speed at
which data flows. Further inquiry requires rigorous study.



The gulf between “life sciences” and “healthcare” is closing – fast. Big data is entrenched in
life sciences research, including genetics, biomedical research, computational biology, and
nanomaterial science. However, these advances are quickly making their way into point-ofcare decisions (e.g., shared physician and consumer decisions about treatment plans).



There is no consensus on what big data means in healthcare. Depending on the stakeholder,
big data has different meaning, even within stakeholder classes. This makes achieving an
interoperable platform almost impossible. Of the many big data definitions in both scholarly
and grey literature, only one article was found that attempted to define “big data in
healthcare” big data refers in the healthcare context to longitudinal medical claims data for
millions of patients linked to their EHRs (Begley, 2011).



Consumers do not have enough trustworthy, credible information to understand the scope
and depth of big data and its impact on their health and healthcare.



Patient informed consent and privacy regarding the use of an individual’s big data are as
challenging to overcome as interoperability of HIT.



Data Scientist is a generic term that requires no unique skill beyond that of a statistician. In
fact, depending on one’s need for big data, a basic level of education will suffice (e.g., citizen
scientist).



Industry and marketing firms have dominated the proliferation of big data through
conference proceedings, marketing materials, white papers, and blogs.

35
Based on the grey literature, there were six dimensions to big data that conveniently began
with the letter “V”. Gartner, the information technology and advisory firm, captured the
industry’s attention by introducing the popular “3 V’s” of big data - Volume, Variety, and
Velocity. The table below (Table 4) provides an inclusive overview and characteristics of the six
dimensions of big data that are noted in various documents in both scholarly and grey literature.
CHARACTERISTIC

DEFINITION

High Volume (G)

Enterprises are awash with ever-growing data of all types, easily
amassing terabytes—even petabytes—of information.
 Turn 12 terabytes of Tweets created each day into
improved product sentiment analysis.
 Convert 350 billion annual meter readings to better
predict power consumption.

High Variety (G)

Big data is any type of data - structured and unstructured data
such as text, sensor data, audio, video, click streams, log files
and more. New insights are found when analyzing these data
types together.
 Monitor 100’s of live video feeds from surveillance
cameras to target points of interest.
 Exploit the 80% data growth in images, video and
documents to improve customer satisfaction.
Sometimes two minutes is too late. For time-sensitive processes
such as catching healthcare fraud, big data must be used as it
streams into an enterprise in order to maximize its value:
 Scrutinize 5 million trade events created each day to
identify potential fraud;
 Analyze 500 million daily call detail records in real-time
to predict customer churn faster
One in 3 business leaders don’t trust the information they use to
make decisions. Establishing trust in big data presents a huge
challenge as the variety and number of sources grows.
Value in healthcare is the health outcome per dollar of cost
expended (Porter & Teisberg, 2006).
A variety of formats as opposed to just one relationally
structured data set (Hopkins & Evelson, 2012).

High Velocity (G)

Veracity

Value
Variability

Table 4. Six Characteristics of Big Data, Including Gartner’s 3 V’s
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The review of the literature demonstrated that scholarly journals in Web of
Science/MEDLINE provided relevant scholarly works about big data in healthcare compared to
select grey literature. A possible reason for the lack of literature includes publication lags: grey
literature found in industry cycles through peer review much faster than scholarly journals.
Companies providing solutions in information technology, engineering, and other science-based
firms have a mission to drive revenue and can quickly publish marketing research and other
materials (e.g., white papers, conference proceedings, blogs, etc.). Companies have sought to
capitalize on a subject few outside of their disciplines understand. The literature review was
continuously revisited and refined throughout the course of this study for accuracy and relevancy
and to ensure adherence to required elements of the modified systematic review standards.
The next two subsections of this chapter are important themes that emerged from the
literature review: metadata and data scientist. A third theme, privacy, also stood out, but requires
a full research paper to do justice on this very important topic. The intent is to provide a brief
overview and discussion of these important themes. While I did not expect the key healthcare
stakeholder narratives to capture the full essence of these two themes, each topic serves as
important background information to the interpreted ‘story’ that this research study produced.
Metadata
At the very core of HIT interoperability is metadata. The Office of the National
Coordinator for Health Information Technology (ONCHIT) issued an advanced notice of
proposed rulemaking (ANPRM), which solicits public comments on the metadata standards.
Metadata standards provide guidelines regarding structure, values, and content (Zeng & Qin,
2008). The metadata standards under consideration relate to:
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Patient Identity Metadata – These metadata relate to patient identity and include: a
patient’s name; date of birth; address; zip code; and relevant patient identifier(s).



Provenance Metadata – These metadata would be used to provide information on the
“who, what, where, and when.” Provenance metadata would include: a tagged data
element (TDE) identifier; a time stamp; the actor; and the actor’s affiliation.



Privacy Metadata – Privacy metadata would include a policy pointer and content
elements descriptions such as data type (e.g., consultation note) and sensitivity (AMIA,
2011).
Metadata is foundational to healthcare data trustworthiness. Various sources of big data

are generated by all key healthcare stakeholders who have the potential to create unimaginable
amounts of data from structured and unstructured sources of data. Where administrative claims
data (e.g., financial, procedure codes, place of service, demographics, etc.) were once the
primary source of data for healthcare decision making, the underuse of unstructured sources of
data puts organizations at a severe competitive disadvantage. Data quality and origination loom
large in the reformed healthcare market. With competition for healthcare consumers and limited
financial resources, healthcare organizations, including hospitals, Accountable Care
Organizations, and technology vendors must share data and knowledge to remain viable.
Systems integration, or interoperability, of fragmented information systems is the conduit to
information sharing among stakeholders. While it is believed that the Volume, Velocity and
Variety of big data are unmanageable, data about data, or metadata, is growing twice as fast as
the digital universe as a whole (Burns, 2011).
Fundamentally, metadata helps interpret and transform data into information (Gudea,

38
2005). One kind of metadata is provenance (also referred to as lineage and pedigree), which
tracks the steps by which the data was derived and can provide significant value addition in such
data in-depth e-science projects (Simmhan, Plale, & Gannon, 2005). Metadata in the form of
provenance information records the how, where, what, when, why, which, and by whom of data
generated in a scientific experiment (Sahoo, Sheth, & Henson, 2008). Metadata provenance is
broadly referred to as a description of the origins of a piece of data and the process by which it
arrived in a database. Most implementers and curators of scientific and healthcare databases
would like to record provenance metadata, but current database technology does not provide
much help in this process. Databases are typically rigid structures and do not allow the kinds of
ad hoc annotations that are often needed for recording provenance in an EHR and personal health
record environment (Acar et al., 2010). Better understanding of how to create, harvest, and
exploit metadata is a very near-term problem to be addressed by today’s information
management professionals. New capture, search, discovery, and analysis tools can help
organizations gain insights from their unstructured data, which accounts for more than 90% of
the digital universe (Burns, 2011).
Data Scientist
The term data scientist is a generic term that includes business analyst, data architect,
engineer, and research analyst. Indeed, with the rapid increase in the Volume and Variety of
health information, clinicians that interact with information systems departments are in high
demand and the chief medical informatics officer (CMIO) and chief nursing informatics officer
(CNIO) are recent additions to the ranks of data scientists. Even with these developments,
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demand for data scientists has raced ahead of supply. The shortage of data scientists is becoming
a serious constraint in some sectors.
Roper (1988) suggested in his seminal article on data and health information that “the
science of healthcare evaluation, still in its formative stages, requires certain resources: money,
data, and people trained in the evaluative sciences, such as statistics, mathematical modeling, and
epidemiology” (p. 3). The data scientist has received an excessive amount of attention with the
emergence of big data. The definition of data scientist has many connotations. The National
Science Foundation (2006) identifies the following capabilities as core to the role of the data
scientist:


conduct creative inquiry and analysis;



enhance through consultation, collaboration and coordination the ability of others to conduct
research and education using digital data collections;



be at the forefront in developing innovative concepts in database technology and information
sciences, including methods for data visualization and information discovery;



implement best practices and technology;



serve as a mentor to beginning or transitioning investigators, students, and others interested
in pursuing data science; and,



design and implement education and outreach programs that make the benefits of data
collection and digital information science available to the broadest possible range of
researchers, educators, students, and the general public.
Harvard Business Review touted the data scientist as the sexist job of the 21st Century

(Davenport & Patil, 2012). The U.S. alone will need 140,000 to 190,000 people with deep
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analytical skills by 2018 just to keep up with the pace of innovation (Brown et al., 2011) and the
explosion of big data. As big data emerges as a driver of value (Porter & Teisberg, 2006) for
public and private sector companies across every industry, analytics is a competency required for
essentially every position.
Pryor and Donnelly (2009) identified four data analytic roles: data creator, data scientist,
data manager, and data librarian. They acknowledge that “in practice, there is not yet an exact
use of such terms in the data community, and the demarcation between roles may be blurred” (p.
160). In their definition of these four roles the crucial words “training” and “formal
qualification” are for the most part absent. Data creators are described typically as researchers
who have acquired a high level of expertise in handling and manipulating data; data scientists
appear to be working closely with data creators and may be involved in creative inquiry and
analysis; and, data managers tend to be computer scientists, information technologists, or
information scientists who have taken responsibility for the facilities necessary to store, access,
and preserve data. Data scientists understand analytics, but they also are well versed in IT, often
having advanced degrees in computer science, computational physics, biology, or networkoriented social sciences (e.g., social network analysis). Their advanced data management skill set
— including programming, mathematical, and statistical skills, as well as business acumen and
the ability to communicate effectively with decision makers — goes well beyond what was
necessary for data analysts in the past. This combination of skills, valuable as it is, is in very
short supply (Davenport et al., 2012).
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CHAPTER III. METHODOLOGY

Study Design
This section describes the research design, data collection methods, and analysis
approach used to conduct a phenomenological study using narrative (Clandinin, 2013; Amedeo
Giorgi, 2009; M Van Manen, 1980), with the aim of discovering important categories of
meaning about big data in healthcare through the insights and perspectives (Cyr & Reich, 1996)
of three key healthcare stakeholder classes. To allow the study participant narratives to remain
the focus of this study, a more detailed description of the research methodology can be found in
Appendix A.
In exploratory qualitative research, social phenomena are investigated with minimal a
priori, or presumptive, expectations in order to develop explanations of a phenomena (Guba &
Lincoln, 1985). I contemplated grounded theory or another theoretical framework, but decided
against doing so since exploratory qualitative research does not rely on the creation or adoption
of a conceptual framework where the abstraction of the subject to be studied may alter or even
not capture the most important characteristics to be analyzed (Guba & Lincoln, 1985). Rather
than being constrained by a structured framework, I chose to stay true to the tenets of
phenomenology, which allowed a cohesive ‘story’ to emerge from the frequent, dominant, or
significant themes inherent in the raw data (D. R. Thomas, 2006). As such, this method required
me to be able to thoughtfully, and unbiasedly, interact with the participants of the study and to
better understand their individual and collective experiences (Creswell, 2009).
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A purposive sampling strategy, which allowed me to exercise my expert judgment with
inclusion and exclusion of study participants, was used to identify the best healthcare
stakeholders to provide “thick descriptions”(Creswell, 2009; Geertz, 1973; Guba & Lincoln,
1985) about the big data phenomena in healthcare. The literature review complemented the
discussion, description, and interpretation of the participant’s stories.
Study participant narratives were analyzed using a general inductive approach for
qualitative data analysis (D. Thomas, 2003). This study produced three important contributions
to the understanding of big data in healthcare: (1) thematized experiential knowledge about the
meaning of big data in healthcare; (2) produced an agile definition of big data that can be
deployed across all industries; and, (3) added to the dearth of scholarly qualitative literature
about the phenomena of big data in healthcare for future research on topics including the
diffusion and spread of health information across networks, quantitative studies, standards
development, healthcare value chain analysis, and health policy.
As a rising scholar-practitioner who has been deeply immersed in many traditional and
innovative practices of generating evidenced-based methods in healthcare including integration
of patient preferences (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996), randomized
clinical trials, and quasi-experimental studies, my current interests in big data in healthcare are
exploring phenomena through multidisciplinary narratives (e.g., government, providers, and
consumers) and subsequent scientific analysis of the collective data to ultimately inform further
health policy. The results of this study confirm a natural collaboration and research agenda
between the disciplines of information science and health policy, as medicine adopts the
discipline of information science (Hood & Friend, 2011; Lester, Zai, Grant, & Chueh, 2008).
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Such an approach resonated with my curiosity about the social and lived experiences of
individuals who use and rely on big data as information and knowledge to meet their
professional and organizational objectives. Borgman (2012) suggests “that by studying how data
are created, conceived, handled, managed, and curated in multi-disciplinary collaborations, we
can inform science policy and practice. Data are the ‘glue’ of collaboration, hence one lens
through which to study the effectiveness of such collaborations is to assess how they produce
and use data” (p. 7). This study was designed to answer the following research question:

Research Question
Q1: Within and across the narratives of three key healthcare stakeholder classes, what
are the important categories of meaning or current themes about big data in healthcare?

Study Influencers and Rationale
In addition to the construct of epidemiology, my approach to this research study was
initially influenced by a study design used in Cyr and Reich (1996), Scaling the Ivory Tower:
Stories from Women in Business School Faculties, which provided powerful detailed narratives
about “women’s personal choices, trade-offs, risks and chances that unfolded as they built their
careers in competitive academic organizations” (p. 1). Independently, each story chronicled
women in various stages of their academic career: early-career, mid-career, and leaders in
academia. Most compelling to me is that aggregately, their stories were the impetus for action,
policy change and influence for other women in academia and other fields facing the same trials
of overcoming personal and professional challenges and the satisfaction of fulfilling dreams.
Summaries of each story followed their narratives and a brief snapshot of each contributor,
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recurrent themes, interesting issues or challenges, and the lessons learned from their collective
experiences was provided in a final summary chapter. This important study provided a
“methodological blueprint” to guide my study approach to answering the study’s research
question. I am hopeful I executed their methodology with the same rigor and preciseness.
As I began a deeper dive into the practical application of big data in healthcare, I was also
strongly influenced philosophically by an emerging social dimension to medicine: narrative
medicine. Traditionally, healthcare organizations have used troves of quantitative data (e.g.,
laboratory values), qualitative data (e.g., text-based documents and demographics), and
transactional data (e.g., a record of medication delivery) to understand a clinical phenomenon of
interest. Narrative medicine “describes the practice of medicine supported and reinforced by the
ability to listen to, absorb, and act on stories” (Charon, 2006, p.1). I contacted Dr. Rita Charon at
Columbia University. Dr. Charon is considered the foremost authority on narrative medicine. I
believe our conversation was mutually informative; her perspective influenced my ideology
about healthcare narratives which is fundamentally different from narrative medicine, which Dr.
Charon describes as “a private conversation between a patient and a skilled physician.” I posited
that healthcare narratives have a theoretical orientation that applies narrative inquiry skills
across and between all healthcare stakeholders involved. Narrative skills are those that enable
one person to receive and understand another person’s story, including the skills needed to listen
actively, to understand what another person’s story means, to attain a complex and accurate
interpretation of the story, and to grasp the situation of the other person and their perspective, in
all of its complexity (Roscoe, 2009).
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The next chapter provides details on the data collection procedures and each study
participant “lived experience” of the big data phenomena in healthcare.
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CHAPTER IV. DATA COLLECTION

This chapter contains a review of the data collection procedures and the data collected
from the semi-structured interviews of the nine study participants. For an in depth description of
the methodology, see Appendix A.
The unit of analysis is the narrative – narratives of individuals that have shared
experience with the phenomena (Creswell, 2009) of big data in healthcare. Study participants
were identified through a purposive sampling method. Semi-structured interviews were
conducted with a total of ten key healthcare stakeholders: three policymakers; three providers;
three consumers (advocates); and, one healthcare leader with a global perspective across the
three healthcare classes (Figure 4). However, the global perspective interview (BasInt1) was
omitted because it did not meet the established parameters described in the Interview Guide and
eventually created a fourth stakeholder category that fell outside of the study design. Thus, nine
interviews were used as part of the data explication, results, and discussion.

Sampling Frame
Boyd (2001) regards “two to ten study participants” (p. 93) as sufficient to reach
saturation and recommends “long interviews” (p. 95).

Figure 4. Interview sequence of selected healthcare stakeholders
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Most studies of narratives are based on small samples, fewer than 50 cases (Bernard,
2006), simply because there is so much work involved. I chose cases on purpose – not randomly
– dividing the sampling frame into three strata (e.g., government, providers, and consumer
advocates). I selected three study participants within each stratum to capture their experiential
narratives. This method allowed me to discover, describe, and interpret in detail themes,
challenges, and categories of meaning that were similar and different across the subgroups
(Teddlie & Yu, 2007). This sampling method is not to be confused with quota sampling, in
which the researcher decides on the subpopulations of interest and on the proportions of those
subpopulations in the ﬁnal sample (Bernard, 2006). This was a small study that fit the purposive
sampling approach.

Snowball Sampling as a Supplemental Strategy
When necessary to mitigate the risk of study participants falling out of the study, I relied
on snowball sampling, which produced a sample of study participants through referrals made
among people who shared or knew of others who possessed the same characteristics that are of
interest to this research (Biernacki & Waldorf, 1981). Snowball sampling as a supplementary
sampling strategy was invaluable as it allowed me to capture a geographically disperse study
participant sampling frame but also required me to slightly modify the study design’s data
collection method from exclusively face-to-face interviews to a mix of both telephone and Skype
interviews. Such a modification was appropriate because the study did not require me to elicit
emotions and body language through observation – only study participant narratives.
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Recruitment
Key informants are people who know a lot about their culture and are, for reasons of their
own, willing to share all their knowledge (Bernard, 2006). It is critical to be certain of the
knowledge and skill of the informant when doing purposive sampling, as inappropriate
informants will render the data meaningless and invalid (Tongco, 2007). During the recruitment
phase, I made initial verbal inquiries through email, phone, and in-person, with sixteen potential
study participants who met the following selection criteria (Table 5).
POLICYMAKER
Senior Executive
Service (SES) (ES –
Level I - Level V)
Upper management

Title

PROVIDER
MD or DO
Register Nurse
Manager
Hospital Executive

CONSUMER
Director
Executive Director
Chief Executive
CIO

Responsibility

Provide leadership
Provide senior
Provide executive
in a federal or state executive leadership leadership in a
healthcare agency
for a large integrated recognized
that provides or
delivery system,
patient/consumer
supports the
accountable care
entity; Advocate for
development of
organizations, or
healthcare issues or
national healthcare hospital
part of a multipolicy
advocacy agenda
General Criteria  Be of at least 18 years of age and be willing to participate in a
across the three
qualitative research study;
stakeholder
 Have at least ten (10) years of work experience in a healthcare
classes
related field;
 Currently represent a federal government, provider, or consumer
advocate organization, in the healthcare sector;
 Possess a working to expert knowledge of “big data” and
“healthcare” and possess in-depth insights into the current
challenges and future opportunities for big data in healthcare;
 Fully participate in both initial and follow up interviews;
 Be willing to speak freely and engage in a conversational, twoway in-depth interview sharing rich, detailed narratives about
professional “lived experiences” in big data and healthcare.
Table 5. Selection criteria based on a purposive sampling strategy
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CHAPTER V. KEY HEALTHCARE STAKHOLDER ‘STORIES’
To maintain the confidentiality of each study participant’s name and professional
organization, I assigned a unique code for analysis and a pseudonym generated by an online tool
to each study participant and provided a general description of the type of organization where
each is employed. Each study participant’s pseudonym is found under the title of their story. To
further protect their identities, I deleted any references to their educational institutions, board
appointments, research centers, and proper names of colleagues mentioned in their respective
narratives. I also omitted references to geographic locations that appeared in the narratives.
Before offering the key healthcare stakeholder narratives, below is a brief profile on each study
participant categorized by their respective key stakeholder class.

Study Participant Profiles
Government Stakeholders
Mr. Peter Erazo is a director at a federal government agency. His role is to provide
leadership, strategic vision, and execution around data, data analytics, and data dissemination.
He has held a variety of healthcare roles.
Dr. Myles Renneker is a director at a federal agency. After completing medical school, he
was assigned to work on projects dealing with quality, patient safety, and electronic health
records. Beyond his medical education, he earned an M.B.A.
Dr. Matthew Blocher is a senior fellow at a government agency. His education is mostly
in mathematics, physics, and chemistry. After graduation he began working in the life sciences
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industry and has been conducting research for more than two decades. As a healthcare thought
leader he directs various scientific projects.

Provider Stakeholders
Dr. Nickolas Thompson is chief clinical information officer (CCIO) of a regional
integrated delivery health system. His primary responsibilities are to sequence the health
system’s technology and optimize the data analytics of the organization.
Dr. John Boyken is an associate dean at a medical school. After medical school, he
became very interested in informatics and computers and the role that information technology
and information management would play in healthcare.
Dr. Barry Jensen is the chief quality officer at an integrated delivery system. He leads
research that has an immediate impact on care delivery operations within the delivery system.

Consumer Stakeholders (Advocates)
Dr. Darwin Watkins is executive director of a patient-centered healthcare organization.
He earned a medical degree and a master’s in epidemiology. After epidemiology training, he
became the director of a research department at a regional health maintenance organization.
Dr. Arnold Daniels is executive director of a non-profit patient advocacy organization
that helps patients find money to pay for medical co-pays and premiums. He completed a doctor
of pharmacy degree and has a master’s degree.
Dr. Frances Milburn is medical director at a patient-centered quality association. His
responsibilities include oversight of clinical informatics and quality improvement. With a public

51
health background, his medicine background complimented work in chronic illness care from a
population health perspective.
The following table (Table 6) is a brief summary of study participant’s profiles:
CLASS
Government
Government
Government
Provider
Provider
Provider
Consumer
Consumer
Consumer

TITLE
Director
Director
Senior Fellow
CCIO
Associate Dean
Chief Quality Officer
Executive Director
Executive Director
Medical Director

ORGANIZATION TYPE
Federal Agency
Federal Agency
Federal Agency
Integrated Delivery System
Teaching Hospital
Integrated Delivery System
Patient Research
Nonprofit
Quality Improvement

EDUCATION
Statistics
Medicine/M.B.A.
Math/Physics
Medicine
Medicine
Medicine/Physics/Biostatistics
Medicine/Epidemiology
Pharmacy/Research Methods
Medicine

Table 6. Profile of study participants occupation and education
Study Participant Narratives
The following study participant a priori narratives on big data in healthcare are presented
in the study participants own words. The interview data was abridged without losing the essence
of their stories. To reiterate, pseudonyms and generalizations of people, places and organizations
were used to strictly protect the identity of each study participant. Narrative titles were chosen
from the study participants own words that best demonstrated the spirit of each ‘story.’
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Government Stakeholders
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“A Whole Heap of 1’s and 0’s”
“Peter Erazo, M.S.”

Professional and Academic Experiences
Mr. Peter Erazo is a director at a federal government agency. His role is to provide
leadership, strategic vision and execution around data, data analytics, and data dissemination.
He’s held a variety of healthcare roles.

Meaning of Big Data
I think that frankly the expression of big data has become a little overused. I personally
prefer the term “smart data,” but if we are talking about big data it’s traditionally defined by
volume, variety and velocity. Again, I think for that breakdown I think you can have many,
many important data driven activities that contain some but not all of these. I think obviously the
rapidly emerging technologies in this area do allow people to crunch ever larger numbers of data
in helping us bridge the gap between structured data analysis and unstructured data analysis,
which I think is very important.
I think big data in healthcare can manifest itself in a number of ways. We can get the data
to market quicker whether that’s for internal analysis or distributing it to people externally. So,
big data could mean getting researchers data that is weeks old instead of years old. Big data
could mean routinely giving providers granular information of the beneficiaries they treat instead
of shrugging your shoulders and not being able to do anything about it. Big data could be large
scale hypothesis free data mining to maybe find an insight to correlations that weren’t available.

54
Big data could mean the integration of administrative clinical and other patient generated data.
So, it means lots of things in my mind.
I think the jury is still a little out, again to the extent that big data helps inform clinical
files as far as effectiveness and real operational type medical decision making. Then, yes, I think
it can help evidence-based medicine. As far as the attributes of big data that are different from
traditional analysis, again, I think it’s the ability to quickly secure in an agile manner to combine
different datasets and have developed insights that we may not have from administrative data
alone. So part of that is storage and part of it is new data matching techniques.

Medicine as an Information Science
I’m not sure I’m qualified as a non-clinician, but yes.

Healthcare Big Data Drivers
Practically one of the biggest drivers of big data in health care is the Affordable Care Act
because what it does is places data and the ability to harness and leverage data at multiple points
throughout the healthcare ecosystem at the center as opposed to at the trenches. Data used to be
a byproduct of healthcare delivery. Now for successful healthcare delivery and healthcare
transformation, data, it used to be you could almost argue it needs to be the center with
providers and beneficiaries orbiting around it or at the very minimum it needs to be on the same
level as what was previously considered the other core components in healthcare delivery,
clinical knowledge, etc.
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Sources of Data and Data Scientists
The sources of data that we use are pretty varied even though I’d say that administrative
data is the foundational component. It actually meets the volume and the variety criteria we use
records for multiple parts of the Medicare system, the Medicaid system, the enrollment data,
hospital data, physician data, assessment data, laboratory data, Medicare data, and Medicaid
data. I know we’d obviously be interested in adding other paired data to the mix. Then there’s
survey data and there is some pretty rudimentary Meaningful Use attestation data but we don’t
have any actual Meaningful Use data yet.
We’re working hard to integrate quality data for the various cooperative reporting
mechanisms and it’s important we get a reliable clinical data stream we’d obviously be interested
in incorporating that. So, that’s what we work with. Again, everybody’s conception of big data
is different.
I have people who manage big data for me. I have a team of skilled data scientists who
are part IT knowledge, part systems integrator, part subject matter experts, part analyst
programmer; a data scientist isn’t necessarily one person. You have a data scientist practice in
which people specialize but talk to each other but you might have somebody doing the IT
integration stuff and another separate subject matter expert and another programmer. So to put it
in perspective, again, I know that some people consider big data not to be “big” until it’s in the
trillions, but we manage 400 billion discrete pieces of information that talks to each other pretty
well and pretty efficiently, and it’s growing by about four or five billion data records a year.
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Organizational Challenges
I think the main challenges are cultural and leadership for this agency to truly transition
to data-driven decision making. The impetus or the commitment is at the very top and its other
people’s sense that the commitment is not there. Ultimately, data driven decision making won’t
gain traction. Another challenge to data driven decision making is that occasionally government
agencies are not necessarily in control of their own destiny and they may be subject to external
political pressures that render data driven-decision making moves. These are the biggest
challenges.
Unintended Consequences
I think one of the unintended consequences in the case that I have seen is that people
think that big data is a panacea and again this gets back to the mix of human capital that you
need to integrate big data successfully into your enterprise. I think there’s a mistakenly held
belief, not necessarily at my agency, but you know among other aficionados of big data that if
you just install a minute stack that everything will magically be solved.
I think another unintended consequence is purely relying on machine learning without the
application of subject matter expertise and also the application of a clearly defined set of goals
can lead to an organization of big data actually distracting an organization from its core goals
and outcomes.
Big Data’s Future in Healthcare
I think everybody’s hope is that in five years’ time, there will be widespread integration
of administrative, clinical and patient generated data that will be available through big data; it’s
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assuring that the right person gets the right data at the right time and the right format for them.
So it will be a big plus for analytic purposes directly to patients if that’s appropriate to providers,
etc. while obviously obeying all privacy laws and regulations. So the one thing I know very little
about is that people tend to get excited about biometric data. I’m not even sure I know enough
about biometric data to get excited about it. But I know when people talk about big data they
mention that a lot. I think also integrating device interoperability and the data that comes from
medical devices is potentially very important.

Metaphors and Symbols
People like buzzwords but there’s no question that we’re dealing with great volumes and
types of data than we ever have before, and we have the tools to deal with it. I think that the true
challenge is you can have all the data in the world but until you translate it into actionable
information, it’s really just a whole heap of 1’s and 0’s.

Closing Thoughts
I think big data is an area of incredible promise for healthcare that is also currently
fraught with hype and over promising. So there will be hits, there will misses, and hopefully
again in five years’ time, we’ll have a lot better idea of what exactly we should be doing with all
this data.
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“Mapping the Knowledge Base of Medicine”
“Myles Rennaker, M.D.”

Professional and Academic Experiences
I’m a physician by training. I had a mandatory service requirement and was assigned to
work on projects dealing with quality, safety, and electronic health records. I became very
interested in that and I went to business school instead of going back into residency thinking that
there were many things that were going to change about healthcare, including increasingly
information technology changing healthcare which was apparent even back in those days and the
whole quality issue became fascinating to me – how you actually measured clinical performance.
I’m interested in the issues of quality, safety, and how you can use IT to enhance the quality and
safety of care including through electronic health records.

Meaning of Big Data
What big data means to me is just using information technology to analyze databases that
have large units of whatever it is, whether it’s patients or accounts, or customers – just getting
beyond small scale and having very large volumes of data to analyze. Nobody’s ever defined it
for me. I’ve heard it used a lot and I guess that’s what I’m thinking it means. I would also say
that I never thought about it until you asked me. I just assumed that I sort of knew what it was.
The advent of our increasing capacity to store things and the processing speed has
allowed us to do things that were very hard to do even a fairly short time ago. I can remember
working with computers and processing stuff where it would actually go overnight and at least in
the realm I’m familiar with you don’t have to do that very much anymore, you can process so
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many transactions, so many records in such large databases and it’s so fast that I think that has
ushered in the concept of big data. I do think that to some extent big data has become the latest
buzzword, the latest fad, the latest craze, and to some extent I don’t know how much new there is
in big data other than the fact everybody is getting excited about it. At many conferences they
talk about big data as if suddenly somebody invented big data and then came along and it’s a
new thing.
It really is an evolutionary thing and I think that it has a potential to perpetuate a myth
that persists in IT generation after generation: That if somehow information technology can sell
substance problems that people haven’t put their minds to, the computer just does what you tell it
to do and if you haven’t solved the problem of structuring the analysis right, the computer is
going to do it for you.
An example is the electronic health record where we’re very poor at structuring clinical
information so we come along and we turn everything into electronic form and we somehow
expect that electronic records to solve all our problems and it doesn’t do that unless you think
through how you’re going to structure the data before it goes in and what everybody else is
doing. You’re going to have big data and right now there are over 2,000 records that have been
certified by CCHIT as meeting the Meaningful Use Stage One criteria and they’re all written in
different languages, different interfaces, different databases and they can’t talk to each other. So
it’s kind of a mess.
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Medicine as an Information Science
It’s clearly an information science. If you’re going to treat a patient you’re going to use
symptoms of the patient, you’re going to use physical findings from an exam, you’re going to
use laboratory values, you’re going to use imaging, and those are all data. But at the same time
they don’t all get put into a computer and processed to get the answer. The computer is not a
human brain and while we have computers that attempt to match many of what people do, much
of what doctors do we don’t have computers that can do all that doctors can do and that final step
of processing, especially in complicated cases really needs to take place in the human mind, but
it is processing of data for sure.
So I would say yes it’s an information science, but it’s one that has not been entirely
encompassed by man-made; it’s aided by man-made IT.

Healthcare Big Data Drivers
I don’t think big data has had the kind of impact in healthcare that it’s had in other
industries and that doesn’t mean I don’t think it can down the line, but I think we haven’t
structured the information in healthcare to the extent necessary to allow big data to have the kind
of impact it will potentially have on the future and it’s not an indictment of the healthcare
industry. So many people are critical of healthcare and say healthcare is in the 18th Century and
healthcare is extraordinarily complex. I was giving an international speech in Europe. While I
was talking about measuring quality and safety somebody got up and asked me, ‘well why don’t
you do it just like a bank has an ATM,’ and I didn’t laugh but I felt like it. I just said because
everything isn’t an integer, it’s not as simple as a balance sheet or income statement, or a
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checking account. It’s a whole different ball game and the relationship between processes and
outcomes in healthcare is not totally defined. You can give the same drug to two patients in the
same way, the same age, the same diagnosis and they’ll react differently, and it’s just we’re not
making patients.
I mean in most other industries, the service is defined by the industry or is produced by
the industry, we’re dealing with patients that are highly complex organisms which in some
respects, many respects, black boxes. We know something about them, but we don’t know how
they’re going to react to everything and they have many complicated problems and it’s all
underneath the surface and we have to do diagnostic tests to get a little bit of it. So healthcare is
enormously complex and so it’s just a whole different realm.
It’s not like big data allows the retail industry to behave differently just by the volume of
processing because we’re still not processing things that are very elementary in other industries
because we haven’t structured the knowledge to be able to go into the computer. For instance,
I’ll give you a concrete example, let’s say we have three different electronic health records, three
different offices and they get three patients in there with abdominal pain, an elevated temperature
and elevated white count have tenderness in the upper right quadrant of the abdomen, well those
are the classic signs of appendicitis. So the way that information first of all, most of that
probably gets put in the lab IOB and the temperature will be in there, the patients symptoms will
be free text, it won’t be probably won’t be in a defined field and there’s no program in there that
says this is the definition of an acute abdomen or even with the probability of 95% or whatever,
it’s the definition of an acute abdomen and therefore you should think about appendicitis. Those
laboratory values will just sit in the lab area of the electronic record. The temperature will sit in
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the vital sign section, the narrative will sit in the narrative, nothing ties them together, there’s no
way to compare, there’s no way to go into a database of thousands of patients and say how many
of them had an acute abdomen. The data aren’t structured that way. Could they be? Yes. So I
think big data is not able to move things in healthcare the way it is in other industries.
Having said that, the drivers that are pushing IT, getting us more into big data that will
invite us to try and answer the questions that will allow computers to be more helpful are
certainly driving costs. The question, healthcare cost is making people say we’ve got to marshal
information technology to make this whole power of data more cost effective and produce more
for our providers.
Then the increase in technology, the improvements in technology for other purposes as
well as in medicine are really, really good. The improving technology is making it easier to do
the things that you need to do in healthcare to be of more assistance to the people providing care.
So I think that’s changing. What is not happening in an organized structure way is to try to
analyze clinical medicine and represent it electronically in defined fields so that everybody can
talk to each other and we could represent all the complexity in medicine. I can’t ever foresee a
time when you won’t want to have the ability to collect narrative for at least some of the
electronic record. But we need to get, right now probably the majority of most records, it’s
certainly true, the majority of most clinical information records is in narrative form and you can’t
use big data on. So we need much more of a structured knowledge base and that work isn’t really
going on in a very organized way right now.
I want to get people to use the same definition for enough time so that we can aggregate
data, match it up against reality and then refine the definition so that the sensitivity and
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specificity of it, the accuracy, when the true positives and not a lot of false positives, not a lot of
false negatives, so that all gets worked out by making the definition very precise and having
people record it that way. It’s the opposite end from natural language processing which says put
it down in a precise or sloppy way we don’t care about. We’re going to go in and search for
whatever we can find and we’re going to hopefully be able to find things that are similar with a
clear degree of accuracy. I want to go on the other end and say we’re going to be very precise
and then we’re going to use that precision to refine the definition over time based on big data.
I’ve actually been engaged in such a process. The first thing you found out about is
whether the standards worked or not, and so you could actually refine the measures by
processing large amounts of data against those standards and validating it with the actual real life
circumstances and that way the definitions could get more and more precise over time. We need
to go through the whole knowledge base of medicine that way and map it. No one is even talking
about doing that right now so we’re a very long way from getting medicine to the point where we
can do the kinds of things that they can do in other industries where the structure of data is
simpler.
Sources of Data and Data Scientists
All of those skills of epidemiologists, biostatistician, physicians, all of those things are
important skills. What I found in the quality area is there’s a kind of unique skill of being able to
think logically and distill the measurement process into binary form so that words like
‘consistent with’ or you know anything like that can’t be measured. You have to find a way to
triangulate what you’re after and use binary thought processes to try and reduce highly complex
situations to something that can actually be measured in concrete terms. So I don’t know if that
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makes any sense but it’s sort of like you look at the beautiful color that you have on your module
on different colors and it looks analog really, but at the end of the day you got a machine
language that’s all 1’s and 0’s. When you measure quality, everything has to be in 1’s and 0’s at
the end of the day. Then you have to realize that it’s as good as you can get with it. You always
have to be humble about whether you’re right in an individual case or not, but the better you get
with measuring so you can at least be right about trends and populations.

Organizational Challenges
I have found it difficult to find clinicians who have the ability to stop practicing medicine
and to turn around and think about things in very objective binary ways. It’s not impossible but
it’s hard. But one of the things when you’re looking at quality, you’re basically looking
retrospectively. If you want to do big data, it could be populous in real time patients, but then
you have problems with denominators and patients that are evolving. If you want to look at a
population where it can be static and you can have denominators that allow you to draw
conclusions, its material that’s going to have to be completed at some point in time and to get
people to look retrospectively and think that way instead of thinking prospectively on the terms
of uncertain conditions. That it might seem it would be easy to do, but apparently it isn’t so easy.
For instance, you can’t use pathology reports to find out whether a surgeon made the
right decision to operate because you didn’t have them at that time or she didn’t have them. You
have to use the presenting symptoms and lab values and so on and so forth, it’s a time the
decision had to be made to operate or not, so that may sound simple but I’ve actually tried to set
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standards with people to say things like just go use the pathology report, you can find out
whether the operation was needed or not.
Big Data’s Future in Healthcare
My hopes for big data in healthcare would have to do with the fact that I hope we have
common standards for how to represent the major clinical problems that patients have, both
processes and outcomes of care, so that when electronic health vendors revise their programs,
they write to those common standards and data get collected in defined fields in electronic
records in a way that we can begin to compare apples to apples and we can begin to understand
that what we’re doing with treatments across the board because the results from one record can
be compared with results from another record.
Also, that incidentally would make transferring information from one provider to another
a lot easier. Right now, we have thousands of different health records and then a handful of
other major vendors and then a whole bunch of do it yourself. Overall, there’s just an enormous
variety of electronic records out there that are not interoperable and can’t produce information
that can be benchmarked or compared or learned from really. So my idea would be that
information could be moved more easily, could be benchmarked, compared, trended over time
and I don’t think that’s unique to me – everybody has that vision. But I think it’s going to take a
little longer because I think the complexity of structuring the knowledge base of clinical
medicine is a job that we haven’t even defined how to do that job yet. Nobody has said much
about doing it in a regular way.
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Closing Thoughts
I have one last thought and that is in healthcare we tend to spend a lot of our time
analyzing healthcare data that exists in electronic form knowing that it’s incomplete and
inaccurate to do the job, mainly billing and administrative information and sort of throwing up
our hands and saying we know the analyses aren’t very complete because the billing data doesn’t
have everything. But it’s the only data we have so we’re going to use that and we’re going to
base judgments on it. Since the billing data represents probably some tiny fraction of 1 or 2% of
the clinical information about a patient in any setting, those data are not sufficient to make the
kinds of judgments that one needs to make in terms of quality, safety, reimbursement, or policy.
So I think that when we get to the point where we define the data we need to then figure
out how to get it in an efficient and effective way. We’ll be far better off than saying okay what
data do we have, how can we shoehorn that in, or try to stretch it to make what we need to do.
So on defining what the objective of whatever endeavor we’re in, whether it’s quality or safety,
or policy, defining the objective then defining the data that we need, the questions that we need
to answer in order to drive that objective and then getting the data to answer the questions, doing
so in that order instead of taking the data that we have is an essential step in moving this whole
field forward.
We have been churning in terms of analyzing, re-analyzing, and making more and more
powerful sophisticated programs to analyze administrative data for 30 years now and we haven’t
really moved along very well because the essential information you need isn’t in electronic form.

67
“My Big Data – Your Big Data”
“Matthew Blocher, Ph.D.”

Professional and Academic Experiences
My education is mostly in mathematics, physics, and chemistry. I graduated college and
worked in the healthcare and life sciences industry and have been working in that field in one
way or another ever since. It wasn’t a trajectory that was straight into the medical field, but
physics, mathematics, problem solving, handling data, and understanding analysis is one of those
skills that you can apply to just about anything. It’s one of those things full of interesting doors
that opened and once I got into it and really understood what could be done, it was a lot of fun.
I was really into the mathematics because it was much more rewarding.
I started out primarily as a drug discovery analyst, a person who was doing computer
aided drug design in a lab and helping other researchers do their research. Basically, I did the
computational part whether it was designing drugs or explaining how proteins interacted and
doing simulations. I quickly understood that one of the biggest issues that I had interacting with
people was trying to explain the amount of data that they had and how much I generated to them,
so I started looking into visualization as well and got more into the graphics and visualization as
I tried to communicate more and more information to the investigators.

Meaning of Big Data
I’m going to be like a lot of the folks that I’m reading on a lot of the blogs right now. Big
data has become I think an over-bloated word. What I mean when I say big data is ingesting and
integrating lots of data, lots of complex data that may be able to be used to answer questions
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either more rich questions, or answer questions more deeply and get down to the causes as
opposed to just kind of scratching the surface. I’m literally interested from the etiology all the
way down to the molecular and cellular levels. I have data coming in about your age, your
background, your genetic background, hopefully the microbiome and all of the bacteria that live
inside of you. How do those interact? When I start looking at not just the data, but all of the
possible connections between all of the data, then I have a huge explosion of the data space that I
need to explore to be able to find answers to the questions that I’m asking and trying to eliminate
red herrings and false starts quickly. To me that’s big data.
If I can answer those questions, it can then lead me to more relevant questions of causes
and the etiology of the disease. Once I understand, if a particular gene is mutated in a way that
isn’t necessarily obvious, that it causes the problem but it leads to something two steps down in
its pathway, I now can develop a drug against that and correct that disease. That’s something
that’s important and right now we’re not able to easily mine that. I’m searching for the holy grail
of biomedical research, to be able to go and say I can find those hopefully, true associations and
then we can ask the critical question that really is, if you will, the question to be able to address
that disease.

Medicine as an Information Science
I would say that information science pre-dated medicine and allowed medicine to
prosper. Until you were able to collect evidence objectively and to classify that in terms for
differential diagnosis, the idea of classification of information and really the application of what
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your definition of information science is actually allowed, in my opinion, the development of
medicine. So of course the answer is yes; it’s absolutely an information science domain.
I’ll take some of the examples that we’ve gotten recently and trying to get into. That kind
of streaming data coming in, that kind of availability and the fact that it’s the human view of the
data and it’s transferring, it’s gaining knowledge out of that data, transferring it to the human so
that the human can actually do something useful with it. At the same time there’s a cultural shift
going on where people are much more willing to share it.
You know it was taboo to talk about things like that let alone put it on a public space
where the whole world can get to it. There’s a real shift where people are much more willing to
post their genomes online. I could just go to Amazon and pull it down and do an analysis, but
that’s clearly what a thousand genomes project and now you know the 10,000 genomes project
and all the other projects are going. People are now making data available in the hope that
somebody can come along and use it in a much more meaningful way. Further, we’re now
recognizing even more acutely that it isn’t the professional scientists that will always find that
link. There are other people out there that are citizen scientists and allowing them to have access
to this data as well. They may come up with a solution that no one ever thought of.

Healthcare Big Data Drivers
I think there are a whole lot of drivers to this. The data complexity, the data volume is
increasing and the richness of what is there is increasing to go out to ask questions we never
could ask before. We’re also collecting a lot of junk but clearly that’s the big deal, right? You go
gold mining and it’s not all gold.
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I think genomics and the ability to do sequencing is the first statement of it. I think that
monitors that have come from telemedicine are really driving that as well. I no longer have to
own all the computational facilities to be able to store my data and to analyze my data. It can be
distributed around the globe and I think that that’s driving the decision for people to both collect
and store a lot of the data. I think that clearly the internet is a huge factor. We also are have an
aging population that grew up relatively privileged and they’re viewing mortality differently
now.
Cancer and other diseases are big problems and I think too that the change in lifestyle we
have where we’re starting to see metabolic diseases are much more prevalent in the world.
We’re starting to see what were at one time typically western diseases or health issues becoming
a global problem. A problem that was let’s say antibiotic resistant, the disease that occurred in
some small country in Africa that people in America didn’t care about it and now all of a sudden
within 12 hours that disease could be sitting here in New York LaGuardia Airport and spread
across the United States just like SARS. I think that was a giant wake-up call for people. So
we’re realizing that focusing just on a small area is not going to solve this. The problems are
global now and the data has grown globally.

Sources of Data and Data Scientists
I bristle just a little bit at the term ‘data scientists’ because every scientist whether they’re
a professional scientist or not is a data scientist because a scientist without data is a philosopher.
So I understand what people are saying. But at the same time it kind of lets people off the hook
that if they’re doing science that means that they don’t mean data. So going back to where does
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data come from? We generate a lot of data here and I’ve been talking about a data tsunami
coming ever since about 1999-2000 as we were just getting ready to see the human genome
project made publically available. We were getting lots and lots of data coming in from the
genome sources from that point and we were ingesting it and trying to be able to analyze it at
that point. You also have MEDLINE/PubMed, you have the National Library of Medicine has a
ton of information that they store and they serve up free to the public. You’ve got a lot more
sources coming in now, such as I said in the Human Genome Project, you’ve got the Human
Microbiome Project, you’ve got European projects, even the Chinese now are starting to
contribute and make their data available. So you’ve got a lot of information coming in from just
the research world, but I think the healthcare world is starting to throw information out there as
well and I think people making their health histories available through direct consumer
marketing like at 23andMe.com where you send in your DNA and they start giving you
information. People can argue whether or not that’s a good thing or a bad thing. Of course
everything can be abused in one sense or another so you know there’s much more of that risk.
And if you have children and there’s a genomic disease or whatever I think people are just much
more aware and motivated to go in and try to explore. So I think that the source of the data is
coming from everywhere.
I think that we’re starting to see the boundaries of the different sciences break down
which is a good thing. You know the people used to be in either medicine and research and
biology or another discipline. Now it’s crossing back and forth. Chemistry crosses back and
forth; physics comes in and crosses. There’s a lot more information now for people coming in
and bringing in physics information into what goes on in oncology and what goes on in various
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other fields. Cross fertilization is bringing new views into the questions that we ask and the
answers that we can get.

Organizational Challenges
Organizations don’t want to share and we’re not necessarily incentivized to share. I think
the monetization of big data causes some biases and perhaps maybe even causes certain things to
be left out which might be critical, even in a large federal organization. Just remember a large
federal organization is made up of people and you’ve got people who are trying to advance their
career, they want to keep their job, they want to grow their lab, they believe their research is at
least as important if not more important than everyone else’s, so they want to drive that. That
means having a competitive advantage over somebody else and in today’s world that is
information and sometimes that’s data, and especially if I haven’t mined all of the data;
therefore, I want to hold onto that data forever because there may be another nickel I can get out
of it. That’s an unfortunate view the world that’s short-sighted in my opinion but then that is
human nature and I understand it.
All too often, the more data we have, the more fodder we have to beat it into submission
and say what we wanted to from the start. Organizations, like people, suffer from such biases and
challenges. Big data can also be used to open new areas to question and suggest new alternatives.
People have shown that, in the case of ulcers, that there’s a bacteria involved. We get caught in
research bias and so we get rushed. I mean you can take big data and you can use it with your
blinders on to prove a lot of different things, or you can take the blinders off and be surprised.
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So we all too often have our blinders on. But I think it’s mostly, even in a large organization like
the federal government because it’s made up of people.

Data Sharing
We do share, but in my opinion we don’t share enough. No one has the answers by
themselves and sharing data, sharing experiences, working together, working across in
collaborations is a way that we really drive findings and unexpected findings where you didn’t
realize that ‘A’ and ‘B’ were connected because I’ve been studying ‘A’ for 25 years, you’ve
been studying ‘B’ for 25 years and we never talked. But if we can make the data more available
then it could be a person who’s never done research in either ‘A’ or ‘B’ but mined the data set
and came back and said did you guys know that there’s a giant correlation here. But we don’t
incentivize that. We're just beginning to develop organizational programs to facilitate ‘data
science.’
As much as I appreciate privacy and I really like to be private as much as I can, we have
to be able to share that data and we have to have as many eyeballs looking at it as possible. Are
there going to be people that may do various things with it? Yeah, that’s life. I think most of the
barriers are cultural and legal as opposed to technical.

Unintended Consequences
So, let me tell you something what’s going on, a transformation I’ve seen over the years.
Very often in computational sciences some people are doing theory and they crunch on
computers and do math, and there’s those people over there that go in the lab and they do lab
work and they generate data. Then it became people in the labs realized they needed these other
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folks and started to collaborate with them. That progressed to maybe we should incorporate
them into the lab and started hiring some of them, but yet the problem was that data was still
completely localized. So now there’s a lot of folks who were bioinformatics professionals who
were at universities who don’t really have labs but they have now been able to say I can call up
‘Company A’ and get cell lines, I can have that company send it to ‘Company B’ and do the
sequencing, I can have them send those cells to ‘Company C’ and have them look at proteomic
analysis of it and I can have company ‘B’ and ‘C’ send me all the results so that I can do the data
analysis. I never did an experiment and I never interacted with an experimentalist, but I have
data and I’m now integrating it with all the other public data that I have and I’m getting some
really interesting results.
We find the similar type of things here where often times we’re asked to analyze one type
of investigator’s data and then we’re asked to analyze a different investigator’s data and we’re
going say maybe you guys should talk because we’re finding commonality between them. And
if that data was put together in a larger context then even other investigators that might be a little
more inclusive to actually advance research and drug discovery and hopefully cancer
therapeutics or even diagnosis at a much more rapid rate. I think that one of the commonly
discussed things is when Google says we can start looking at searches and we can tell the CDC
when there’s about to be an outbreak. That’s an authentic unanticipated finding by mining big
data.
I think as we start doing more and more global sensors and people share their life we’ll
see even a lot more. We’re in a really exciting time to see an even bigger explosion and
understanding of the integration of data from bacteria and viruses in humans because my guess is
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we’re already starting to see such an interesting ecosystem. The ecosystem includes all of this
and how we rely on bacteria and viruses, they rely on us and other animals that this is turning
into a really complex scenario.
Big Data’s Future in Healthcare
I never want to see a parent have to lose a child over something as stupid as something
that we can solve in a medical sense. There are a lot of things where we’re getting ideas
integrated with genetics, we’re getting information about environment, and we’re getting
information on health. Clearly this web of all of these interactions and the interaction between
you and me affects our health.
We’re looking at human-beings holistically. The reductionist approach I think as useful
as it has been. It needs to be augmented, I won’t say it needs to be replaced, but it needs to be
augmented, a much more holistic approach. I can look at cells all day long but until they're
organized into tissues, into organs and into systems and then into whole species and individuals
it really sort of doesn’t matter. So it’s understanding human health, understanding how choices
we make in shifting policy decisions so that we put investment where it matters the most as far as
human condition and I think letting people realize their full potential as far as health and
happiness as well. My vision is if it can lead to opening and the democratization of health,
because clearly we’re having a fight over healthcare in this country.
There’s a huge disparity in terms of economics and wealth in this country, but you know,
we have to somehow make it to the point where everybody has a fair chance to healthcare and
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education and emotional and mental well-being and I’m just hoping that maybe the data that we
come across will help humanize everyone as opposed to just the few and fortunate.

Metaphors and Symbols
In my opinion, we don’t have a language that’s commonly accepted to discuss this issue,
and when people first started talking about these various types of problems whether it’s the Jim
Gray’s talking about the Fourth Paradigm, or whether you’re talking about data tsunami or
you’re talking about big data, you’re talking about whatever other metaphor people use it’s the
problem that I don’t have a common language. I’m trying to communicate often times to
funding agencies, policymakers, other thought leaders in the field that I need resources or trying
to talk to other people in the field saying I’m trying to prepare for this or I’m trying to deal with
that, or here’s where other people are at and we don’t have a common language to say this is
what we’re talking about and I think that the reason because it’s relatively young. We come up
with these terms to start building up some sort of language and we use a term like big data.
Well now you’ve got a lot of other people come into the field who think maybe this is
something either interesting to them, something that they should know about, something they
haven’t dealt with yet, but maybe they think there’s a problem or hearing somebody else talk
about a problem that seems similar to what they’re saying and they’re using that term; therefore,
that would be the same term as they have, so you’ve got a lot of people who don’t understand
what the original context was that maybe the first person or first few people used for that
language and then repeat it. That’s why I say if I look at it today and big data has kind of lost
some of the meaning that it had at the early part and maybe even gained, and eventually will
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probably gain maybe a specific definition to make it useful again. I think it’s the problem that
we’re all trying to communicate something that we’re seeing .We’re all trying to describe our
view of big data and you know we have different experiences and we’re all going to explain it a
little bit differently and so big data to me is complexity and difficulty in analyzing and
understanding it. Somebody else is just here for pure volume, you know, and other people it’s
the velocity of numbers and sensors coming in. It’s all of that, and I think that’s just right now
it’s a complex phenomenon that none of us fully understand; therefore, you get a lot of different
colorful terms.

Closing Thoughts
Big data is a tool to solve problems and answer questions. Like any other tools, it can be
used both for good and for bad and it’s just the reality we have to live with. There needs to be a
central policy of how we treat these large quantities of data and how we share the data and I
think we could go back to I think to your central question of data sharing and acceptable use
policy. I think it basically comes down to a sharing and acceptable use policy that is going to be
very critical about how valuable big data can be to the population as a whole as we go forward in
the future. Clearly, if this is all held by one secret government agency and used as to invade our
lives that may not be a good thing. At the same time if it’s trying to keep us safe from nefarious
folks who are out to hurt us, then that’s a good thing. The debate continues.
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“Always Create Data for a Purpose”
“Boris Jensen, M.D., M.P.H.”

Professional and Academic Experiences
I started a Ph.D. track for physics, heard about medicine, applied to one medical school
and they accepted me. I joined the university faculty in biostatistics and was appointed professor
of biomedical computing. I built the first computer network for a school of public health and
established the computer network for the biostatistics department. My organization is an
integrated delivery system of hospitals and employed physicians: about a 60% primary care, 40%
of specialty mix. We are a charitable not-for-profit intended to be extremely patient-driven.

Meaning of Big Data
Turns out, there are many definitions for that term. Let me give you three. I’m going to
start with some of the other ones that are commonly used in the marketplace and then finish up
with mine. One definition of big data is that you have truly stunning amounts of data, but it’s
very well focused, it’s not random data at all, just collected for specific purpose but just in truly
massive quantities. The data that you collect you then analyze looking for rare events that was
actually one of the original meanings of big data, right. Another related one, is if you’re doing
genetic sequence you know what you have are enzymes that will cut up DNA and you get them
cut at particular points but in random lengths and then you can sequence the resulting lengths of
DNA. What you get out of them you can analyze to figure out what the original genome was.
You’re dealing with truly massive amounts of data in doing this. So that’s the first class.
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A second class is data mining. The idea behind data mining is that you found a bunch of
existing data of different types just anywhere you could find them. It tended to be again very
large amounts of data. Then you applied automated statistical routines to them in the belief that
this would give you some sort of insights that you would find associations. It’s really a
hypothesis generating exercise. You find things that became useful. This particular one, I’ve
come to the opinion from having done research all my life that good answers come from good
questions.
The idea that you just run statistical software and it’s going to happen by useful
association. You have to filter this with so many spurious associations finding anything that’s
useful that it’s not a very productive use of time. That’s called data mining. Ten years ago, it
was massively counted, about leaving some of these computer programs that now run down
through the databases and find these associations an almost magical learning from it. It never
really materialized. It even felt like you’d think it would. At least a chunk of the current
emphasis on big data is the reprise of that. Now, this is the cynical side of me talking. You see a
consulting group selling this as some sort of a black box magical solution to a not very intelligent
system leader.
The third class of big data for me is the kind I find useful. Dr. Deming, from who I
learned quality theory, use to say that ‘aim defines the system.’ That’s the fundamental truth.
That is particularly true for data systems. You build data systems, they cost so much money to
actually collect the data it’s quite expensive. They’re built for specific designated purposes and
it’s fairly important that you know what the purpose is before you start. Well, Deming also said
that you should organize the thing around the processes, so quality improvement of course is the
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science of process management. While some years ago we went through and analyzed all the
care we delivered and were able to identify a series of processes that make up the bulk of our
work. We started with a little over 1,400 identifiable clinical processes. We used our existing
hospital and outpatient data to prioritize them on the basis of number of patients affected and
health risks to the patient which turns out they have a really tight correlation to cost of care.
We organized it through our enterprise data warehouse which contains roughly about two
petabytes of storage. But what it is – is patient care data done over time organized along these
processes of care and then you use those data to understand and systematically improve your
care delivery. Now when I say you use it to organize and understand and systematically improve
because of the way it’s organized any patient who comes in to receive care us effectively was on
a trial. But another way of thinking about it, for every patient who comes in we track what
happens to them. We know what happens to them. By the way that we’ve structured that system
as we care for patients I can measure what its actual outcomes are at least within our population
the way that we delivered the care.
For example, I could track for medications and for complications that aren’t recognized
in their initial approval process. I can also track the actual outcomes of care associated with a
particular treatment. So when we sit down to counsel a patient, its informed consent and here are
your treatment options. I can tell them actually here’s what you’ll get with this treatment and
these are the results you should expect.
Now it turns out those datasets are fairly extensive, they take the form of registries or
data marts. They’re effectively a registry but many times end up with millions and millions of
records just because we’re tracking all patients.
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Medicine as an Information Science
I’ve been saying for 20 years that medicine is inherently an information science; the
better data you have the better you can diagnose. The more effectively you can select treatment,
the better you can actually see those treatments. It’s unquestionably an information science.

Healthcare Big Data Drivers
I think of it a little bit differently. I just did a carefully designed data system that is very
purpose specific. They’re designed for a specific utility a specific purpose and they just happen
to collect massive amounts of data but they’re always for a specific purpose. There are an
infinite number of data points I could collect. There’s effectively no limit to them, so good
answers come from good questions. Nearly always to answer that good question you have to
have data that matched that question. They’re very purpose specific.
Now once you have the data it turns out that you tend to get really rich data because,
explicitly because they are the right data for clinical management, clinical process management,
and many times you can take those data and they’re more likely to be useful for other
unanticipated applications, you darn well better have the ability to modify your data systems on
the fly because more often than not that’s what you’re going to have to do, you’ll find that it will
point you toward an interesting question. You’d really like to examine in detail but then as you
start to examine that question you realize that you’re missing a few critical data elements without
what you really can’t interpret the data, and so you’re going to have to go back and somehow
add those data in order to properly answer the question. So you build that into the structure of
your data system. Ask questions and then generate useful data on the fly.
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Sources of Data and Data Scientists
I have master’s level analysts whose time is assigned to a particular clinical area and
they’re the main analytic resource for the clinical teams for managing and improving care,
testing changes in care, deploying best care, and tracking performance in the system. Now it’s
the funniest thing on this, most of my statisticians have some computer science background and
regard themselves as fairly competent data architects. So as far as I can tell all of the data
architects see themselves as analysts but when you’re more than past familiarity with both fields
you’re different, and they’re radically different. So you got to make sure that you have both of
those areas available to you because it’s specialty knowledge, really profound specialty
knowledge on each side of the line and you have to get people working where they are most
effective in that regard. So part of my job is to manage that and defend it.

Organizational Challenges
What I routinely get is an administrator who can understand the budget but they don’t
understand why I get so excited protecting that professional environment for my analysts. Now
it’s easy to show the performance that you get by protecting it. But on the other hand, somebody
has to know and be able to manage them.
When I talk about having a rigorous method, we figure out what data I need to manage
the specific process. So rather than it’s called availability bias rather than just using the data that
I happen to have available because I’m already collecting it for financial purposes. I understand
that’s big data where you’re repurposing existing financial claims data and then trying to make it
somehow work for these other things.
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As you might imagine, you can completely justify some fairly significant outlays that
you’ve invested for purposes of clinical management. Now the fact that it also becomes a full
learning system that allows you to generate through knowledge at a paralleled rate, that’s just a
really nice side benefit. So what you’re doing is a mining aim.

Data Sharing
We are discussing with some of our colleagues what might happen if they were collecting
the same data fields for the same conditions and the other thing it means, imagine if somebody
raises a question about best care. Effectively, my routine care becomes the control arm of the
trial and so I can run ‘X’ therapies in amazingly short periods of time if we decide that it’s worth
the effort to do it. We had a fight that cropped up in the system about two medications that you
can use for community acquired pneumonia which one is best for a patient. We eventually
decided that it was worth the effort required to run a full trial on them, a full randomized
controlled trial and we put about 5,000 patients in about three or four months. The routine
treatment under that protocol was the control arm. So you kind of standardize treatment and so
routine treatment was the control arm and then what you do is you just inform the patient, get
informed consent in other words and then you randomize them and just have two therapies there
so it becomes just part of routine care. That cost has dropped to a fraction of what it was before.
I think of it as sharing at two levels. The first level you share is existing data and that
depends a little bit on the current capabilities of the systems collaborating together. You simply
share existing data, whatever you happen to have. By far the most common data are financial
data, whether technically claims data, it’s not purely financial, but mostly financial. So you share
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claims data from the system. Now the next step which we’re starting to do is rather than just
straining existing claims data, you take a step forward and you start to generate specific clinical
data that has a lot more meaning as you might expect has a whole lot more meaning.
Imagine that we’re addressing a specific clinical topic like diabetes mellitus. The
argument is that diabetes is kind of diabetes whether I’m in New Hampshire, or Minnesota, or
Oregon. When you look at it, we ought to be collecting about the same data in about the same
way as my process management system. You see the whole key is to be able to justify this thing
on a financial basis as a care management system. That’s how I get the justification for it, that’s
how I get money guys to put up a lot of money because it costs money. You’ve got to design
them to that purpose so that will get better clinical performance. If I remember the goal, the best
medical result at the lowest necessary cost. So the way I hope to sell it if I don’t wait for my
colleagues to come get me is I basically hold myself accountable.

Unintended Consequences
Well, first of all big data is never used for its intended consequence. So however you care
to classify that in terms of being useful and actually managing care is so badly incomplete and
there’s a beautiful theory you can relate to it, it has to do with what’s called decision layer in a
process setting. An unintended consequence is it tends to create a group of clinical partners for a
massively cynical ends to make change very difficult because it destroys trust. It’s interesting
because it’s not just insurance companies, you can argue that most of the report card scoring
systems of people are out there creating and using these datasets trying to repurpose existing data
somehow and when you evaluate them technically they don’t produce an actual result. By that I
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mean they, if you measure the confidence intervals or the scores that they produce the confidence
intervals are so modestly useless. This is actually pretty well known.
Big Data’s Future in Healthcare
There’s this concept that effectively every patient goes on trial because of the way the
data systems are structured. Now the jargon we used for that is a learning healthcare system
where you build the learning, the knowledge management and it’s an information science tool
that comes out of this you quickly learn is it’s perhaps the key capability in a system like this, it’s
knowledge management. How do you identify best practice knowledge, how do you
systematically and routinely deploy it into routine use. What it means is I get much better
clinical data in a real-time feed. Now the next piece beyond that is when you’re using these tier
process models you use the clinical processes to drive your care delivery, you can use it to
integrate research. So I can justify this stuff purely on a financial basis see, that’s the idea
behind it. And then how do you use the resulting structure to rigorously learn from your
experience. That’s the learning system.
I want to get to the point where we will run at least 1,000 published papers in a single
year. And by the way that’s quite reasonable, that’s not unreasonable. See for me that’s big data.
But it’s interesting, it’s not random data. It’s big but it’s not random. A lot of people seem to
think it’s random; no, it’s not random. I’ve got colleagues in some of the other big integrated
systems if we can start to collaborate together and as we work out the content of those data
systems together so that we share the data back and forth it will accelerate the whole process. So
the things that I could run a trial on that it would take me six months, I mean that’s compared to
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ten years right now, the structure I might be able to get them done in six months. Under that
structure we could do it in three weeks or at least that’s the idea.

Closing Thoughts
We probably did cover it, but here’s how I would say it: big data doesn’t mean
unstructured data. You always create data for a purpose, right. That’s the human creation. It
always has purpose, you have to understand the purpose if it’s going to be effective. And then
everything else is just a tool.
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“Big Data Means Greater Truth”
“John Boyken, M.D.”

Professional and Academic Experiences
I became very interested in informatics and computers and the role that IT and
information management would play in healthcare but I had no training or background in it. In
my first two years of medical school, I had the opportunity to work in a lab that was focused on
using technology to help transform the way we teach our medical students and I found it just
fascinating.
I then started my clinical years of medical school and really became very interested in
general internal medicine, mostly in-patient hospital medicine, and I did my residency in internal
medicine and during that year became reconnected with this world of the power of health
information technology to the point where I said this is going to be a big part of my life and I did
a two year research fellowship in medical informatics. I began to realize how important big data
was not only in our clinical and research missions but especially for me very important in our
education mission and how we could use the same analytic approaches, we could use the same
structured data collection, the same storage techniques, the same warehousing even the same
software analytics tools to begin to transform the way we measure our students, our house staff
and our faculty as we do our patients and our research subjects and our genes and proteins.

Meaning of Big Data
So that’s a good question because it is a popular term that means a lot of different things
to a lot of different people. I would say what it means to me and what it should mean to
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healthcare it means two things. First, it means turning data into knowledge and insight, that’s
not a database, that’s not a data warehouse, it’s the actual analytics. So that’s the first part
carrying data into knowledge and insight, but that only gets you halfway there. Second, I think
the other part of big data is actually using that knowledge and insight to change practice, to
change what you’re doing into big decisions. A lot of people are heavily involved in producing
knowledge and insight from massive data sets but that last of actually translating what you learn
into agile dynamic operational changes and informing what you’re going to do next. That’s the
part that I think has the least maturity in all of this. It’s the most exciting and potentially
powerful part.
I arrived at this definition through experience. It’s experience of building systems,
building dashboards, synthesizing very large amounts of educational data and seeing the power
or the lack of power that those conclusion could have by whether or not people were embracing
them and using them to make decisions and implement changes or just using them to make slides
in a PowerPoint presentation.
Big data is different from data. The type of competencies of the person who potentiates
the big data, your analytics people and the research people answering these questions, their
competencies are fundamentally different from someone who’s working with small data and it’s
more about the analytics than that, the algorithms and the causality sort of detection than it is
about things like more straight forward regression analogies.
But when it comes to the volume of data, that’s arbitrary and it’s really a spectrum. It’s
big and it tends to involve from a very engineering perspective, it tends to involve database
storage technology that is not your standard desktop or even your standard relational database, so
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that’s important. I would say that often times people approach big data with the viewpoint that it
contains answers to questions they don’t yet know whereas they approach small data with how
can we answer this existing question using the data in front of us. I think that both of those
approaches have opportunities and pitfalls but I’d say that that’s kind of one of the differentiating
factors.
Medicine as an Information Science
Yes, absolutely, medicine has always been an information science. But whether or not
that information has been at the individual patient level or at the group of patients a provider
takes care of or at the population level has been the things that have changed. So when we see
the big data revolution we’re seeing that transformation of the maturity of information science in
medicine go from that individual patient, the anecdote to the types of patients, the whole
constellation of patients I’ve seen my career, to understanding the relationship of clinical and
biochemical data across population which is truth, that is big data.

Healthcare Big Data Drivers
I think that the availability of big data is certainly something that’s driving it and that
definitely correlates with technology, whether it’s clinical technology to measure biochemical
signals from people or sequence genes or sequence proteins or sample the air or whatever. The
availability of data is one thing that’s driving it. I’d say that the willingness to base decisions
and planning on truth and the desire to have more finely grained and precise measures of truth is
another thing that’s driving this thing.
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People want to know especially in healthcare, how we’re doing, what is quality, what is
safety, how can we be more efficient both to make our patients healthier, but also to make the
care we deliver less expensive and more efficient overall. I think those things are big drivers as
well.

Sources of Data and Data Scientists
That’s a complex question in our environment. So since we are an integrated academic
medical center in our school, in our hospital our one entity we don’t have many political barriers
between data that is in our clinical world, in our research world and in our educational world. In
fact, our leadership is extremely committed to transparency of those data and through as many
people having appropriate access to them as possible so that we can make better decisions and
we can be stronger because of them. If we don’t have access to these things it’s a missed
opportunity. That being said we have safeguards in place with our IRB and we have other data
access request review boards that say what people can and can’t do with the data and who can
and can’t see things to protect our patients and to protect our students for the most part.
We have fairly robust resources of people who work on the data and infrastructure, so we
have a large central data warehouse team an enterprise data warehouse team and then in my
group for education we have a full time person whose job 100% is to run our education data
warehouse and to create all of our reports and dashboards. Then we’ve also just created in my
group a new division of education quality in analytics who are the scientists who work off of the
data, who work off of creating the analytics and using the data and the knowledge and insights to
translate them into decisions about how to improve our students, our faculty and our patients.
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The tenant of what makes a psychomatrician or a data analyst or a data person are
becoming much more about these competencies of managing large data sets of implementing
analytics, of working with warehousing and non-relational databases, so these skills are key and
they’re not easy to find in people. We don’t look so much for content expertise, in our world it’s
not like we’re going to go out and find somebody who necessarily is an expert in health data but
they can learn that here. The stuff that we really are looking for is for them to have the ability to
use these tools to figure things out to invent new tools and event new knowledge and new
techniques etc.

Organizational Challenges
So the organizational challenges are about, you know, are related really to agility, right,
the ability to keep up with all of the conclusions and knowledge that you draw. There are often
organizational challenges although we’ve been pretty lucky in respect to them about
transparency and people willing to share the data or people worried about sharing data or
fighting for silos or turf we haven’t seen that much here. A big organizational challenge that is
often overlooked is that you need to create value from the data for the people who are
contributing the data. For example, here for our medical students and our faculty they conduct
all these evaluations of each other and these evaluations are very important, they monitor the
performance of people, they monitor the educational quality and if they’re entering all these
things and they don’t see the value that aggregating all this data and analyzing it provides then
they just view it as just an annoying server they have to keep fiddling out. So if all we do are
create tools that show our deans and our vice presidents what these data mean and we don’t give
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any feedback back to the people who are contributing it, it’s going to extinguish itself very
quickly.

Data Sharing
Almost all of our sharing is where we’re giving data to somebody else has been internal.
We have physically integrated our education data warehouse, our clinical data warehouse and
our research data warehouse, we said let’s take this beyond this step of sharing, let’s just
integrate these actual data and eliminate all of the technical silos and that has been amazingly
powerful. Especially in healthcare it’s hard to share some of this data outside. The good news is
that the government and the state government, federal government and state governments, are
beginning to take the data that they’re paying us for with Medicaid and Medicare and many other
things and put it out there for us to use, for researchers to use and so when it comes to some
clinical data, performance data you can actually begin to download big datasets publicly online.
I’ll give you an example of something we just did in the last few days. The health
department publishes every single hospital discharge of every patient per year online and you can
download this massive dataset. It’s like a one gig CSV file that has every single discharge, what
the diagnosis was, what the procedures that were performed, what zip code the patient had, what
age they were, their gender and the license number of the doctor that took care of them so we
know who the doctor was and that is this giant dataset that we can use that the state is facilitating
by putting it out there, it’s terrific, it’s awesome.
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Big Data’s Future in Healthcare
My hope is that we get increasing transparency that data portability across the silos of
organizations, of research settings, of educational settings is key because we need our big data to
get bigger. We need to actually aggregate this stuff. So to do that what does the future need – it
needs standards. It needs standards for clinical data, standards for research data, and standards
for educational data. That’s beginning to emerge but it’s definitely not there yet. We need
reasonable and rational policies around how to protect these data but also how we can flexibly
use and release the data.
Often times the barrier to sharing is not political or financial -- it’s regulatory. I’d say
that we also need the ability of the consumer whether it’s the patient or the student or the
research subject to have access to their own data and be able to do more with their own data if
they want to be able to move it around or integrate it with some other source, etc. But
empowering the people whose data it is should be an important value for all of us as we go
forward. I think that one of the things that we’re not yet seeing and that we should is so big data,
especially big clinical data has enabled things like hospital report cards and there’s a hospital
compare websites where you can go online and say is this hospital better at hip replacements
than that hospital and make a choice based on it. So we haven’t seen, we’ve seen a lot of big
data being used to produce these things but we haven’t seen the general public embrace those
kinds of things to make their decisions. So we haven’t seen people outside of these ivory towers,
outside of these research topics where experimental pilots or you know clinical improvement
that’s real but it’s happening top down as opposed to bottom up. We haven’t seen that sort of
grassroots use of big data, you know, there’s lots of stuff that’s happening in the consumer side
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with Twitter using big data for cure locations and detecting trends. It would be great to see the
people say let’s use this data to help us make decisions. They already do on Amazon; they should
do the same thing when it comes to picking where they’re going to have their hip replaced. Our
hospital was just ranked number one for quality and safety, so I can say that with confidence that
they should use those data to make their choice to come here.
Insurance companies and that’s how they’re going to run their practice, that’s how
they’re going to negotiate with insurance companies, and that’s how they’re going to make sure
they’re doing a good job and these things have not been extremely present in medical schools so
we are really interested in changing that. The Affordable Care Act and the whole direction of the
content of data and quality driving how we evaluate how we’re doing and how we make course
corrections makes that even much more important. But these are the things that absolutely need
to be very prominent in medical school, they are the critical skills of the future physicians, the
present physicians, and they’re not taught nearly to the degree that they should be in medical
schools in general.

Closing Thoughts
So there is new science that’s only potentiated by big data and that’s a whole other thing.
But here like in the clinical world or the educational world, big data means greater truth. It
means answering questions that were not answerable well before. But it also does mean
potentially really empowering consumers and that’s one of the most important things.
The integration of genomic data and phenotypic data, which is clinical data in the
electronic medical record, is something that every academic medical center is racing to do
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because the answers are not going to be in one or the other. The answers are going to be in the
combination of both and so that is absolutely the future, a very reasonable approach.
I think that we’re going to see a lot of start-ups in this space, a lot of companies that are
going to race to fill those voids inexpensively. I think that the federal government is also going to
play a role in all of this and they’re going to provide some views of data from their perspective.
So it’s uneven right now but I think it will rapidly become more uniformly used. And it will
become cheaper.
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“The Art of Applying Information and Evidence”
“Nickolas Thompson, M.D.”

Professional and Academic Influences
I graduated medicine/pediatrics and took on an internal medicine position and at the same
time was doing a pediatric hospital rotation at one of the local hospitals. I got pulled into the
research informatics side of the equation. We had competed for clinical translational science
award for a couple years and I wrote the informatics section and we got funded. Then I had a
very unusual opportunity after having done some consulting work. While I was doing my work
at the university, I had a chance to go to the Middle East and work at an ultramodern from the
ground up pediatric and women’s hospital.
As the chief clinical information officer (CCIO), my responsibilities are more around
sequence in technology over time into the future and also working on kind of re-orchestrating the
data analytics of the organization and other jobs not otherwise specified. When I got here, a lot
of people were using beepers and pagers and so forth and so moved them all over to smartphones
so we can leverage that platform. I had them use usernames and passwords across a bunch of
applications so I’m moving them over to single sign-on tools so that they can just tap their ID
and get into the systems if they need. I saw them using a fairly old version of EPIC so I
accelerated the path to get to EPIC 2014 just to get to contemporary code.

Meaning of Big Data
Well, I like the definition that Gartner coined years ago where big data is a high volume,
high velocity, high variety information asset that demands cost effective innovation, you know,
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basically something used to enhance insight in decision making. So the key I think is sort of
insight discovery and hypothesis testing. So what does that mean for us? If I look at better
velocity it means that if we look at current systems and how we copy in the traditional data
warehouse model, so EPIC is a MUMPS-based programming system; it’s not relational so every
day from MUMPS to Clarity which is their relational data base. We need something to be able to
get that to load faster and we need something that is going to be able to process that in a velocity
fashion. Then for the health system to have better variety it means pulling more than just the
data that we have, public data, other forces of data not typically used for healthcare really for
more of the hypothesis generation.
Then for volume it means accommodating the ever increasing deluge of data that’s
coming from our own data sources. EPIC is the obvious one, but there are other things like
location condition-based services, patient outcomes, all the biomedical device interfaces we have
in the organization sort of like IV pumps and vents and physiologic monitors and so forth. And
then I suppose you could add another of the Gartner’s V’s, Veracity, meaning that all the
transactional systems work properly when people enter things perfectly the way it’s supposed to
that doesn’t always happen. I think that can sometimes be an issue in terms of trusting the data or
people finding the system to be too inefficient so creating a separate data warehouse that are
cleansed within themselves but don’t come back to the main data warehouse. Sort of some of the
traditional data warehouse problems that we have.
Then for healthcare, I think we need to do our best to learn lessons from other industries
because we’re not the only regulated industry in the market area, banking, insurance others are
regulated and still using big data more than we are.
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Medicine as an Information Science
My direct answer is no. I would say medicine isn’t just an information science; it’s also
about smartly moving information around clinicians. It’s the application science of information
as well so you know the art of translating patient’s observations when they come in with signs
and symptoms, their complaint is the history of the physical exam, the art of applying
information and evidence in particular patients. That human therapeutic relationship between the
patient and the team, between the patient and the doctor and so forth, so I’d call it that medicine
includes information science, but amongst other arts and sciences that it has to dip into.

Healthcare Big Data Drivers
It’s probably going to be a combination of some things that other industries are seeing
and some things that are very specific to healthcare. So IBM will say that 80% of the data that is
deemed collected is unstructured and therefore potentially untapped until we use big data tools.
Also, I’ve seen several times that 90% of the data that is currently being produced ever has been
produced over the past two years kind of suggesting that we’re in sort of an accelerated
exponential growth of the amount of data that’s coming to us.
But from a healthcare perspective there’s one very, very important part of the missing
piece which is value based purchasing and moving away from the lack of accountability of fee—
for—service. This whole ‘sign and forget model’ to get the patient and then send them off
somewhere and if they come back is more money for me. So moving more towards the database
means that I’ve got to start showing in, you know, connecting the dots of things that are outside
of my line of sight. As I take care of a patient I need to really make sure they’re actually doing
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better because otherwise somehow it’s not going to work out for my practice for example. So I
think value based purchasing is a pretty big driver to find out what other things can help fill the
gaps for me in terms of understanding what’s going on with a patient, could be behavioral
economics, it could a number of other things. I think another one is the Office of the National
Coordinator has been pushing these Meaningful Use Standards and that’s resulted in an
abundance of data, and there’s more demand on doing analytics with the data and they’ll be
actually in Stage Three more expectations around producing outcomes and you can’t really
produce outcomes without data. So I think that’s going to help as well.
I think there’s a desire to maintain a competitive edge, you see all that, you’re just doing
the old data warehouse thing and just like anybody else would because the invented tool is
beginning to mature at the warehouse level but for those of us who are kind of embraced in data
science and data scientists and trying to push the envelope I think that we’ll be able to keep that
competitive edge.
I think another thing is the fact that hardware is getting faster and is available at low cost
points. We compel them to use it as a result looking to solve some of the data problems by
throwing more hardware at it to be able to have it crunch faster through new software
applications including Hadoop, MapReduce, and NoSQL that Google has had for a while. I think
healthcare organizations are starting to understand a little bit the fact that they’re sitting on a
mountain of data that they’re not necessarily tapping into that’s not really being acted upon. So I
think they’re trying to figure out if we have all these people that we’re paying in healthcare to
basically collect and digitize all the information from the patients and the EMR’s are we really
using that data that they’re collecting to potentially affect the patient’s health. I think other
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things like new data sources including genomics, senomics, and other ‘-omecs’ that are out there.
Metropolomics, for example, are generating huge amounts of data that need to be processed in
ways different than we have in the past.

Sources of Data and Data Scientists
I want to caution one thing: I think our health system, is still reasonably early in the
trajectory relative to big data. I think we’re kind of proceeding kind of cautiously. I can give you
some concrete examples. We do some work with natural language processing like most people
do. We’re finding some ability to go from unstructured text to structured text. Imagine out of the
million radiology reports that were generated last year or this past year we were able to take what
was being dictated and turn that into a structured text that’s in a CDA mark-up and it kind of
ends up in an XML format and you know the natural language processing is helping us do that. I
can use that to be able to do correlations with other things, even the imaging data to understand
health. If I understand that this report is normal and that the image that I have here is normal, I
can send both of those to a machine loading tool and basically, over time, get the machine to help
me figure out what’s normal and what’s not normal.
I think that there are some key things in terms of our desire to get closer to real time. I
mean it’s really not very useful for me to identify that a patient is in need of something 24 hours
later after the opportunity has kind of come and gone. So our looking at our current system
that’s 24 hours behind is helping us in some ways but really not, it helps us maybe more in a
population health side, but not so much on a prospective what am I doing with the patient right at
the point of care side. We are still very SQL dependent and are slowly shifting over to other
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options to embrace NoSQL and MapReduce. We’re just starting to look into social media and
geospatial data from tweets. We’re trying to get an idea of the behavior economics.

Organizational Challenges
I think one of the problems is trust in data quality and data fidelity. I think people don’t
really know yet if this is something worthwhile yet. We put everything in a little black box and it
comes out the other end and it gives me a relationship. People are not so sure if that actually is
true or not. So to the degree, at least initially people will be able to use it as hypothesis
generation and maybe the hypothesis testing is actually occurring on the standard enterprise data
warehouse tools.
I think there’s still a very limited skill set out in the industry in terms of the people who
know how to do this, so it’s going to be hard to recruit a team of data scientists. There are some
programs out there but there are not a whole lot of people that come out through them. They’re
going to get mopped up very, very quickly. I think a correlation to that is finding somebody
who’s got 10 years of experience in big data is going to be pretty impossible to find. So getting
experienced people, there’s going to be a lot of on the job training and that’s going to be a
challenge for people.
Then there’s no proof points yet really that are real concrete in terms of projects that are
out there especially in healthcare, but in terms of what the outcome is if it’s going to be
something that will be feasible from an economic or even a regulatory standpoint is still a little
bit of an open ended question. I think that’s still out in terms of being able to figure out if that’s
going to happen. Then you know, all this work may generate a lot of reports but I wonder to
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what end it will produce data but the question will be to what extent will the data be useful to
actually produce an outcome and I have some examples of things that we are working but it’s
right on the tip of the hype curve right now and I think it’s not going to be the kind of solution
that’s going to solve all data problems.
Finally, it used to cost billions of dollars to sequence the DNA and now we’re down to
like $1,000 and then it’s anticipated that in the next few years we’ll be down to a $200. It’s
going to be pretty useful to create an account where you can go to Google and look up your
genetic code and figure out what things are associated with that.

Data Sharing
First, it’s kind of important to talk about what our capabilities are in terms of our set up.
We have a computer computational predictive modeling set up that basically we use for
personalized predictive medicine. So we have some of our staff that are taking vast amounts of
data from clinical and molecular radiographic economic data to create basically models that can
help inform decision support the doctors make every day and we use high performance computer
cluster that has the typical multicore and we have 400 core, 50 CPU’s at 2.2 terra bytes worth for
computational ram that have some in memory database management systems which is kind of
the newer way of doing it and plenty of dedicated storage. So the center basically is going to
leverage this parallel cost of computing to be able to do some of the mathematical and
computational modeling that’s necessary. With it, we’re part of a collaborative developed to
identify what’s in your DNA and how the patient presents where there’s a relationship that can
basically be put into the EMR itself. So that particular project has a couple of parties you know,
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one is to from the EMR get a precise phenotype and the other one is to basically return an
actionable genomic result so that we do something different with the patient so that the use case
is something I can’t give medication for a patient like Warfarin but I usually start at 5 mm but
this particular patient I may want to start only at 1 mm because if I were to start at 5 mm, they
would have a brain bleed, so it helps me to understand where I’m starting certain medications
based on a genetic code.
We also are involved in a collaborative project that established a virtual data warehouse
of basically it simplified data sharing by having a very reasonable similar data model that’s
federated across all different organizations and it has demographic data, physical measures,
personal medical history, management treatments, diagnosis, health claims and so forth and
basically this data model retains control and stores data and stores kind of standardization across
all sites and people can use this as a tool to do their research. It’s an immense data depository as
you can imagine. I think the third example is the Whole Genome Sequencing component. It’s
more of the genetics side of the equation over the patient’s life span and helps predefine clinical
context based on the genetic information. So I think that’s hopefully going to help us with
neurogenetic diagnosis decision support in the electronic medical record so some of the things
you see in 23andMe.com by maybe more sophisticated in terms of patient genomic test reports
and that kind of thing.
Big Data’s Future in Healthcare
Again, I don’t think it’s going to necessarily replace what we currently do. I think you’re
still going to need people who are going to have to, you know, the big debate is will it be to the
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point where I don’t even need extraction tools and I don’t really even need semantic errors, and I
don’t even need data marts and data warehouse anymore because I can basically just take
information in an unstructured format and then just put it into this box and it’s going to tell me
how the data is actually organized and what the correlations are and what’s the approximation
size and so forth. I think that’s a little bit too nirvana. I’d love to get rid of the infrastructure and
not to even think about it and have systems basically think about it for me.
But I think especially probably in healthcare there’s still always going to have to be
somebody who’s going to be the data steward, who’s going to really make sure that people
understand what something means. I want to recast our current system into a data warehouse
model. I want to turn that into a logical data warehouse that has your standard component that
has an ETL in tune data warehouse and then starts giving us different data marks, but also for
certain data sources can tap into the big data needs and then for others that are more real time I
use more of an operational data store as opposed to a data warehouse.
So something that hasn’t been fully mapped out into the analytical processing scheme
that I want or something that’s more real-time feed that I can actually act upon much quicker. So
there will be some components that are real time, some components that are like data warehouse
and dashboard based and then some components that are for big data for large data sets and for
better insight. So I can go to my big data to find the hypothesis. I can go to a data warehouse to
test that hypothesis and I can use my real time data to basically put that hypothesis into action
with decision support.
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Metaphors and Symbols
You may be somebody who likes the whole quantitative self-movement. You may get on
the scale and it gets WiFi’d and set up to your computer or you may track your sleep, you may
track your mood, what you eat, a number of different things that could be tracked and you could
do that every day. That information is going to become very helpful because it will help a bit of
phenotype documentation, so when we’re trying to match it up with a whole series of EMR
derived data or decision support, you know, it kind of gives us a better idea of behavior
economics of what’s going on with a patient. There are other things that we were talking about in
terms of pills and medication compliance and there are all kinds of tools that are now making
themselves available that go beyond just the actual bottle having some sensor in it. In other
words, you swallow this and like a potato chip that activates in your stomach and sends out a
signal to a little sensor that’s on your skin and tells me exactly when somebody has taken a
medication versus not and it’s actually been ingested and digested. So those kinds of things will
be pretty helpful.
I think other things in terms of matching patients up with clinical trials will be helpful as
well, getting a better idea of simulation platforms when you’re trying to figure out how people
respond to different medications. I think the promise of the big data is the fact that you can use
all kinds of sources whether it’s social media or even peer view literature like what IBM Watson
is doing where they just consume all the literature so people don’t have to read it. I’d much
prefer this because I can’t possibly get through the literature; yet, there’s some useful stuff in
there and if I can have a computer absorb it and then I can just ask it questions and it can tell me
well based on the literature X, Y, Z then I think that could be beneficial. So a lot of the
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personalized medicine type of initiatives that match the patient to a treatment requires a lot of
information and data to make that happen all in real time. I think the key thing is if you set the
issue, if you generate data that’s great, but we got to make sure we generate the causal
relationship as well. So I think that’s always a challenge.

Closing Thoughts
The battle for Accountable Care Organizations and the Affordable Care Act, you know,
is really being fought here and we’re able to demonstrate for example that we can make money
on Medicaid patients and that we can make money on Medicare patients if we look at a
population base level instead of this individual fee for service. I think that’s the thing we
differentiate ourselves with, we’ve invested in IT infrastructure, we’ve invested in bundles of
quality care and we’ve invested in care coordination and we’re now able to demonstrate as a
result of having done that. We can get better mortality numbers and better outcomes for the
patients in a way that’s going to be compatible with where the legislation is going as opposed to
being forced into it. So I think the fact that we’re in the big data equation now is just testament
to the fact that we like to stay on the leading edge and we want to be able to help solve the
healthcare equation as much as possible and help share that information with everybody else so
that we can just take better care of patients.
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“Learn to Talk to the Patient about Data”
“Darwin Watkins, M.D., M.P.H.”

Professional and Academic Experiences
I was a family physician working at a neighborhood health center and later in my career I
kind of got talked into going and getting a degree in public health/epidemiology and I was
actually interested in doing that because computers were just coming to the neighborhood health
centers in those days and I was very interested even then in what you could do with
computerized data from healthcare delivery in terms of beginning to understand your patient
population and what were the common problems and what worked and what didn’t work. So as
far back as 1983, I could see that that was a very good idea. After I took my epidemiology
training, I wound up at a place which over the next ten years just moved hugely into
computerized data. From 1984 through really 2000 we made huge investments; whereas, when I
first got there, you had to do almost all research by abstracting paper medical records. By 2000,
just about everything was in computerized databases and all you had to do was link them
together. You had a population of three million people and you could build registries and you
could do comparative effectiveness studies and other kinds of functions.
We were at the head of the curve then; others were too. We had a very large defined
population and really good databases even at that time and they just kept getting better through
the 20th Century and then they got a full-fledged electronic health record and that took a little
getting used to because we were very used to the computerized data systems which kind of
backed up this simpler electronic record. So we had all the lab results, all the prescriptions, all
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the diagnoses, all the visits and visit types and all the procedures. Subsequently, we switched to a
real EHR so we had all the notes and stuff was in a very different structure. But certainly we
continued to be able to do richer and richer analysis.
We think big data are important because we think the kind of studies we want to fund are
really best done in real world settings and the best way to do some of those studies without
completely disturbing the natural setting. In the process we want the whole enterprise to take
advantage of the big data from electronic health records and other computerized databases that
these systems have with the active involvement of the patients, and the active involvement of the
clinicians, and the active involvement of the systems. We have a particular notion called patient
engagement and we want the patients to be engaged but we also want to take advantage of the
bigness of the data that are now accumulating and answer important comparative questions.

Meaning of Big Data
To me it simply means lots of data, lots more than you’re used to and you know, the
reason big data is important is because without it you wind up with studies that are almost
always too small. Smaller than ideal, because it’s just simply too costly to go out and collect all
this data on the very large numbers of people that you need. So we’re hopeful that the existence
of these big sources of data allows us to do studies in a million people instead of 10,000.
And the reason that’s important is because first of all everybody feels more confident
generalizing from an unselected population of a million people than from a much smaller
population where you had to really work hard to get these people to participate in your study and
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give you the data, a much more selected volunteer population. So advantage number one is
you’ve got real world data now, unselected data.
Advantage number two is we’re really interested in how treatments work for individuals.
In the past, because studies couldn’t be that large nobody could afford to fund a million person
clinical trials study. You really always had to settle for the average affect, the average difference.
You know, I had a randomized trial and I got 100 people in each arm and the average response
rate was 70% in treatment A, and 60% in treatment B, the average difference, and that’s about all
you can do; with 200 people that’s all you can do, and it wasn’t statistically significant. You
know, never mind that each arm had people of all ages and all levels of co-morbidity and
certainly they differed genetically dramatically. So if you can increase that tenfold, then you can
begin studying the same comparisons but you can subdivide them into males and females, over
75 and under 55 with a genetic marker versus without.
So big data number one is usually more representative and number two it’s much more
powerful and allows you to zero in and get much more refined answers and ultimately that comes
back to being able to tell the individual patient this is what works better.

Medicine as an Information Science
Well medicine could become an information science I think if the clinicians and patients
got actively involved in it. I think, I like to imagine that back in the 16th Century when somebody
went to the doctor that doctor had maybe a few books, but he also he made mental notes, or
perhaps he kept written notes of his patients and he learned from patient to patient and he passed
on what he learned, he kept it on paper, he kept it in his head, did his best to learn everything he
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could from each experience and passed it on to future younger doctors and took it with him to
see the next patient. I think that with the arrival of the computer we could see the same thing but
on a much richer, more detailed, more accurate, precise scale. So I think if clinicians got into
that frame of mind, they’d pay more attention to what they were writing in the electronic health
record. If patients got into that frame of mind they’d answer patient reported outcomes
measures, they’d participate in randomized trials at higher rates.
So I think that healthcare delivery, medicine as you call it, could become an information
science. It could become clinical research if the patients and the clinicians become willing
participants, and I think most clinicians in the long term if they had time and were incented
properly would be happy to do that. Patients I think it’s going to take a little bit more work just
to get them to accept the fact that a lot of the things doctors are doing to them they’re doing
without good evidence you know. They’re doing with uncertainty and so I think that we have
work to do and elsewhere there’s work to be done to convince patients, doctors, delivery systems
that clinical care really ought to be research, you call it information science. Everybody
participates in some kind of learning.

Healthcare Big Data Drivers
Well I think probably the main drivers are a desire to be able to bill accurately, okay, so
that’s a huge driver of electronic health records believe it or not and the second one is a, you
know, this rapid rise of performance measurement. So you know, one of the things that I saw
drive the deployment of computerized clinical data systems in EHR was when NCQA began
asking for all these performance measures and Kaiser wanted to monitor its own performance
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and improve it. To do that they had to be able to measure that performance in an affordable way,
you couldn’t have millions of people sitting down with paper records trying to figure out what
the blood pressure level was, so you needed it in the computer. So I think those are probably the
two biggest drivers.
I think clinical efficiencies lagged way, way behind and in fact I think it isn’t necessarily
more clinically efficient. It might be higher quality care but it takes much more time. It’s not
you don’t wind up going home faster at night because you have an electronic health record; in
fact most people say the opposite. So I think billing, accurate billing with the increasing
requirements of data related to billing and performance reporting are the two biggest drivers that
occur to me. That’s the reason we picked the electronic health record that we did pick at my
previous job because it was the leading electronic health record for billing.

Sources of Data and Data Scientists
Others basically generate the data and we haven’t made any significant effort yet to gain
possession of copies of data I would say and that’s maybe not even in our future, you know. We
don’t aim to become a big data processing shop. We are going to support this infrastructure and
it will in fact ultimately become a data processing shop, but we won’t be driving it, it won’t be
here.
We do require that everybody who’s been funded to submit a final report and a version of
that report gets put up on the website, so we do publish reports from our studies, but we also
strongly encourage grantees to publish in the scientific literature and we use other means when
the findings are really important and need to disseminate the findings more broadly.
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I think the bigger the data sets the more complicated I think the platforms that are used
for storing it and for analyzing it. So you know, all of a sudden you’re moving to Oracle and
beyond to places I don’t even know. You no longer are just keeping little SAS data sets sitting
around and so I think that’s one thing that takes a lot of programmer expertise at a high level and
then there are statistical, analytic kinds of questions that come into play and so you need the kind
of expertise that asks the question.

Organizational Challenges
First of all it costs a certain amount of money to extract the data and analyze it. So
organizations spend billions building up these systems but they have a hard time justifying
spending a million to analyze all that data, so it just is crazy but that is seen as a challenge.
Trusting the data and the methods that were used to analyze it can be a second. Changing
practice based on what one sees in the data is a third because sometimes even though you see it
still the incentives aren’t necessarily aligned to make it easy to change. Let’s say you have a big
system and you’ve got a bunch of cardiac surgeons and you’ve got a bunch of cardiologists and
you do an outcome study yourself and you find that either the surgery or the stents that the
cardiologist placed are not doing as well as the alternative. You want to move in one direction.
Well you know you’re going to have a certain amount of opposition there and from the people
who are being told to do less and so incentives, the incentives to act on the data. I’d say
spending the money to analyze the data, trusting the results, and knowing that the results are
really reliable and should be acted on and then rearranging the incentives in the organization so
that you can actually make the move that the data suggests you should make.
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When you’re using real world data you always have to ask yourself whether the fact that
one treatment looks like it leads to better outcomes than another than a competing treatment.
One explanation is that one treatment is better than the other. That’s what you’d like to think but
first you have to resolve the possibility that it might be because the patients are different and that
there’s confounding selection bias that patients who get one treatment are just different in ways
that effect outcomes from the patients who get the other treatment. So I think another huge
question is what do you do about missing data? So a lot of clinical data has lots of ‘missingness’
in it and how do you sort of account for that ‘missingness’?

Data Sharing
What do you do if five systems each have part of the data and they don’t actually want to
send their data anywhere, they don’t want to share it? So this notion of distributed data
collection, distributed queries, and distributed analysis is a big methodological issue that people
are working on. Let’s say I’m the CEO of a health plan and some of the researchers in my
organization are in part of a network and they’re in along with people from United Healthcare
and Blue Cross Blue Shield, as a CEO I might be concerned that the data that we shared might be
used for some purpose other than the stated research questions. So you know, you feel better
saying couldn’t we accumulate the data here and be ready to look at it whenever you ask, but
we’ll just send you the aggregated results on the questions you asked then you can figure out
how to put them together with those from United Healthcare and Blue Cross Blue Shield. So I
think there’s a lot of interest in the idea of distributed analyses.
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Unintended Consequences
Well I think the critical thing is whoever provided the data and that includes the patients
as well as the systems, need to be kept in the governance. If you get to the point where this data
is getting repurposed, pretty soon you’re going to have somebody that’s very angry and decides
to withdraw.
Big Data’s Future in Healthcare
I think that our vision is that delivery systems, whether they are big HMO’s, whether they
are neighborhood health center networks, whether they are Accountable Care Organizations
which are starting to come together all around the country and turning communities into systems
of a certain type, they will begin to see it in their interest to capture the data, to ask and answer
the questions, to share the findings broadly, and to drive quality up and cost down as part of what
we call a learning healthcare system. So you know, you’ve got to get familiar with data and
convinced that the data can actually lead you to decisions and then you’ve got to overcome those
other barriers which are spending the money, trusting the findings, and changing the incentives.
I think that that’s got to happen, it will probably eventually happen but not as soon as it should.

Closing Thoughts
Well, just a couple last things, three things. Number one, something we didn’t talk about
today but is going to be part of big data pretty soon is genetic information. I think it’s just a
matter of time before doctors are ordering genomic screens, the whole genome, and somebody is
going to have to store that information somewhere and when it’s stored then somebody is going
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to want to use it for research, so that’s number one and that will take a lot of space, that will be
really big data.
Number two, there’s a lot of work to be done on patient privacy and the oversight of this
research. Yes everything has to be done to keep this data secured and protect people’s privacy.
On the other hand, when these studies are not posing any physical harm to patients because
we’re just looking at data, you do not need to require that a patient sign a 10 page or 20 page
consent form. Even in certain randomized trials, yes, you need a consent form but it doesn’t
need to be 20 pages long if it’s a very low risk question. So I think figuring out these issues
about now that we’ve got big data, how do we work with IRB’s and human subjects oversight to
rationalize how we use it and how we talk to patients about use. I think a subpart of this is we
have got to learn to talk to the patients about how these data, how and why these data are being
used and why it’s a good thing and certainly leave room for people to opt not to participate, but
mainly beat that drum that, you know, we’re practicing with uncertainty. We don’t know what
we’re doing and we can learn from the data and you could contribute.
The third thing is just the extreme costs. We have to look for ways to make this more
efficient cost-wise and I think part of it is deciding that there’s enough value in getting the
answers to the questions that can be asked and that you give up on the notion that your data is
one of the ways you make money. I think some of the big HMO’s and others have seen their
data as a commodity that they can capitalize on and that really gets in the way of data sharing
and being in the learning healthcare system.
As for patients having the ability to make data driven decisions, part of the research we
fund is research on how do you help patients make these kind of decision. So it’s one thing to do
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the studies and get the data, it’s another thing to present the data in ways that patients can
appreciate, even the clinicians can appreciate. When you get to genetics, most doctors wouldn’t
have a clue what to do with the results of a genomic screen, so you really need to figure out ways
to take the data and take what’s known and put it into a format that people can use it.
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“A Sentinel that Signals Problems Ahead”
“Arnold Daniels, Ph.D., Pharm.D., M.A.”

Professional and Academic Experiences
Towards the middle to the end of the 90’s the drug costs were going up dramatically, the
cost of the benefit. Some drug companies would ask us to do really unethical things to cut their
costs without making hard decisions. I was always in a position where I could stump it and I was
caught off guard by this so I sought some formal training and some help from some different
ethicists that could help me figure this out and I wound up working with a couple very prominent
philosopher ethicist types. From there, I wound up doing a doctorate in medical humanities
because once you get into the ethics and you start to understand the place of illness and the
human condition really want to understand that, it’s the humanities that renders it much more
clearly than any science does. So I pursued the ethological end, that’s where my mind usually is
and my greatest interest is where illness and the arts kind of work together.
The research we did was often using that huge administrative claims database and we had
combined it with other things. So it could be prescription records, it could be prescription plus
medical, but we had tens of millions of people that we had data on that we would use to do
various research, look for various trends, help for our planning. We used it to affect drug
selection, drug utilization by sending messages to docs, sending messages to pharmacists,
messages to patients. We could send docs information about a certain patient’s patterns of drug
utilization, and did, so they could take care of their patients better. We worked with public
health officials from time to time to show them certain trends. Sometimes, we were just being
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silly and we would look at things like the effects of drug utilization after a certain TV show and
focus on it.
My patient advocacy organization has been around for quite some time now. We are
responsible for I think at the highest level beating back the utilitarian impulse we all have which
is to do the most good for the most people. We also have patient assistant programs that can help
patients find money to pay for co-pays, premiums, etc.

Meaning of Big Data
Big data has gotten to be almost like a parody. ‘Big pharma’ was a way of distinguishing
the big institutional pharmaceutical giants that had almost unlimited resources and influence
whereas those who were not ‘big pharma’ didn’t. So that’s how I understood the first use of big
data in that fashion. I don’t think of big data as any particular company. I think of it as data sets
that have huge numbers of elements and are organized in a way that can be mined to discover
things, but also can be used to alter the course of events and improve performance and outcomes.
I think of it mostly in a predictive way. We helped physicians and pharmacists make decisions
about drug use for individual patients at the moment their deciding based on what is in the files,
how we can access it, the sophisticated systems and the software allows us to access it, analyze it
and produce something that’s usable in split seconds. So big data to me is not just a big data set;
it’s also how it can be used to alter a course of events or approve some sort of outcome from
parking to healthcare.
I arrived at this description by seeing it, being involved in it. I was part of the group that
would write rules that would affect how certain prescriptions that came in through our system,
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how they would be adjudicated, you know, when would we send an alert out to a pharmacist that
says look below. We tell a patient that more information is needed before we can adjudicate the
claim or not based on what was in their file or not. I saw the power of big data or what was
available from a lot of the big database sites we were in. I’m paying attention to what’s going on
out there like what IBM does with some of these cities: manage traffic, manage water, etc. I
mean every time you turn around it’s a big data conference; it’s the big thing.

Medicine as an Information Science
I’m going to say no. Medicine can use it, it applies it but it’s not it. Medicine still
requires listening to the stories, it’s touching and hearing and smelling, and all that. So
information is part of it, like I said information is part of the decision support systems but that’s
all.

Healthcare Big Data Drivers
Some of it is the science. Now that we’ve sequenced the genome, now big data involves
the computational biology, you need big data to just be able to make sense of all that genetic
information. Some of it is just trying to make sense of all the information that we have now so
it’s an organizing approach. How do we make sense of all the data that we’re getting from the
science? There’s a lot of pressure on clinical performance and there’s a lot of pressure on the
economics and with good reason. There’s thinking that you can use a lot of information to create
these decision support systems needed to come from big data. Again, it’s kind of the predictive
analysis. That helps people understand what they should do or help them make decisions. I
would say that those things that are driving it in healthcare.
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Sources of Data and Data Scientists
I think where big data could come in real handy is the diagnostic odyssey. The average
time for people with a disease to get diagnosed is eight years. It ranges from eight minutes to 80
years, but it’s a long time and you just hear these stories constantly of people who have gone
from doctor to doctor to doctor, test to test to test and it just takes a long time and while if you
spent some time in healthcare like in the clinics and in the hospitals and while you see that the
docs will always list the disease and their differentials to show their brilliance and their chops,
it’s rare they’ll go after it because the mantra in medicine is common things happen commonly
so don’t waste your time on the esoteric.
What big data could do is to help bring some precision to when a patient is presenting
whether or not there’s a strong likelihood of a particular illness. This is what I suggested to my
Watson friend there at IBM was you could add into this, they take a lot of the clinical data,
scientific data, but I think you should add in the patient experience. That trajectory is
meaningful. What docs do they go to first? Which ones sent them on their way? What was the
sequence of docs they saw? What sequence of drugs they might have been given, what was the
sequence of tests, are there certain things that you could make out of that that are consistent or at
a high predictive value for a given disease that you could interrupt that odyssey early. That to
me would be an important application of big data in healthcare.

Unintended Consequences
I’ll tell you, in my professional focus, time really matters, and there’s so much damage
done by that duration that the time it takes to get diagnosed, so much damage done in that period

123
of unnecessary tests, etc., that it lowers that risk. But that risk is there. All it can do is predict
and so there’s certain probabilities of being right but it comes with the probabilities of being
wrong so it could be a problem.
Repurposing of data – it’s happening actually. I don’t know if we’d say data is being
repurposed, there’s a bit out there, there are a lot of drugs that are sitting in laboratories or were
on the market and taken off for a variety of reasons that are being repurposed for rare disease. I
suppose what comes with those drugs is information on them and they wind up, there’s several
drugs that have just either fallen by the wayside and get brought out because additional
investigations find out that they have a role there. So it’s a combination of bringing out the old
drug and using the information available. But that’s big and actually causes a lot of problems
because it could be effective therapy where there wasn’t any before. But sometimes they pull out
these drugs that cost pennies and they get repurposed and then charge hundreds of thousands of
dollars a year. But with the drug comes data. I suppose you could say it’s been repurposed.
Big Data’s Future in Healthcare
Well the hope is that its use is predictive in a few ways. One is to be able to use it for
surveillance, to be able to find in clinical trials. And so those one in a million events that can kill
people, one in 100,000 are myths and so big data should be able to conduct a surveillance that
serves as a sentinel to find the signals or problems ahead. So part of it surveillance for problems
… picking up signals that could not be picked up in the pre-clinical testing phase.
The other is to be able act as decision support for patients and for whoever is taking care
of people to know that with a certain set of attributes and certain environments what’s going to
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happen to these patients with a range of options. That’s the future state that I’d like to see. Now
it’s threading the needle, I don’t know if you have, but I have, where there’s way too much of a
reliance on technology and information I think on the part of healthcare professionals. Even just
these clunky electronic health records, the doc doesn’t even look at you anymore. They’ve got
their head in the computer, let alone take the stethoscope out and listen or just take a look at you
or listen to your story. So the future state also somehow doesn’t create this automaton of a
healthcare professional, nurses, you name it, who forgets that there’s a human-being setting right
there and just produces these weird robotic type of interactions where they don’t think about the
situation.

Metaphors and Symbols
I’ve used it but I count on experts to help me with it when I need it. So to me big data is
very non-descript. I can’t come up with a metaphor because I really don’t know. It’s not
descriptive enough for me. I don’t know if people in big data, I wouldn’t know what they’re
talking about or when they talk about it, do they mean just how it’s set up, are they just talking
about volume, are they talking about a certain type, are they talking about certain capabilities
with it, or is big data just like lots and lots of information in a particular area or does that also
encompass the things you can do with it, I don’t know. So to me it’s too vague to even come up
with a metaphor.

Closing Thoughts
I think the cause of big data would be better served by characterizing it more clearly for a
lot of us and their own constituencies if they want to be able to move forward. People can be
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afraid of it, so between not really understanding what’s meant by it and by being afraid of any
big thing, it needs to be clarified and demystified because I’m not sure what the hell they’re
talking about.
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“An Unnecessary Euphoria”
“Frances Milburne, M.D.”

Professional and Academic Experiences
I spent about 13 years at a managed care plan were my involvement with data and
analytics really was about primarily learning how to think about populations in healthcare
because as you probably are aware most clinicians really only think about the patient in front of
them or a handful of patients at a time and aren’t really used to thinking in terms of populations.
Certainly my public health background and then the fairly exciting work that was going on at
there at that time in the early 1990’s on population management and how clinical medicine
needed to be thinking about chronic illness care from a population perspective. That was work
that was done by Ed Wagner and his colleagues. I found that very intriguing.
I left the managed care plan in the late 90’s because I’d actually been sharing my practice
with a clinician who had gotten informatics training and was also an internist and I became
aware though just conversations with him about how important the electronic health records
were going to be. This was long before there were any electronic health records but I then had
the opportunity in the late 90’s to help start up a clinical network for a university. So that was
really where I began thinking about data from a clinical perspective on a more organized fashion.
I do not have training in informatics; it was really on the job. So I moved after several years into
a role of being the medical director for clinical informatics. While I was in that role what I
basically did was start setting up reporting out the backend of the EHR’s which nobody was
doing at that time. In fact, even though we were using what is now probably the pre-eminent
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EHR in the country, it did not have any way to report out of the backend and so I actually wrote
a grant to one of the pharmaceutical companies to get a beta version of their relational database
that’s now just standard operating equipment for the EPIC installations but we tested it out and
started generating clinical reporting out of the backend for things like diabetes, heart disease,
hypertension and stuff like that. So that was really my experience, it was on a very, very
practical application.
Another activity that I was involved in that sort of overlapped with that somewhat or at
least from a privacy and security perspective was essentially set up at the request of several
governors at the time try to come up with some national standards for health care information
exchange simply because each state had its own rules and regulations and policies and
procedures and it was becoming very, very challenging to exchange health information across
state lines. So that was some insight into some of the issues around handling large data.

Meaning of Big Data
What big data means to me is that you assemble information from multiple sources that
then get assembled in a large dataset and who knows where that actually resides in various
servers around the country or even around the world I suppose which is sort of euphemistically
referred to as the cloud and assuming that privacy and security constraints are being
considerations for being adhered to which is I think a big question mark. Then you know there
are certainly ways that large datasets can be used to recognize patterns which are otherwise hard
to spot.
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I don’t even know where it’s all coming from but I think there’s a sort of euphoria being
built around big data that is not necessarily, I think it’s, and you get this sense there’s this sort of
train leaving the station and everybody is supposed to get on it and yet as I said I think where
information has the greatest potential to improve health and raise cost is in the way it’s used in
individual provider’s practices and in delivery systems. But, I think there are some really risky
things about big data.

Medicine as an Information Science
Clearly medicine is a very information rich endeavor. I mean it’s one of the most
informative, it’s orders of magnitude more data rich than finance let’s say. A lot of the models
that we come up with for certain thinking about how to handle big data are based on finance, but
it’s just orders of magnitude more complicated. So I think there’s no question that it’s an
information science. It’s more than that though because it doesn’t lose its human side. What I’m
referring to is the fact that so much of the information we use in medicine is imprecise or
irrelevant or just background noise. Computers are really good are really good at setting things
up so that they flawless. They will do the same task with the same information over and over
again so they’re very good for example at prompting humans to remember to do things that have
to be done over long time intervals that are really easy for us to forget like screening and they’re
very good at presenting information in patterns that we’ve programmed the computer to present
information in. The other thing computers are really good at is when we have to actually slow
down and think something through and figure something out then computers can organize
information in ways that make it easy for us to solve difficult problems. So that’s really the use
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of computers. But we have to remember all the time that computers aren’t anywhere near as
smart as the person that’s using them, so what the human brain is really good at is recognizing in
patterns where we didn’t know there was a pattern, computers can’t do that at all.
But I think it’s unrealistic to expect providers and patients to really adhere to strict
privacy and security standards which for the past 10 years we’ve taken very seriously and then
just find out that we just sort of shrug our shoulders. I think it really is a crisis that has to be
addressed.

Healthcare Big Data Drivers
I think industry really sees big data as an opportunity to selectively market to the
American people based on their individual healthcare needs. Now this may get sort of promoted
as if we can figure out which patients need certain drugs and we can get those drugs to them we
can improve their health. Unfortunately, the background reality is that Americans take way too
many medications; only a fraction of them really provide benefit. Certainly blood pressure is a
good example and some of the new biopharmaceuticals that are very specific for cancers or
certain immunologic disease is they have some targeting potential on that. So I suspect that a lot
of the push for big data is from industry, it’s not all the pharmaceutical industry, a lot of it is
medical devices.
I think the use of information in healthcare again as I said is really local and there’s a
cycle, I mean there’s actually a pattern there that I find extremely interesting and it’s basically
this: Information gets entered into the computer and it comes in from multiple sources. It may
come in from lab results and a lot of it comes in from just interactions between people and gets
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documented hopefully as structured data but also as text. Then that information now can be
acted on by tools in the computer that have to be set up. So the way that it’s of greatest
importance in the delivery of healthcare is as in its use in two ways. One, its ease in being shared
with other people including the patient so that more than just the doctor that has the chart can
have access to that information, but other specialists, hospitals, emergency departments, and
most importantly the patient can have that information. So that’s one thing that the flow of
information in the practice does that’s revolutionary.
The other thing I would say is that the public health community particularly is quite
interested in getting involved in the treatment or the management let’s say of chronic illnesses
and they really haven’t been able to do that up until now. Public health is primarily involved with
disease outbreak and particularly reportable diseases, infectious diseases, and then disaster
response. But to start to get involved in chronic conditions, obesity, diabetes, and heart disease
what public health is really looking for is information where they can identify places that public
policy can be driven by patterns of diseases that are right now hard to see: smoking habits,
nutrition, and places in the community where there are high rates of narcotic use.
Another one is just for public policy decisions. For example, where do we put our
resources and what are the biggest health threats to the population? So I think for the potential to
do that is from big data sets is really great. From the perspective of a clinician or a healthcare
policy person, that’s really driving improvements in quality.
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Sources of Data and Data Scientists
It depends on how it’s structured. Providers really don’t interact with big data on that
level. The closest thing that I could think of to that is a provider would have a hosted EHR so
they don’t have the servers in their own organization as is the case for small groups and rural
groups, and so that that information then is hosted externally. One example is the local Regional
Extension Center. They’ve been heavily involved in helping providers install their EHR’s and
have formed a collaboration with a data analytics company and so they then have access to these
streams of information on providers who they have no relationship with and they can basically
go to those providers and say do you know how you’re doing in managing your heart disease
patients and they say no we have no way to get that and they say well look let’s show you and
here is not only here is your population of patients with heart disease but here’s how you’re
doing and actually you know here’s the gap. Here’s where you want to be and here’s how you’re
actually doing. Let us help you fix your processes to improve. In fact, here’s a free iPhone app
you can have if you join our system and you can actually go in and look for individual patients;
you can see how they’re doing. You can also look at how they’re doing in aggregate and they get
their data from the EHR’s and through the laboratories and then they get billing data and they
can do this. So that is a way that I’m starting to see a developing and I think that sort of counts
in the big data, it’s not, certainly not de-identified it’s in a service provider realm that’s
developing.
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Organizational Challenges
I think there’s, it’s really hard to make a case of big data if we’re going to make it’s
where the money is and it’s been my observation that if we start getting sort of distracted by
these things that big data can do in terms of disaster response that that really leaves out where
most of the work that happens that is involved with healthcare quality takes place, and that is in
the provider’s office. I think it’s pretty hard to make the argument that it is going to provide a lot
of benefit for providers and patients on a one-to-one basis. I’m pretty skeptical about that.
I think most of the action with information in the EHR has to do with getting it into the
EHR so that it’s accurate which is a major challenge because there’s a lot of inaccurate
information in most of the EHR’s. Also, learning how to report out of it so that practices see
how they’re doing taking care of their populations on a very local level. So what percentage of
my patients, who are my patients first of all, that’s the big one, but after you get that, what
percentage of them have been immunized properly, have been screened for cancers properly, if
they have chronic diseases are being taken care of properly, that’s not a big data issue that’s an in
the practice use of data so I think that is where the real action is as far as use of the EHR’s.

Unintended Consequences
The downside I think there are two, and unfortunately I think this is where big data is
largely being used and what’s unfortunate is it doesn’t get talked about very much. The
advocates of even in public health tend to just sort of quietly move to another subject if you bring
these of negative uses of big data up because they’re so enumerative the potential. One of them
is marketing.
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The other place that I think big data entails a huge risk is simply in abuse from national
security. I think it’s very, very clear that the NSA is all over big datasets and there’s no reason to
think that healthcare is any different. Very clearly there’s a need for government to identify
individuals who may oppose risk to the rest of the population. But that’s a very, very different
proposition than gathering and doing large scale population surveillance and simply sucking up
everything. I think we’ve tended to shrug off the revelations that have come out over the past six
months or so about how large datasets are being used for security agency surveillance which is a
major departure from what we’ve assumed was the case in the past.
I think that by setting up large datasets in healthcare in the cloud, I mean we can say that
they’re secure but those are now just words and so I think we may very well be coming to a point
where, well there’s something changing and it’s not clear to me what’s going to happen. I mean
the Europeans are certainly starting to sort of disconnect themselves from interactions that are
easily surveyed although they have the exact same issues there and certainly some of their
security agencies have been part of the whole thing, but I think we’re either moving into a field
where we just kind of give up on privacy and say well that’s kind of over or we have to say no
look we actually do take privacy and security seriously.
Big Data’s Future in Healthcare
Everything that I have talked about that I see as a benefit for big data can be
accomplished if the data are completely de-identified. So public health surveillance, disaster
preparedness, situational awareness, disease patterns, public policy, every single one of the
beneficial activities or purposes can be accomplished if there is nothing in there that allows
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identification of individual patients. One can argue that if you put in some identifiers it allows
some additional benefit. For example, if you really wanted more information out of how people,
what percentage of people with asthma admitted to the emergency rooms are ending up in the
ICU and then a week later bouncing back then you have to put patient identifiers on them. You
can get that same information out of delivery system data on the local level if you find a place
where you need to investigate further.
So my vision would be that big data sets first of all have strict purposes rather than let’s
create big data and then figure out what we might do with it. I think there needs to be a what are
we addressing, what information do we need, and how are we going to use that information. I
think that first of all patients need to be informed of where their information is going so that they
know and I think they should have an opportunity to opt out if they don’t want it. Then I think
that any information that’s gathered and compiled and aggregated and then looked at for public
policy or for any of the public health purposes we’ve talked about should be strictly deidentified. That would be a vision there for what it might look like. Then I think you would
avoid the two pitfalls which are marketing and a lot of the national security abuse I think would
be avoided in that case.

Metaphors and Symbols
I spend a lot of time thinking about information, but as I said most of it is on a very local
level. For example Accountable Care Organizations will really only work if everybody
understands the metrics against which they’re being compared and everybody is using the same
metrics, every insurance company is using exactly the same metrics, so one is the saying well
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we’re measuring the percentage of patients who have hypertension who have a blood pressure
average on the last three or whatever under 140 over 90 let’s say, and the next insurance
company says yeah we’re doing that too only it’s actually greater to or equal to, less than or
equal to 140 over 90. Those are two totally different targets because people round to whole
numbers. So and blood pressure is imprecise, or one might say 130 over 80.
An ideal system would be one in which the providers actually have an internal dashboard
that’s identical to what the payers are seeing and that the providers are allowed to manage their
outcomes to where they get to a point where they say we’ve got them where we want them, now
we send them to the payer and they can come and audit us and make sure that our process is
correct. So I think we’re going to have to have a lot of transparency. So how do we set this up so
that we can actually manage outcomes and costs and agree that we’re both measuring the same
thing?

Closing Thoughts
I’d like to point out that what providers need more than anything is analytics. They need
to be able to use the information in their systems to tell how they’re doing and to figure out what
to do and to set priorities and that’s what’s lacking. It’s not clear to me that big data, the way it’s
set up in cloud base will allow that to happen but it may. One way that big data could be used is
to identify emergency high utilizers.
These are patients who are completely overwhelmed by their disease or their medical
conditions and their social situation, so they end up going back to the emergency room over and
over again and running costs up at an extravagant rate. It’s very destructive, and big data could
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be used to identify places and people where that’s happening. Big data can desperately identify
social and mental health services needs and that’s the type of thing that probably should be done
inside a practice.
So there’s lots of ways that this could be brought in to help in specific situations. But I
once again want to caution the way we’ve gone about this is let’s build huge datasets and then
I’m sure some great social benefits will accrue. I think what we’ve done is we’re raising the risk
of what I consider to be misuses of data in ways that are not necessarily in the public interest.
Yes, there clearly is a role for big data in public health policy, public health intervention, and
high utilizers and I’m sure other uses will show up. So having big data capacity is I think very,
very useful. Again, I don’t see that it requires identifiable information but you know that may or
may not hold up.
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CHAPTER VI. RESULTS

Overview
This chapter provides the research study’s findings assembled through a general inductive
approach to qualitative research which is commonly used in healthcare (D. Thomas, 2003). Data
were collected through nine semi-structured interviews with key healthcare stakeholders from
three classes: government, providers, and consumers (advocates). The results describe (Amedeo
Giorgi, 2009) and interpret, as accurately as possible, a first-hand account about the phenomenon
of big data in healthcare across and within the three key healthcare stakeholder classes.
Triangulation of the three stakeholder groups was an important strategy that facilitated any
inclination towards researcher bias. The analysis was anchored by the following research
question:
Q1: Within and across the narratives of three key healthcare stakeholder classes, what
are the important categories of meaning or current themes about big data in healthcare?
Further in-depth analysis produced “units of meaning” used to reconstruct key stakeholder
narratives into a cohesive yet agile statement about the meaning of big data in healthcare –
without losing the essence of narratives in their entirety. The words of Van den Berg, translated
by Van Manen (1997, p. 41) profoundly captures the essence of phenomenology as both a
philosophy and a research method:
[Phenomena] have something to say to us — this is common knowledge among
poets and painters. Therefore, poets and painters are born phenomenologists. Or
rather, we are all born phenomenologists; the poets and painters among us,
however, understand very well their task of sharing, by means of word and image,
their insights with others — an artfulness that is also laboriously practised by the
professional phenomenologist (M. Van Manen, 1997).
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Explication of the Data
Groenewald (2004) revised Hycner’s description of “data explication” (Hycner, 1985),
suggesting “the term [analysis] usually means a ‘breaking into parts’ and therefore often means a
loss of the whole phenomenon …whereas ‘explication’ implies an … investigation of the
constituents of a phenomenon while keeping the context of the whole” (p. 17). Explication
resonated with my edict to maintain the essence of the key healthcare stakeholder narratives. As
such, explication of the data was yet another strategy to eliminate any predisposition of
researcher bias on the research design.

Results
Four distinct, yet interrelated, important categories of meaning naturally emerged during
the course of the data explication: (1) Ontological Framework of Big Data in Healthcare; (2)
Humanistic Dimension of Big Data in Healthcare; (3) Information and Knowledge Science for
Big Data in Healthcare; and, (4) Governance of Big Data in Healthcare. A description of each
category of meaning and the number of times an event was coded within each “theme” is found
in Table 7. Through the process of reading and rereading the text of the transcripts,
contextualized data initially produced approximately 41 initial nodes. These nodes were reduced
to 17 distinct “subunits of meaning,” categorized into the four “important categories of meaning”
Each category of meaning constituted the essence of big data in healthcare as described
by nine leaders from three key healthcare stakeholder classes. The general inductive approach
allowed me to derive a description and interpretation of the key healthcare stakeholder narratives
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while also presenting a description of the categories of meaning within and ultimately across
each key stakeholder class.

Table 7. Description of four important categories of meaning of big data in healthcare reduced
from over forty sub-meaning units.
From a Husserlian phenomenological perspective, the description of narratives, even
though transcribed and possibly written, still remains a description (Amedeo Giorgi, 2009).
Keeping with the construct of phenomenology, my objective was to also engage in the
interpretation of the study participant’s interpretation (“double hermeneutic”) of big data in
healthcare. I consciously set aside my own presuppositions so as not to bias the data explication
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and interpretation through bracketing (Groenewald, 2004) out my own experiences about big
data in healthcare. Bracketing was yet another strategy to control for researcher bias. Using the
raw transcripts as a primary reference, the clustering of important categories of meaning
(“themes”) emerged iteratively through the study participant’s own words.
Phenomenology focuses on the common elements of a phenomenon, rather than on the
individual. In keeping with this aspect of the chosen methodology for the study, I did not include
participant names or pseudonyms in presenting excerpts from the interview transcripts. The
header box before each category of meaning was extracted from Figure 7 to assist maintaining
the reader’s orientation of each category of meaning and associated subunits of meaning.
Findings were not intended to be generalizable across or within key healthcare stakeholder class.
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Ontological Framework of Big Data in Healthcare

Category Definition
This category refers to an informal representation of interrelated concepts, knowledge,
words (and buzzwords) and phrases that describe the characteristics, attributes, and meaning of
big data which produce information for wisdom and decision making in healthcare. In addition to
Gartner’s popular characterization (not definition) of big data as Volume, Velocity and Variety
(3V’s) is here augmented with another “V” - Value (Porter & Teisberg, 2006). Value is created
by producing, through the disciplines of information and knowledge management, usable
information for healthcare intelligence and decision making. These attributes and characteristics
encapsulate big data’s realized – not potential – intent. Many study participants exhibited a
skeptical position on big data in healthcare by characterizing it as “over-blurted”, “a parody” and
“the latest craze” and observing the “expression is overused.” Or as a government stakeholder
said, “it’s a heap of 1’s and 0’s.” When study participants did define big data, intuitive
references emerged such as “smart data” that has an ability to “answer questions more deeply
and get down to the causes as opposed to scratching the surface” as described by another
government stakeholder. This category refers to both human and organizational forces and events
which drive the emergence of big data in healthcare. Big data drivers are those internal and
external forces of the healthcare ecosystem which possess the ability influence or drive the use
and advancement of big data in healthcare. Big data influencers could be a thing (e.g.,
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technology), a policy (e.g., Affordable Care Act) or an attribute (e.g., better question generation).
According to McKinsey, fiscal concerns, or healthcare costs are the primary driver of big data in
healthcare.9 Provider billing policies, public health surveillance, and marketing to individual
patients were cited as other drivers of big data in healthcare.
1.1 Purpose
The analysis found that big data in healthcare must be collected with a purpose that is
well defined during the initial planning stage for a project or initiative. Because of the massive
data sets that are collected and the associated costs of designing systems to capture and analyze
big data, a stakeholder posited:
You build data systems, they cost so much money to actually collect the data it’s
quite expensive. They’re built for specific designated purposes and it’s fairly
important that you know what the purpose is before you start. I just did a
carefully designed data system that is very purpose specific. They’re designed for
a specific utility a specific purpose and they just happen to collect massive
amounts of data but they’re always for a specific purpose (Provider).

A government study participant pointed out the unintended consequences of purposedriven big data by stating, “Purely relying on machine learning without the application of
subject matter expertise and the application of a clearly defined set of goals can lead to big data
actually distracting an organization from its core goals and outcomes.” While potential
nefarious uses of protected health information do exist, study participants overall welcomed
repurposing big data for an array of uses:

9

http://www.mckinsey.com/insights/health_systems_and_services/the_big-data_revolution_in_us_health_care
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So public health surveillance, disaster preparedness, situational awareness,
disease patterns, public policy, every single one of the beneficial activities or
purposes can be accomplished if there is nothing in there that allows
identification of individual patients (Consumer).

Another consumer stakeholder agreed with the ideology of planning, with a purpose, for
big data collection. Planning for big data usage at the onset of a project or initiative suggests that
simply amassing large data sets as an organizational asset is only part of the strategy to realizing
big data’s true potential:
So my vision would be that big data sets first of all have strict purposes rather
than let’s create big data and then figure out what we might do with it. I think
there needs to be a what are we addressing, what information do we need and
how are we going to use that information (Consumer).
1.2 Precision
Terms including precision medicine, personalized medicine, and resource-based medicine
are interchangeable references to medicine that, at the very least, combines transactional data
(e.g., claims) with computational biology, and genomics data based on an individual’s genetic
and social epidemiology profile. The meaning unit – precision – was not interpreted as the
process of collecting and managing big data but big data’s trustworthiness. The combined
attributes of big data quality and trust creates confidence in the level of big data’s preciseness. A
provider government stakeholder states, “I think one of the problems is trust in data quality and
data fidelity.” He further expressed his view on a lack of confidence in the precision of big data
connectedness:
I think people don’t really know yet if this is something, you know, put everything
in a little black box and it comes out the other end and it gives me a relationship,
and people say I’m not so sure if that actually is true or not (Provider).
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While one provider study participant voiced his concern that, “there’s no proof point yet
that is kind of real concrete,” another study participant from the consumer stakeholder class pins
his hopes on the premise that big data precision is necessary to support optimal hypothesis
generation in patient episodes such as rare clinical cases:
So what big data could do is to help bring some precision to when a patient is
presenting whether or not there’s a strong likelihood of a particular rare disease
(Consumer).
A government stakeholder cautions, “Big data is currently fraught with hype and over
promising.” He also believes big data “is an area of incredible promise for healthcare.”
Furthermore, there are approximately 500 petabytes of healthcare data in existence today and
that number is expected to skyrocket to more than 25,000 petabytes within the next seven years
(Savaiano, 2013).10 According to several stakeholder narratives, these clinical and administrative
data held in fragmented information systems will not produce the timely and accurate insights
yield better questions for better answers. A government stakeholder adds:
I think everybody’s hope is that in five years’ time, there will be widespread
integration of administrative, clinical and patient generated data that will be
available through big data; it’s assuring that the right person gets the right data
at the right time and the right format for them (Government).

10

In the construct of Orders of Magnitude, a petabyte is the equivalent of 1,000 terabytes, or a quadrillion bytes.
One terabyte is a thousand gigabytes. One gigabyte is made up of a thousand megabytes. There are a million
petabytes in a zettabyte.
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1.3 Provenance

The consumer stakeholder class elicited responses that focused on the individual and
population health informational needs: “we’re really interested in how treatments work for
individuals.” Provenance of big data, which one study participant suggested is the vital
commodity, notes, “data is very nondescript.”
Data provenance refers to the information sources about data and includes data points
such as contextual and physical metadata and Meaningful Use attestation data. In the government
stakeholder class, one respondent spoke of the integration of genetics stating, “We were getting
lots and lots of data coming in from the genome sources from that point and we were injecting it
and trying to be able to analyze it.” Life science disciplines including biomedicine, neuroscience,
genetics, and genomics were intentionally excluded in the definition of big data in healthcare. I
intentionally wanted to let life sciences narratives naturally emerge from the narratives, provided
study participants viewed the subject as an important theme. Genomics did naturally emerge
from the narratives as an important source of big data (“New data sources including genomics,
senomics,and other “-omecs” are out there. Metropolomics, for example, are generating huge
amounts of data that need to be processed in ways different than we have in the past”). In
deference to Gartner’s classification of big data, genetics and genomics fit into the High Variety
classification group. Genetic and genomic data are fundamental to achieving precision in clinical
hypothesis testing and is foundational to delivering personalized medicine. The richness of
genetic information was championed across all stakeholder classes:
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Government:
I think genomics and the ability to do sequencing is the first statement of it [as a
driver of big data]. You know, there are a lot of things where we’re getting ideas
into genetics, we’re getting them information about environment, and we’re
getting information on health. What affects us, what affects us mentally, you
know, our health affects our mental state and our mental state affects our health,
our emotional states (Government).

Providers:
I mean the integration of genomic data phenotypic data which is clinical data in
the electronic medical record. It’s something that every academic medical center
is racing to do because the answers are not going to be in one or the other. The
answers are going to be in the combination of both and so that is absolutely the
future, a very reasonable approach (Provider).
I think the whole genome sequencing components so again some more of the
genetics side of the equation over the patient’s life span and helps predefine
clinical context based on the genetic information. So I think that’s hopefully going
to help us with neurogenetic diagnosis decision support in the electronic medical
record again so some of the things you see in 23andMe.com may be more
sophisticated in terms of patient genomic test reports and that kind of thing
(Provider).

Consumers:
Well some of it is the science, you know, now that we’ve sequenced the genome,
now big data involves the computational biology, you need big data to just be
able to make sense of all that genetic information (Consumer).
Something we didn’t talk about but is going to be part of big data pretty soon is
genetic information. I think it’s just a matter of time before doctors are ordering
genomic screens, the whole genome, and somebody is going to have to store that
information somewhere and when it’s stored then somebody is going to want to
use it for research, so that’s number one and that will take a lot of space, that will
be really big data (Consumer).
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Although information for decision making as an output of big data was important to key
stakeholder classes, almost all study participants were still plagued by the quality and
trustworthiness of big data in healthcare, as one study participant put it, “I think there are some
really risky things about big data.” Another study participant gathered:
I think the cause of big data would be better served by characterizing it more
clearly for a lot of us and their own constituencies if they want to be able to move
forward. People can be afraid of it, so between not really understanding what’s
meant by it by being afraid of any big thing, because big things you know can take
advantage of not big things, there needs to be, whoever big data is, whatever it is,
it needs to be clarified and demystified I think, mainly clarified I’d say because
I’m not sure what the hell they’re talking about (Consumer).

Several study participants emphasized the emergence of other new data sources into the
big data equation, including “biometric data from sensors which people tend to get excited
about,” and the emergence of “device interoperability and the data the comes from medical
devices.” Among all of the transactional and biometric types of data mentioned, one respondent
added a forgotten source of data - narratives:
I’m not against that whole thing on natural language processing and using
narrative, it just has a different goal and the goal is to try and take somebody’s
really unstructured but maybe highly intelligent thinking and try to sense what
general thing were they getting at, what can we discern from that … (Consumer).
In two key stakeholder narratives, big data was characterized simply as “a whole heap of
1’s and 0’s” and “at the end of the day you got a machine language that’s all 1’s and 0’s”
without structure, governance, and purpose. As a government stakeholder speculated:
“I know that some people consider big data not to be ‘big’ until it’s in the
trillions, but we manage 400 billion discrete pieces of information … and it’s
growing by about four or five billion data records a year.”
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Of note is Gartner’s High Variety characterization of big data. Healthcare is a
transactional business that relies on “administrative data as the foundational component.” But
stakeholders highlighted a host of data sources commonly used in their day-to-day routine,
acknowledging that, “it’s incomplete and inaccurate and there are no common standards.”
“missinginess” is a big problem, and there are an “infinite number of data points I could
collect.” The following table (Table 8) provides an aggregated summary of the sources of big
data cited by study participants.

Government
Enrollment Data
Hospital Data
Physician Data
Assessment Data
Laboratory Data
Medicare Data
Medicaid Data

Articulated Big Data Provenance
Providers
Consumers
Financial
Social Media
Administrative
Public Data
Human Genome Project
Demographic Data
Human Microbiome Project Physical Measures
Meaningful Use Standards
Personal Medical History
Management Treatments
Narratives (Stories)
Other
Sensors/Biometric

Table 8. Big Data provenance of referenced in key stakeholder narratives
1.4 Gartner 3 V’s
In the provider stakeholder class, two of the three study participants said big data “means
a lot of different things to a lot of different people.” Gartner’s “3V’s” characteristics were
referenced by several study participants across the three classes. One provider study participant
said, “I like the definition that Gartner coined … where big data is a high volume, high velocity,
high variety information … used to enhance insight in decision making.”
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Provider stakeholders require speed, or in Gartner’s characteristic of big data, High
Velocity to provide the best clinical care at the lowest cost. But there is more work to be done to
fully realize the “hype” of big data in healthcare. A provider stakeholder referenced the work of
IBM and its capability to “consume all the literature so they don’t have to read it.” Another
stakeholder noted:
So something that hasn’t been fully mapped out into the analytical processing
scheme that I want is something that’s more real time feed that I can actually act
upon much quicker. So there will be some components that are real time, some
components that are like data warehouse and dashboard based, and then some
components that are for big data for large data sets and for better insight. So I
can go to my big data to find the hypothesis. I can go to a data warehouse to test
that hypothesis and I can use my real time data to basically put that hypothesis
into action with decision support (Provider).
Summarizing the insight of the many study participant viewpoints on the Gartner’s “3V’s”
characteristics of big data in healthcare that are currently in use and those which we can
anticipate, one study participant asserted:
The sources of data that we use are pretty varied even though I’d say that
administrative data is the foundational component. It actually meets the Volume
and the Variety criteria we use records for multiple parts of the Medicare system,
the Medicaid system, the enrollment data, hospital data, physician data,
assessment data, laboratory data, Medicare data, and Medicaid data. I know
we’d obviously be interested in adding other paired data to the mix. Then there’s
survey data, there is some pretty rudimentary Meaningful Use attestation data but
we don’t have any actual Meaningful Use data yet (Government).
1.5 Value
Consistent with increasing healthcare costs, one provider healthcare stakeholder believes,
“Value based purchasing and moving away from the lack of accountability of fee—for service-
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service” is key driver. Consumers of healthcare seek personalized medicine that is unique to their
individual medical care and treatment plans. One consumer stakeholder gathered the “rapid rise
of performance measurement” is a driver of big data in healthcare. Clinical performance
measures (CQM) are developed by measurement developers to focus on patient-centered
measures and the patient experience, creating value for patients. Another stakeholder believes
big data is being driven by healthcare industry marketing strategies. The stakeholder proclaimed,
“Industry really sees big data as an opportunity to selectively market to the American people
based on their healthcare individual needs.” Then he further elaborates it is possibly all
unnecessary:
I think there’s a sort of euphoria being built around it that is not necessarily, I
think it’s, and you get this sense there’s this sort of train leaving the station and
everybody is supposed to get on it and yet as I said I think where information has
the greatest potential to improve health and raise cost is in the way it’s used in
individual provider’s practices and in delivery systems (Consumer).

National health spending has grown at historically low rates following the deep recession
that ended in 2009. Whether this slowdown stems from broader economic factors, structural
changes in the healthcare system, or some combination of the two,11 big data in healthcare is
seen as a commodity that if harnessed by technology and humans, can help make the delivery of
healthcare even more cost-effective. But there was general disagreement on whether the costs of
building healthcare systems and collecting and analyzing data is rising or falling. A government
stakeholder says, “It’s much cheaper to collect big data and it’s cheaper to store it,” and a

11

Source: Kaiser Family Foundation (www.KFF.org)
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provider stakeholder adds, “Hardware is getting faster and is making itself available at low cost
points.” But another healthcare leader suggests that the exorbitant costs of collecting big data
have to justify their spending to manage big data:
First of all it costs a certain amount of money to extract the data and analyze it.
So organizations spend billions building up these systems but they have a hard
time justifying spending a million to analyze all that data, so it just is crazy but
that is seen as a challenge (Consumer).
Another consumer stakeholder is in agreement. He speculates that there is an association
between deriving enough value from searching for optimal answers and good questions:
The third thing is just the extreme costs, you know, we got to look for ways to
make this more efficient cost-wise and I think part of it is deciding that there’s
enough value in getting the answers to the questions that can be asked that you
give up on the notion that your money is one of the ways, your data is one of the
ways you make money. I think some of the big HMO’s and others have seen their
data as a commodity that they can capitalize on and that really gets in the way of
data sharing and being in the learning healthcare system (Consumer).

Summary
There is an awareness problem about big data in healthcare. A consumer study participant
admitted, “Nobody’s ever defined it for me but I’ve heard it used a lot.” Another frankly
commented, “I never thought about it until you asked me. I just assumed that I sort of knew what
it was.” A government stakeholder narrative insightfully cautions us that because of the
awareness issues associated with big data in healthcare, big data could potentially loose its
momentum:
If I look at it today and big data has kind of lost some of the meaning that it had at
the early part and maybe even gained, and eventually will probably gain maybe a
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specific definition to make it useful again. Some government stakeholder views of
and formed opinions on big data in healthcare revealed feelings of cynicism and
relevance. Its existence and possibly importance is undeniable. However, it
requires a collaborative, momentous effort to define it and broadly diffuse its
meaning – fast (Government).
Another government stakeholder suggests that big data “is currently fraught with hype
and over promising,” and he also thinks big data “is an area of incredible promise for
healthcare.” Key healthcare stakeholders perceive big data as a buzzword or slogan that is not
universally understood. Also other drivers of big data in healthcare were uncovered – a consumer
stakeholder gathered that while the “rapid rise of performance measurement” is a driver of big
data in healthcare, another stakeholder believes big data is being driven by healthcare industry
marketing strategies (“industry really sees big data as an opportunity to selectively market to the
American people based on their healthcare individual needs”). A government study participant
confirmed McKinsey’s assertion that big data can influence the spiraling costs of healthcare. He
commented, “We need to make the care we deliver less expensive and more efficient overall.” In
addition, “culture and leadership” are important influencers of the explosion of big data in
healthcare. Another study participant supported the notion that government rules drive big data
in healthcare, “Because it places data and the ability to harness and leverage data at multiple
points throughout the healthcare ecosystem at the center as opposed to at the trenches.”
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Humanistic Dimension to Big Data in Healthcare

Category Definition
This category is a philosophical and ethical stance that, augmented with technology,
emphasizes the value and agency of human beings’ cognitive and critical thinking contributions
towards optimizing the potential of big data in healthcare. Big data in healthcare is foundational
to achieving precise decision making and refined hypothesis generation. The unparalleled ability
of the human mind is crucial to realizing the potential of big data in healthcare. The anatomy of
the human body which is a complex maze of interacting systems and organs that make big data
in healthcare unlike any other big data generated in industries such as retail, transportation, and
banking. The reduction of narratives in this category inductively generated four meaning units
including humanities, narratives, bioethics, and pattern recognition.
2.1 Humanities
Achieving big data in healthcare, according to government stakeholders is an ability to
link the capabilities of computers to the capabilities of humans. Where computers will facilitate
the movement towards Singularity, analytics still requires humans to make decisions based on
those findings. A study government participant pointed out, “it’s the human view of the data and
it’s transferring, it’s gaining knowledge out of that data, transferring it to the human so that the

154
human can actually do something useful with it.” Another study participant gathered there is a
complementary role for humans and computers:
The computer is not a human brain and while we have computers that attempt to
match many of what people do, much of what doctors do we don’t have computers
that can do all that doctors can do and that final step of processing, especially in
complicated cases really needs to take place in the human mind, but it is
processing of data for sure (Provider).

Computers, and specifically highly portable tablets and smartphones, have become
commonplace in inpatient hospital and outpatient clinic examination rooms. Technology is
essential to facilitating access to complex drug databases and interoperating with patient’s health
histories and narratives of other clinicians almost instantaneously. Technology is also
fundamental to establishing “health homes” for a physician practice’s panel of patients. Yet, with
the advent of health information technology, key healthcare stakeholders do not want to lose the
spirit of the doctor-patient relationship. A study participant in the provider stakeholder class
asserted that there is a “human therapeutic relationship between patient and doctor.” From the
analytical domain, providers see computers as being instrumental and necessary to provide
personalized care demanded by patients. Study participants from this stakeholder class
undoubtedly maintain that while the capabilities of computers and humans are vastly different,
they are interrelated:
Again, I don’t think it’s going to necessarily replace what we currently do. I think
you’re still going to need people who are going to have to, you know, the big
debate is will it be to the point where I don’t even need extraction (Provider).
Advocates for consumers were concerned about the erosion of the “human therapeutic
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relationship” between patient and doctor and cautions against the reliance on technology in the
exam room and at the bedside. A study participant hopes, “It doesn’t lose its human side.”
Another study participant commented on the over-reliance of technology and the sterilization of
the patient-provider relationship:
There’s way too much of a reliance on technology and information the part of
healthcare professionals. Even just these clunky electronic health records, I
mean the doc doesn’t even look at you anymore. They’ve got their head in the
computer, let alone take the stethoscope out and listen, or just take a look at you
or listen to your story. Somehow don’t create this automation of a healthcare
professional, nurses, you name it, who forgets that there’s a human-being sitting
right there and just produces these weird robotic type of interactions where they
don’t think about the situation (Provider).

Another consumer study participant expounded further on the differences between
computers and humans. Human brain cognition is rooted in “intuition” and “how humans are
really good at figuring out the relative importance of different conflicting information and
computers don’t do that well.”
2.2 Narratives in Healthcare
Narratives in medicine are usually captured at the point of care and are often embedded
in the patient’s electronic medical record. While this unstructured source of big data is an
important personal account of the patient’s experience, big data in healthcare is not usually
associated with “storytelling.” While narrative medicine is the one-to-one interpersonal clinical
conversation between provider and patient about illness, healthcare narratives captures the manyto-many conversations among healthcare stakeholders not just on illness, but about the
experiential accounts of healthcare processes, insurance, access, and a host of other purposes
related to the entire encounter with the healthcare system. A government study participant
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shared, “I can’t ever foresee a time when you won’t want to have the ability to collect narrative
for at least some of the electronic record.” One consumer stakeholder also suggests narratives
are an integral part of the human experience and should not be lost as a data source that is not in
the form of 1’s and 0’s:
This is what I suggested to my Watson friend there at IBM was you could add into
this, they take a lot of the clinical data, scientific data, but I think you should add
in the patient experience. That trajectory is meaningful. What docs do they go to
first? Which ones sent them on their way? What was the sequence of docs they
saw? What sequence of drugs they might have been given, what was the sequence
of tests, are there certain things that you could make out of that that are
consistent or at a high predictive value for a given disease that you could
interrupt that odyssey early. That to me would be an important application of big
data in rare disease (Consumer).

2.3 Medical Ethics (Bioethics)
Published scholarly literature on bioethical analysis customarily focuses on human
healthcare including issues of abortion, euthanasia, cloning, and health disparities. Big data and
information in healthcare is an emerging topic in the field of medical humanities and bioethics.
Big data bioethics was derived from the narratives of two consumer stakeholder’s experience.
The discipline of medical ethics allows moral discernment to ground the understanding of illness
and health. A study participant posits:
… once you get into the ethics and you start to understand the place of illness and
the human condition really want to understand that, it’s the humanities that
renders it much more clearly than any science does (Consumer).

Another consumer stakeholder introduces the element of uncertainty about what is done
in healthcare by policy and clinical professionals. By learning to talk to patients about big data
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and how it will be used to facilitate creation of individual treatment plans to cure illnesses, such
conversations present a moral dilemma for the entire healthcare system:
I think a subpart of this is we have got to learn to talk to the patients about how
these data, how and why these data are being used and why it’s a good thing and
certainly leave room for people to opt not to participate, but mainly beat that
drum that, you know, we’re practicing with uncertainty. We don’t know what
we’re doing and we can learn from the data and you could contribute
(Consumer).

2.4 Pattern Recognition
In healthcare, pattern recognition, or assignment of labels to variables is a key statistical
operation in population health and public health. There similar study participant views on
whether the computer is more adept at pattern recognition than humans. One study participant
proclaimed, “There’s a whole bunch of different things the human brain tends to work on
intuition and pattern recognition on a speed that is far faster than computers actually,” while
another study participant spoke of the advantages of the human brain and its pattern recognition
capabilities:
So if I want blood pressure to be set up as a graph so I can see whether it’s
getting better or worse with the individual numbers on a spreadsheet. They’re
very, very good at it, but we have to remember all the time that computers aren’t
anywhere near as smart as the person that’s using them, so what the human brain
is really good at is recognizing in patterns where we didn’t know there was a
pattern, computers can’t do that at all (Consumer).

Key healthcare stakeholders identified the human dimension as complimenting the
capabilities of technology (“I don’t have a really strong faith that computers are going to
somehow be smarter than people”), working as an integrated unit to achieve big data’s latency.
And the emergence of big data is well documented in industries including aerospace,
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transportation, and banking. However, in healthcare, big data is a very different and complex
endeavor which makes comparisons with other industries difficult. Comparisons of big data in
healthcare to other industries that have mature big data capabilities are spurious and as one study
participant remarked cannot be compared across industries:
I was giving an international speech in Brussels. While I was talking about
measuring quality and safety somebody got up and asked me, ‘well why don’t you
do it just like a bank has an ATM,’ and I didn’t laugh but I felt like it. I just said
because everything isn’t an integer, it’s not as simple as a balance sheet or
income statement, or a checking account. It’s a whole different ball game and the
relationship between processes and outcomes in healthcare is not totally defined.
You can give the same drug to two patients in the same way, the same age, the
same diagnosis and they’ll react differently, and it’s just we’re not making
patients (Government).

Another consumer stakeholder delved into the complexity of human organisms and the
connections across intricate bodily systems which constitutes the entire person. His narrative
supports the ideology that comparisons with industries that produce “widgets” and defines their
unit of analysis (e.g., retail) is unauthentic and that in the delivery of healthcare, the person has
to be viewed holistically, making big data in healthcare unique:
We’re looking at human-beings holistically. The reductionist approach I think as
useful as it has been needs to be augmented, I won’t say it needs to be replaced,
but it needs to be augmented, a much more holistic approach. You know, I can
look at cells all day long but until they're organized into tissues, into organs and
into systems and then into whole species and individuals it really sort of doesn’t
matter. So it’s understanding human health, understanding how choices we make
in policy, shifting policy decisions so that we put investment where it matters the
most as far as human condition and I think letting people realize their full
potential as far as health and happiness as well. My vision is if it can lead to
opening and the democratization of health (Government).
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Summary
Harmonization between technology and humans was an essential perspective shared by
many study participants of humanism in big data. While big data in healthcare is still an
emerging phenomena, stakeholders in the three key stakeholder classes uniformly agree that the
potential of big data will not be achieved without the complementary relationship between
humans and technology. It was widely suggested that big data in healthcare is vastly different
than big data in other industries because the complexity of human anatomy and physiology are
not comparable to any “widget” that can be defined and produced by other industries. A
consumer stakeholder summarizes this point succinctly:
One explanation is that one treatment is better than the other, that’s what you’d
like to think, but first you have to resolve the possibility that it might be because
the patients are different and that there’s confounding selection bias that patients
who get one treatment are just different in ways that effect outcomes from the
patients who get the other treatment (Consumer).

As humans and technology combine to realize the potential of big data, big data
information science and knowledge management is a framework that allows the vast “natural
resource” of big data to produce precise insights and knowledge. The next category explores
study participants experiential knowledge about the association and application of information
science, knowledge management and the role of the data scientist in healthcare and big data.
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Information Science & Knowledge Management and Big Data in Healthcare

Category Definition
This category consists of the interconnected fields of information science and knowledge
management, facilitated by a team of scientists, primarily concerned with the analysis, storage,
dissemination, and ontologies of big data and its knowledge engineering and visual
representation. This category also includes study participant perspectives and insights on the
skills and knowledge of the data scientist. The healthcare system, in part, is defined by its many
disparate transactional (e.g., financial) and claims information technology systems which are
created with the intent to derive healthcare intelligence.

3.1 Information Science
The intentionality of this important category of meaning arose from a hypothesis that
there is an implied relationship between medicine and the discipline of information science. In
saying true to phenomenological research, during the in-depth interviews, I did not frame a
definition of information science – allowing the conversation to flow naturally based on the
study participants experiential knowledge. Only one study participant inquired about what was
meant by information science. All study participants were asked to specifically state “yes” or
“no” and further elaborate either way. This study participant introduced the notion of cloud
computing and the assumption of its privacy and security:
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What [big data] means to me is that you assemble information from multiple
sources but then get assembled in a large dataset and who knows where that
actually resides in various servers around the country or even around the world I
suppose which is sort of euphemistically referred to as the cloud and assuming
that privacy and security constraints are being considerations for being adhered
to which is I think a big question mark (Consumer).
From the government stakeholder’s experience, it was generally agreed that medicine is
an information science, or at least it “could be.” One government study participant responded,
“I’m not sure I’m qualified as a non-clinician, but yes.” In the information-rich field of medicine,
when data was once a result of healthcare delivery, data and its resulting knowledge is now a
prerequisite for delivering high quality, cost effective care. One study participant offered an
argument regarding medicine as an information science is at the epicenter of care delivery:
It used to be you could almost argue it needs to be the center with providers and
beneficiaries orbiting around it or at the very minimum it needs to be on the same
level as what was previously considered the other core components in healthcare
delivery, clinical knowledge (Government).
One respondents’ narrative challenged me to reflect even deeper on the question and how
it was posed. Which discipline emerged first? Their responses elicited further exploration into
the history of medicine and information by commenting, “I would say that information science
pre-dated medicine and allowed medicine to prosper.” While this statement is arguable, it piques
a curiosity into further research and interpretation on the subject. A “double hermeneutic” was
also accentuated, as I attempted to interpret the study participants interpretation of what was
meant by an information science. The question objectively asked about medicine, but in
reviewing my reflexive field notes, I wrote, “… a definition of information needs to be included,
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and medicine could be misinterpreted as healthcare delivery.” A study participant highlighted
this point pretty succinctly:
Yes, absolutely, medicine has always been an information science but whether or
not that information has been at the individual patient level, at the group of
patients a provider takes care of or at the population level has been the thing that
has changed. So when we see the big data revolution we’re seeing that
transformation of the maturity of information science in medicine go from that
individual patient, the anecdote to the types of patients, the whole constellation of
patients I’ve seen my career, my experience, to understanding the relationship of
clinical and biochemical data across population (Provider).

The only stakeholder to definitively claim that medicine is not an information science
resides in the government stakeholder class. Even still, the study participant suggests big data is
“also about smartly moving information around clinicians,” which is suggestive of the
knowledge engineering and information sharing dimensions of information science. It is
disputable whether a definition of information science would have biased this study participant’s
negative answer about big data as an information science. Looking back on my field notes, I
documented the study participant was “very sure of his response and gave no indication of
uncertainty.” As sure as this study participant was certain medicine is not an information science,
another study participant concluded:
Oh I’ve been saying that for 20 years. Medicine is an inherently an information
science, the better data you have the better you can diagnose. The more
effectively you can select treatment, the better you can actually see those
treatments. It’s unquestionably an information science (Provider).

Unlike narratives from the government stakeholder class, a study participant from the
provider stakeholder class acknowledges a reliance on just transactional data generated in the
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delivery of healthcare which was collected for that singular purpose. This study participant
asserted:
I suppose you could add another of the Gartner’s V’s which is something that’s
been a problem has been Veracity meaning that all the transactional systems
work properly when people enter things perfectly the way it’s supposed to that
doesn’t always happen and even then just the way the data architecture is sorted
in the transactional systems that has really designed for transactional processing
(Provider).

As a dimension of information science and a core attribute of healthcare delivery,
including information technology and HIT interoperability, information sharing was discussed
extensively by each study participant. There was a desire (possibly influenced by legislative
mandates), among key stakeholder class to share data and information; however, a paradigm
shift has occurred, according to one government respondent: “[Data] is much cheaper to collect
and it’s cheaper to store … at the same time there’s a cultural shift going on where people are
much more willing to share it.” There was also disagreement about how much information is
shared and the consequences for (or not) doing so. One government stakeholder wittily
suggested:
We do share, but in my opinion we don’t share enough. If I share something and
lose out … then that kind of means I’m going to be less likely to share” or
furthermore, “organizations don’t want to share and we’re not necessarily
incentivized to share (Government).

Whether these barriers such as incentives and competition are real or perceived,
organizational culture and competition plays a central role in sharing information assets in
healthcare.
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Study participants from the provider stakeholder class shared a strong desire to share
data, information and knowledge across the entire healthcare ecosystem. Empowering providers
and consumers was mentioned as an objective, but one provider remarked “especially in
healthcare it’s hard to share some of this data outside” because of real and perceived barriers
which includes “transparency”, and “people worried about sharing data or fighting for silos or
turf.” One provider stakeholder concluded that things are getting better because of the leadership
role federal government has assumed and the historic precedent set by “liberating” big data and
releasing it for research and innovation in sites like www.Healthdata.gov:
The good news is that federal government and state governments, are beginning
to take the data that they’re paying us for with Medicaid and Medicare and many
other things and put it out there for us to use, for researchers to use and so when
it comes to some clinical data, performance data you can actually begin to
download big datasets publicly online (Provider).

Providers are also collaborating to create cooperative big data sharing cooperatives. The
perception is integrated delivery systems potentially have enormous amounts of big data and
customarily keep it within the clinically or financially integrated health system for their own
competitive advantage. But their big data combined with big data from other large delivery
systems (e.g., “My big data – Your big data”) creates an unprecedented amount of aggregated
big data for precise decision making. Another study participant inferred:
We can start to collaborate together and as we work out the content of those data
systems together so that we share the data back and forth it will accelerate the
whole process. So the things that I could run a trial on that it would take me six
months, I mean that’s compared to ten years right now, the structure I might be
able to get them done in six months, well under that structure we could do it in
three weeks or at least that’s the idea (Provider).

165
3.2 Hypothesis Generation
While there was no attempt to generalize study participant’s narratives, an ability to find
answers to complex questions was a driver that resonated with each of the three stakeholder
classes. As one provider study participant observed, “If I can answer those questions, it can then
lead me to more relevant questions of causes and the etiology of the disease.” Other study
participants provided the following insights on hypothesis generation:
Having said that, the drivers that are pushing IT, getting us more into big data
that will invite us to try and answer the questions that will allow computers to be
more helpful are certainly driving costs (Government).
Also,
I think there are a whole lot of drivers to this. The data complexity, the data
volume is increasing and the richness of what is there is increasing to throw out
to ask questions we never could ask before. We’re also collecting a lot of junk but
clearly that’s the big deal right, you go gold mining and it’s not all gold
(Government).

Essentially, the three government study participants uniformly expressed the fact that big
data allows for hypothesis generation and alternatively better question development in
healthcare. In the provider stakeholder group, similar to the government stakeholder group, one
stakeholder believes the ability to develop good questions is a byproduct of big data which has
an ability to produce – good answers:
There’s effectively no limit to them, so good answers come from good questions,
nearly always to answer that good question you have to have data that matched
that question, right, and so that’s that idea back again (Provider).
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3.3 Information Technology
Information technology and clinical decision support are to conduits healthcare
intelligence for providers (“How do we make sense of all the data that we’re getting from the
science?”). There is also relevant application in policymaking and healthcare consumerism. A
consumer stakeholder suggests that clinical decision support is required to organize and generate
contextually relevant information:
The second thing that’s revolutionary is that that information then becomes the
input for decision support engines and there’s a whole bunch, there’s a whole
array of ways that clinical decision support can be set up, it can be in templates
that prompt us to remember to do things we would otherwise forget. You know,
chart order entry facilitators, again to help us to just make it easier and more
efficient to order something because most of our orders are complicated and
involve more than one thing or at least a lot of them are, you know, data
presentation like graphs or spreadsheets and charts that’s where we can see
information over time, and then of course, prompts and alerts and things like that
(Consumer).

Several study participants found that clinical decision support is an important function of
information technology which facilitates information organization and structure. A consumer
study participant posits that this is the primary role of computers which are best suited for the
task:
The other thing computers are really good at is when we have to actually slow
down and think something through and figure something out then computers can
organize information in ways that make it easy for us to solve difficult problems.
So that’s really the use of computers (Consumer).

According to a couple of the government stakeholders, electronic health records must
continually evolve to provide the clinical decision support and information structure that is
necessary to organize clinical big data and its resultant information. National policy including
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Meaningful Use Stage 2, which is a process designed to aid clinical decision support provides a
standardized framework, but may not be achievable as a government study participant opines:
An example is the electronic health record where we’re very poor at structuring
clinical information so we come along and we turn everything into electronic
form and we somehow expect that electronic records to solve all our problems
and it doesn’t do that unless you think through how you’re going to structure the
data before it goes in and what everybody else is doing. You’re going to have big
data and right now there are over 2,000 records that have been certified by
CCHIT as meeting the Meaningful Use Stage One criteria and they’re all written
in different languages, different interfaces, different databases and they can’t talk
to each other. So it’s kind of a mess (Government).

Study participants point out an important task to clinical decision making that has not
happened in healthcare: structuring the entire knowledge base of medicine (“We haven’t
structured the information in healthcare to the extent necessary to allow big data to have the
kind of impact it will potentially have on the future”). While the advent of new analytical
methods and the Variety and Volume of big data in healthcare presents a tremendous opportunity
to structure healthcare’s vast body of knowledge in a meaningful way, a government study
participant adds:
We need to go through the whole knowledge base of medicine that way and map it
and it’s, you know, nobody is even talking about doing that right now so we’re a
very long way from getting medicine to the point where we can do the kinds of
things that they can do in other industries where the structure of data is simpler
(Government).

With the advent of advanced health information technology, including electronic health
records, and personal health records, big data is an asset for provider organizations, such as
Accountable Care Organizations, government agencies, and consumers, alike. Big data, which
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“definitely correlates with technology,” has allowed the dimension of genomic data to enter into
the equation of healthcare delivery, as a stakeholder pointed out:
Well, I think that the availability of big data is certainly something that’s driving
it, whether it’s clinical technology to measure biochemical signals from people or
sequence genes or sequence proteins or sample the air or whatever. The
availability of data is one thing that’s driving it (Government).
Consistent with increasing healthcare costs, a provider stakeholder believes, “Value
based purchasing and moving away from the lack of accountability of fee—for service- service”
is another driver, while another spoke of the new electronic health record standards that are a
result of new healthcare legislation:
I think another one is the Office of the National Coordinator has been pushing
these Meaningful Use Standards and that’s resulted in an abundance of data, and
there’s more demand on doing analytics with the data and they’ll be actually in
Stage Three more expectations around producing outcomes and you can’t really
produce outcomes without data (Provider).

Two of the three study participants in the consumer class felt the unintended consequences
of sharing big data were problematic. While sharing data and repurposing it for use by other
stakeholders in the information value chain, consumers were concerned that if data ends up in the
wrong hands, privacy will be potentially compromised. One study participant summed it by
stating “I might be concerned that the data that we shared might be used for some purpose other
than the stated research questions.” While potential nefarious uses of protected health
information do exist, the ability to link structured and unstructured data is the strength of
technology:
I think obviously the rapidly emerging technologies in this area do allow people
to crunch ever larger numbers of data in helping us bridge the gap between
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structured data analysis and unstructured data analysis, which I think is very
important (Government).
And the rise of “apps” developed to satisfy the demand for information access on mobile
technology allows key healthcare stakeholders the ability visualize and assess information, often
in real time, to make comparisons of peer activity, as one consumer stakeholder construed:
… here’s a free iPhone app you can have so you can look in if you join our system
and you can actually go in and look for individual patients, you can see how
they’re doing and what the gaps are for individual doctors, you can look at how
they’re doing in aggregate and they get their data from the EHR’s (Consumer).
Another consumer stakeholder study participant expressed an ability to make sense of the
data and information they receive: “Some of it is just trying to make sense of all the information
that we have now so it’s an organizing approach. Its how do we make sense of all the data that
we’re getting from the science?” Another study participant suggested technology allows people
the luxury to focus and think through complex problems rather than pour though intricate
statistical operations and organizational exercises that once took weeks to accomplish can know
be done in a matter of seconds:
The other thing computers are really good at is when we have to actually slow
down and think something through and figure something out then computers can
organize information in ways that make it easy for us to solve difficult problems.
So that’s really the use of computers (Consumer).

3.4 Learning Systems
Participants in this study talked about creating healthcare learning systems which allow
organizations involved the opportunity to “ask and answer the questions, to share the findings
broadly, and to drive quality up and cost down.” Learning systems in healthcare are similar to
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traditional clinical trials with the difference being learning systems allow provider organizations
the ability to conduct clinical trial –like “research” on patient data warehoused in their
information system networks, effectively generating thousands of published papers in a single
year. The provider stakeholder revealed:
There’s this concept that effectively every patient goes on trial because of the way
the data systems are structured. Now the jargon we used for that is a learning
health care system where you build the learning, the knowledge management and
it’s an information science tool that comes out of this you quickly learn is it’s
perhaps the key capability in a system like this, it’s knowledge management. How
do you identify best practice knowledge, how do you systematically and routinely
deploy it into routine use (Provider).

Another provider stakeholder mentioned his organization has created an immense data
repository that warehouses patient claims data and demographic data, that while not
standardized, allows multiple healthcare provider organizations to collaborate on a distributed
learning network and learn from the data:

We are involved in a collaborative project that established a virtual data
warehouse of basically it simplified data sharing by having a very reasonable
similar data model that’s federated across all different organizations and it has
demographic data, physical measures, personal medical history, management
treatments, diagnosis, health claims and so forth and basically this data model
retains control and stores data and stores kind of standardization across all sites
(Provider).

Generally, the consumer class produces massive amounts of source data from claims
data, narratives and now sensors. Generally, as the participants for a host of public and private
funded clinical trials, this class relies on others in the notional healthcare information value chain
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to reduce big data into credible information for its intended use. One study participant
concluded:
To me it simply means lots of data, lots more than you’re used to and you know,
the reason big data is important is because without it you wind up with studies
that are almost always too small. Smaller than ideal, because it’s just simply is
too costly to go out and collect all this data on the very large numbers of people
that you need. So we’re hopeful that the existence of these big sources of data
allows us to do studies in a million people instead of 10,000 (Consumer).

Members of the consumer stakeholder class are usually targeted to participate in clinical
trials, or in this case learning systems in which “everybody participates in some kind of
learning,” including patients. A provider study participant shared his vision of a learning system
and shared the insight that learning can be distributed across all stakeholder classes. The study
participant suggested healthcare organizations are in a central position to generate and spread
clinical knowledge:
Once you have it you’ve created a learning environment and by a learning
environment I mean a circumstance in which you can generate valid clinical
knowledge by carefully structuring changes within that data environment, so I
change a particular element of care and then causally figure out what that did to
patient outcomes. So you see the idea? We call it a learning health care system
(Provider).

3.5 Data Scientist
I have always had a healthy curiosity about the role and skill that the “new” data scientist
must possess with the advent of big data in healthcare. The provider stakeholder class offered a
range of perspectives and insights into this profession. As clinical researchers, their training
appeared to produce the richest insights into the knowledge and skills of a data scientist to
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manipulate big data. Consistent with findings from the literature review, the specialized skillset
of the data scientist emerged as an important subunit of meaning across key stakeholder classes. I
consciously set aside my own presuppositions about the skill and role of data scientists so not to
influence the explication and interpretation of the data. Providers generate and consume large
amounts of and require their employed or contracted data scientists to have “an ability to think
logically,” as one study participant surmised. Training in medicine, business, and the sciences
were the trademark for this stakeholder group. As such, while each study participant has the
analytical skills to lead data-rich environments, one study participant shared:
I have people who manage big data for me. I have a team of skilled data scientists
who are part IT knowledge, part systems integrator, part subject matter experts,
part analyst programmer; a data scientist isn’t necessarily one person. You have
a data scientist practice in which people specialize but talk to each other but you
might have somebody doing the IT integration stuff and another separate subject
matter expert and another programmer (Provider).

Of note, there were a couple of colorful and profound insights elicited from the provider
stakeholder class regarding the data scientist. One provider study participant proclaimed, “A
professional scientist or not … a scientist without data is a philosopher” potentially as
cautionary words of wisdom to scientists with such “sexy” titles.12
A couple of the study participants were aware of the potential limited labor supply of data
scientists with the requisite skills to manage and analyze big data. Their narratives pointed out
recruitment will be a barrier, as a study provider study participant acknowledged, “There’s still a
very limited skill set out in the industry in terms of the people who know how to do this, so it’s

12

In the book, Keeping Up with the Quants, Thomas Davenport and D.J. Patil proclaimed: “Data Scientist: Sexist
Job of the 21st Century.”
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going to be hard to recruit a team of data scientists” and as another observed:
Finding somebody who’s got 10 years of experience in big data is going to be
pretty impossible to find. So getting experienced people, there’s going to be a lot
of on the job training and that’s going to be a challenge for people (Provider).

While providers typically use a third party administrator to perform the role of data
scientist, particularly in small to medium sized provider organizations, the data scientists’
competencies are more than “creating reports and dashboards.” It’ also about being a trusted
partner, managing large data sets with a degree of confidentiality, implementing analytics, , and
“creating the analytics and using the data and the knowledge and insights to translate them into
decisions about how to improve” the care of patients. One provider stakeholder gathered:
… now it’s the funniest thing on this, most of my statisticians have some
computer science background and regard themselves, they see themselves as
fairly competent data architects. So as far as I can tell all of the data architects
see themselves as analysts but when you’re more than past familiarity with both
fields you’re different, and they’re radically significantly different (Provider).
It appears to be a fair assessment to say that, as another provider posits, “a data scientist
is more than one person” and in order for knowledge to be optimally gleaned and analyzed – to
fully thrive – another study participant suggested we need “citizen scientists” who might find
insights overlooked by the relatively small cadre of bona fide data scientist.
Summary
This category examined the study participant’s perspectives and insights into the place
and role of information science and the skills of the data scientist. Information science and
knowledge management are interdisciplinary fields that are essential to realizing the enormous
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potential of big data in healthcare. However, information science is typically implied as core a
discipline in healthcare and rarely acknowledged as the foundation of healthcare delivery. The
role of the data scientist is also critical to harnessing the potential of big data in healthcare.
However, several study participants posit that the role of the data scientist is multi-faceted and
usually does not consist of a single person. Even still, it’s recognized that the combination of
knowledge and skill of the data science team are in short supply. The next session examines the
results of a common objective across the key stakeholder classes: governance of big data in
healthcare.

175
Governance of Big Data in Healthcare

Category Definition
This category examines study participant narratives about the attributes that are essential
to establishing and sustaining a consensus-based framework for broad oversight and governance
of policies and definitions of big data in healthcare. A set of common standards for big data
could help improve data exchange among all healthcare stakeholders and would enable patients
and providers to isolate parts of health and medical records, respectively, for refined analysis and
information sharing. Classification systems called groupers, which include Episodic Care
Groupers, (ECG) and Ambulatory Care Groupers (ACG) describe the "illness-burden" of
populations (Weiner, Starfield, & Lieberman, 1992). While groupers are used within the
healthcare industry for specific purposes (e.g., risk adjustment), they are not adopted as a
universally accepted standard of big data.

4.1 Common Standards
Within the government stakeholder class it is known that a lack of governance and
common standards, or a “central use policy” termed by one government stakeholder for big data
in healthcare stifles big data growth and a realization of the true potential of big data. Such a
deficiency appears to keep big data firmly entrenched in a spiral of big data “hype.” A familiar
theme materialized in the government stakeholder class: establish a consensus-based common
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big data definition. Study participants concluded it will take time to refine and validate a working
(or agile) definition, as precision in decision making and hypothesis testing are important
attributes of big data’s output. One study participant remarked:
I want to get people to use the same definition for enough time so that we can
aggregate data, match it up against reality and then refine the definition so that
the sensitivity and specificity of it, the accuracy, when the true positives and not a
lot of false positives, not a lot of false negatives, so that all gets worked out by
making the definition very precise and having people record it that way
(Government).

Study participants suggested activation of a common standard for major clinical problems
represented in patients would include “both processes and outcomes of care.” Of particular
importance, the United States was on the threshold of a conversion from the International
Classification of Diseases – Version 9 (ICD-9) to ICD-10 which facilitates data better analysis of
disease patterns and treatment outcomes among a host of other healthcare benefits. While
implementation of ICD-10 has been delayed, the updated code set with requires detailed clinical
documentation could be the impetus to cultural change to include both processes and outcomes
of care that the study participant suggests. However, there are segments within the healthcare
industry that oppose conversion to ICD-10 including costs of implementation, a lack of an
infrastructure to conduct end-to-end testing, and simply an aversion to change.
With the multitude of applications and software vendor products, such standards would be
fundamental to comparisons across a uniform set of big data. As it stands, even with the advent
of electronic health records, no such standards are ready for testing and validation. Study
participants in the provider stakeholder class recognize the lack of a common standard for big
data in healthcare. In research, which is a data-intensive endeavor, there are institutional review
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Boards (IRB) which govern data and data collection standards that “say what people can and
can’t do with the data and who can and can’t see things to protect our patients.” In the delivery
of healthcare, a study participant felt that without big data standards and governance, data
aggregation would not be possible and questions whether big data in healthcare is big enough
due to the absence of a common set of standards:
We need our big data to get bigger. We need to actually aggregate this stuff. So
to do that what does the future need – it needs standards. It needs standards for
clinical data, standards for research data, standards for educational data, that’s
beginning to emerge but it’s definitely not there yet. We need reasonable and
rational policies around how to protect these data but also how we can flexibly
use and release the data (Provider).

The absence of big data governance and common standards is a perceived barrier to big
data’s untapped potential. This raises an important question: without big data standards in
healthcare, is big data truly big?

4.2 Legislation
Healthcare legislation over the last twenty years has been a focal point of political
debates at the national and state levels. As such, legislation was another influencer identified by
several of the study participants. A government key stakeholder supported the notion that
government rules drive big data in healthcare, “Because it places data and the ability to harness
and leverage data at multiple points throughout the healthcare ecosystem at the center as
opposed to at the trenches.” This stakeholder further added:
I think another one is the Office of the National Coordinator has been pushing
these meaningful use standards and that’s resulted in an abundance of data, and
there’s more demand on doing analytics with the data and they’ll be actually in
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Stage Three more expectations around producing outcomes and you can’t really
produce outcomes without data (Provider).

A core issue for each of the three stakeholder classes is repurposing data for different
uses which could lead to breaches of privacy. In the absence of big data governance in
healthcare, study participants identified several unintended consequences that potentially could
come to fruition based on the current informal structure and a lack of governance associated with
big data in healthcare. A stated unintentional consequence was a lack of oversight and adherence
to data privacy policies, which one study participant noted, “There’s a lot of work to be done on
patient privacy and oversight.” Eventually without governance, the healthcare industries will
“just kind of give up on privacy.” A consumer study participant remarked:
I think it’s unrealistic to expect providers and patients to really adhere to strict
privacy and security standards which for the past 10 years we’ve taken very, very
seriously and then have it a very, very highest governmental level completely all
of those standards just find out that a government agency is writing rough shot
over them and just sort of shrug our shoulders and say you know, who knew, but I
mean maybe that’s you know, maybe that’s possible but I think it really is a crisis
that has to be addressed (Consumer).

Study participants in the consumer class advocated for rigorous patient privacy policies.
Two consumer study participants suggested that while there are standard patient privacy rules in
effect, the industry should rethink these rules because, “we just kind of give up on privacy and
say well that’s kind of over or we have to say no look we actually do take privacy and security
seriously.” Study participants pondered the questioned current federal rules regarding
Institutional Review Boards and human study subject oversight as a barrier to effectively employ
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big data. A consumer study participant agrees there is much more work to be done, even
potentially easing the framework of current patient privacy rules:
Yes, everything has to be done to keep this data secured and protect people’s
privacy, on the other hand, when these studies are not posing any physical harms
to patients because we’re just looking at data, you know, you do not need to
require that a patient sign a 10 page or 20 page consent form. Even in certain
randomized trials, yes, you need a consent form but it doesn’t need to be 20 pages
long if it’s a very low risk question. So I think figuring out these issues about now
that we’ve got big data, how do we work with IRB’s and human subjects oversight
to rationalize how we use it and how we talk to patients about use (Consumer).

4.3 Aligned Incentives
A consumer stakeholder believes that within the current unstructured approach to big data
in the healthcare industry, “incentives aren’t necessarily aligned to make it easy to change.”
Another study participant articulated, “Raising the risk of what I consider to be misuses of data
in ways that are not necessarily in the public interest” in the absence of big data incentive
alignment. These risks create different standards for different stakeholder classes; this results in
unaligned incentives. The confluence of a lack of both data standards and transparency (“I think
we’re going to have to have a lot of transparency”) creates a culture of mistrust among
healthcare stakeholders. A study participant commented:
If it’s holding providers to a different standard then you can’t tell what’s going
on, so an ideal system … you get to transparently manage your population
according to outcomes that everybody agrees upon both inside the delivery system
and among the ones are paying for it (Consumer).

Uniform data standards like ICD-10 exist to classify illness. However, ICD-10 is one data
set among potentially hundreds or thousands used in the delivery of healthcare. The absence of a
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common classification system, ontologies, policies and aligned incentives for big data emerged
as a real barrier to realizing the potential of big data.

Summary
Common standards and privacy are commonly referenced subunits of meaning identified
by the three key stakeholder classes. However, study participants highlighted the unintended
consequences of increased competition to develop and publish healthcare intelligence and
unaligned incentives are barriers to effectively achieving big data’s potential in healthcare. There
is evidence of common standards on data through government policies, including Meaningful
Use. But big data taxonomies and ontologies are nonexistent. This is especially troublesome
given the emergence of genomics data as an integral source of data that enables precision
medicine and informed decision making. Governance of big data in healthcare is an objective of
the three key stakeholder classes and must include “the patients who need to be kept in the
governance.”
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CHAPTER VII. DISCUSSION AND INSIGHTS

Overview
This section discusses the findings of the research and compares study participant
insights to observations found in the scholarly and grey literature. The study’s research question,
Within and across the narratives of three key healthcare stakeholder classes, what are the
important categories of meaning or current themes about big data in healthcare, was designed to
elicit a priori insights into the attributes, definitions, and uses of big data in healthcare. As a
reference, I restated the observations found from the modified systematic review of the literature
to make comparisons between findings from the literature and study participant narratives. The
research uncovered important categories of meaning or themes within and across three key
healthcare stakeholder classes. The aim was not to generalize the study’s findings. Rather, the
explication of study participant narratives was intended to delineate categories of meaning to
find common themes within and across study participant narratives and construct a cohesive
‘story’ or framework of big data in healthcare. Unique themes were also included as an important
source of data. Also, a “main takeaway” is offered at the beginning of each category as a
fundamental fact or point of reference for all stakeholder classes to adopt.

Category of Meaning #1: Ontological Framework of Big Data in Healthcare
Main Takeaway: Without a consensus-based “framework” of big data in healthcare,
‘buzzwords’ and slogans will continue to play an important role in describing big data’s meaning
in healthcare.
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Many characteristics, definitions and references to big data across various industries were
mentioned by study participants. A review of the scholarly literature found a host of definitions
on “big data” including “it’s [big data] a characterization of the never-ending accumulation of
all kinds of data” (EMC2, 2012), and big data “is the ability to mine and integrate data,
extracting new knowledge from it” (Roney, 2012). Or “big data is the belief that any sufficiently
large pile of sh** contains a pony” (Arbesman, 2013). Begley (2011) defined big data in
healthcare as “the healthcare context to longitudinal medical claims data for millions of patients
linked to their EHR (p .50)” Begley’s definition conservatively quantifies big data in the
“millions” where petabytes, even terabytes are now the gold standard of healthcare big data
quantification. This definition illuminates a common problem of attempting to quantify big data
in healthcare: data are counted by patient encounters, not petabytes.
The scholarly and grey literature on “big data” and “healthcare” also confirmed there is
no consensus on what big data means in healthcare (Dumbill, 2013; Villars et al., 2011).
Findings from the stakeholder narratives were consistent with the literature. Study participants
generally did not know what big data in healthcare meant (“nobody’s ever defined it for me”;
“it’s like a parody”; and, “it needs to be clarified and demystified”). While Gartner’s credible
“3V’s” of High Volume, High Velocity, and High Variety were referenced across the three key
stakeholder classes, the oft-cited ‘characteristics’ of big data is not a definition. Gartner’s
characteristics of big data have entered into the lexicon of big data in healthcare as buzzwords
(T. Borangiu & V. Purcarea, 2008; Davenport et al., 2012; Rooney, 2012) that continue to play
an important role in the absence of a vetted consensus-based definition.
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Depending on the scholarly communication or source of grey literature, one could find at
least two additional “V’s” – Value (Porter & Teisberg, 2006) and Variability (Gartner, 2013) that
have emerged as some of the important buzzwords that characterize modern big data.
Across all stakeholder classes, the multitude of big data definitions do not sufficiently address
the enormous complexity of healthcare’s aim of delivering precision medicine, commonly
referred to as personalized medicine. In a recent paper by Ward and Barker (2013), they collated
four common definitions of big data which “gained some degree of traction” (p. 1) agnostic to
industry and market sectors. The definitions were extrapolated from big technology and
consulting firms, including Gartner, Intel, Oracle, and Microsoft. After generalizing
characteristics of each company’s interpretation of big data, they constructed their own
definition: Big Data is a term describing the storage and analysis of large and or complex data
sets using a series of techniques including but not limited to NoSQL, MapReduce and machine
learning (Ward & Baker, 2013). This is a progressive definition of big data that intentionally
omits Gartner’s 3”V’s”. Instead, Ward and Baker take into account the tools and technology
required to evolve big data into information and knowledge. Yet, based on key stakeholder
perspectives, their definition seemingly falls short of recognizing the complexities of the “black
box” of big data in healthcare - people.
Ward and Baker’s insight into big data is consistent with the perspectives of key
healthcare stakeholders: big data is only a single dimension of a larger framework whose end
goal is precise information derived with a purpose. Shaw (2014) points out “historically, …
scientists would plan for an experiment to collect and analyze data … because of the price of
storing a bit of data has dropped 60 percent … people now collect everything and then search for
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significant patterns in the data” (p. 34). Several study participants disagreed with such a theory.
A provider study participant pronounced “it’s important that you know what the purpose is
before you start.” The vision of big data from the perspective of a consumer study participant
was to “have strict purposes rather than let’s create big data and then figure out what we might
do with it.” Shaw even agrees his perspective has its inherent risks, which includes data dredging
– data which is statistically significant by chance resulting in poor “scientific output from
throwing everything against the wall and seeing what sticks” (p. 34).
Study participants offer the wisdom that though a consensus-based big data definition is
necessary, its maturity and widespread adaption will not happen overnight. A government
stakeholder postulates the industry needs to “use the same definition for enough time so that we
can aggregate data” for initiatives like healthcare learning networks.

Category of Meaning #2: Humanistic Dimension of Big Data in Healthcare
Main Takeaway: There is a dual ‘humanistic dimension’ to big data in healthcare that
takes into (1) account people’s cognitive contributions; and, (2) the uniqueness of human data as
a unit of analysis.
Big data in healthcare, in part, is about empowering people with information and
knowledge to make evidence-based decisions about policy, clinical treatment plans, and
healthcare consumer choices. Study participants agree, “Empowering the people whose data it is
should be an important value for all of us as we go forward.” Medical humanities and medical
ethics as a potential practical application in the policymaking process (Greenhalgh & Russell,
2009) is an intensely explored subject. Yet, key healthcare stakeholders generally agree
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narratives and the ability to listen to stories remain an essential skill that adds to the body of
knowledge in evidence-based healthcare – augmented with the power of big data analytics. Study
participants fear the art of listening to stories and the “human therapeutic relationship” will be
lost with much of the industry focus on conquering the big “data deluge.” A government
stakeholder further elaborates that “purely relying on machine learning without the application
of subject matter expertise” does not foster precise knowledge for decision making.
While computers are a necessary requisite and tool of big data in healthcare, the human
dimension of big data cannot be lost in the “hype” of defining big data in healthcare. Study
participants agree that computers organize information extremely well, but the human mind is
calibrated for unparalleled intuition, speed and pattern-based recognition. Absent from any big
data definition, characteristic or attribute found in the scholarly and grey literature was the
importance of the humanistic dimension of big data in healthcare. Data and information in
healthcare is still imprecise. Whether used for development of new healthcare legislation or
patients sharing stories about health and healthcare, narrative provides meaning, context, and
perspective (Greenhalgh & Hurwitz, 1999). Gardner (2013) found “individual instances
[narratives] are part of an ever-growing study of pedagogy of a health humanities approach that
focus on narrative, sometimes called ‘narrative medicine’… and involves narrative in a number
of ways, including qualitative analysis” (p. 4). The essence of this research advocates for
introducing narratives beyond exam rooms, but across the healthcare information value chain,
especially as a data collection methodology that is part of big data as a source of clinical and
policy making data.
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In addition, the human body is uniquely complex. Study participants surmised that big data in
healthcare is unlike big data generated in other service industries (“genomics, senomics, and
other “-omics” that are out there. Metropolomics for example are generating huge amounts of
data that need to be processed in ways different than we have in the past” - Provider).
Transactional data used in day-to-day healthcare delivery, human genome data, and human
microbiomic data, if integrated with social epidemiological data, will eventually create an
unthinkable amount of big data from just a single person.

Category of Meaning #3: Information and Knowledge Science and Big Data in Healthcare
Main Takeaway: The ability to link and visualize genomic, environmental, and other
heterogeneous sources of complex data positions the disciplines of information science and
knowledge management at the center of the delivery of healthcare and medicine.
The literature review produced the following observations: (1) consumers of healthcare do
not have enough trustworthy, credible information to understand the scope and depth of big data
and its impact on their health and healthcare, and (2) the gulf between “life sciences” and
“healthcare” is closing – fast. Big data is entrenched in life sciences research, including genetics,
biomedical research, computational biology, and nanomaterial science. However, these sciences
are quickly making its way into point-of-care decisions (e.g., shared physician and consumer
decisions about treatment plans).
In its strategic plan for the Department of Medical Information Science at the University
of Illinois administrator’s confirmed, “in the 21st Century, Medicine will be viewed as an
Information Science” (Schatz, 2006). Shaw (2014) proclaimed “information science promises to
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change the world” (p. 1). This statement is consistent with most study participant’s ideology
about medicine as an information science, or as one provider stakeholder stated, “medicine and
maybe you mean healthcare is an information science.” In fact, a government study participant
speculated, “Information science pre-dated medicine and allowed medicine to prosper.” While
his proclamation is debatable, there is no question among most key healthcare stakeholders,
medicine, or healthcare, is an information rich endeavor (Villars et al., 2011) that is “also about
smartly moving information around clinicians.” A government stakeholder gathered, “Until you
were able to classify that in terms for differential diagnosis and how I should treat it, medicine
was basically voodoo and witchcraft ... the better data you have the better you can diagnose.”
Indirectly, another provider summarized information science as being foundational to
medicine: “the more effectively you can select treatment, the better you can actually see those
treatments.” At the very core of medicine is science and evidence (J. Bellamy & Bledsoe, 2006;
Sackett et al., 1996; Thyer & Myers, 2011), proliferated by the disciplines of information science
and knowledge management. But according to several study participants across the key
healthcare stakeholder classes, medicine is much more than an information science.
In 2006, the National Science Foundation identified a core set of capabilities that are
fundamental to the role of the data scientist including: collaboration, coordination, and the ability
to conduct research and education using digital data collections; serve as a mentor; and, design
and implement education and outreach programs. These capabilities are consist with Davenport
et al. (2012) who wrote, “data scientists understand analytics, but they also are well versed in IT,
often having advanced degrees in computer science, computational physics or biology- or
network-oriented social sciences. Their upgraded data management skill set — including
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programming, mathematical and statistical skills, as well as business acumen and the ability to
communicate effectively with decision-makers — goes well beyond what was necessary for data
analysts in the past” (p. 23).
Study participants want data scientists to also be able to “think logically” with “profound
specialty knowledge” and perform “as a competent data architect.” Many of the skills identified
by the National Science Foundation were noteworthy among study participants across the
classes. Healthcare consists of many domains, (e.g., quality, payment, policy) and in order to
effectively create information from big data in healthcare, specialty domain skills and knowledge
are an essential capability key healthcare stakeholders. Study participants identified a list of
skills and knowledge necessary for the data scientist to become an integral member of the care
delivery team. Participants of this study advise simply calling yourself a data scientist does not
necessarily make you a data scientist, as one government stakeholder points out, “A scientist
without data is a philosopher.”
Harvard Business Review touted the data scientist as the sexist job in the 21st Century
(Davenport & Patil, 2012), with demand for data scientists sharply on the rise. The U.S. alone
will need 140,000 to 190,000 people with deep analytical skills by 2018 just to keep up with the
pace of innovation (Brown et al., 2011) and the explosion of big data. The problem as two
provider study participants observed, “There’s still a very limited skill set out in the industry in
terms of the people who know how to do this … finding somebody who’s got 10 years of
experience in big data is going to be pretty impossible to find.”
The healthcare industry is inherently one of the most information-rich market sectors.
Study participants surmise the entire healthcare ecosystem would be well served by uniformly
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employing the disciplines of both information science and core. This vision can only be realized
with governance and a common set of standards. The next section explores governance of big
data in healthcare.

Category of Meaning #4: Governance of Big Data in Healthcare
Main Takeaway: Data stewardship, modern and refined privacy rules, and a set of common
standards are required for all healthcare stakeholders to realize the benefits of big data in
healthcare.
The NCVHS is an eighteen member statutory public advisory committee to HHS that has
created selection criteria for interoperable clinical data standards and standards for e-prescribing
body (Grossmann, 2010) and other national standards for federal rule-making. No standards have
been passed or are currently under consideration for big data in healthcare (Pavolotsky, 2012) – a
vision of several key healthcare stakeholders. Study participants from both provider and
consumer stakeholder classes envision “widespread integration of administrative, clinical and
patient generated data that will be available through big data.” But the literature suggests a
fundamental barrier to widespread big data integration: health system fragmentation (L. R. Burns
et al., 2002) of heterogeneous health and healthcare data (Grossmann, 2010).
Consistent with the literature, participants in this study identified competition (Cukier,
2010; Frangenberg, 2013; Grossmann, 2010) as a problem in the healthcare industry (“There’s a
“desire to maintain a competitive edge” – Provider and “that means having a competitive
advantage over somebody else and in today’s world that is information.” - Government). Study
participants across all key stakeholder classes generally agree the lack of a governing body and
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organizing framework for big data in healthcare prevents the industry from realizing the true
benefits of big data in healthcare. Several study participants called for a “common set of
standards and user policies.” In the absence of such a framework, unintended consequences such
as barriers to wide-spread sharing will continue to plague the healthcare industry. Study
participants offer the wisdom that though a consensus-based big data definition is necessary, its
maturity and wide-spread adaption will not happen overnight. A government stakeholder
postulates the industry needs to “use the same definition for enough time so that we can
aggregate data.”
Study participants believed privacy was an issue as several pointed out current federal
rules are not appropriate for big data in healthcare. In order for privacy to be effective, HIPAA
rules must be revisited, as patients are sharing increasing amounts of data about themselves and
their health. McGraw (2012) asserts “federal privacy regulations do not set clear and consistent
rules for access to health information to improve health care quality” (p. 75). The linkage of life
sciences data (e.g., genomics) alone to traditional transactional healthcare data dramatically
changes the privacy landscape, effectively requiring an overhaul of healthcare privacy laws.
Genomic information is fundamentally identifiable and the privacy implications are profound
(Shaw, 2014).

Contributions and Implications for Future Research
This research is significant because it: (1) produced new thematic insights about the
meaning of big data in healthcare through narrative inquiry; (2) offered an agile definition of big
data that can be deployed across all industries; and, (3) made a unique contribution to scholarly
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qualitative literature about the phenomena of big data in healthcare for future research on topics
including the diffusion and spread of health information across networks, mixed methods studies
about big data, standards development, and health policy.
In Burns (2013) feature article, Healthcare’s Big Data Tsunami, the author postulated,
“the big data tsunami in healthcare is washing ashore today and few healthcare organizations are
effectively dealing with it” (p. 59). The next logical question is: why are healthcare
organizations not be prepared to effectively deal with what is widely presumed to be an
organizational asset (and in some circles, healthcare’s “natural resource”)? Through qualitative
and phenomenological research using narrative, this study provided new knowledge about the
important categories of meaning of big data in healthcare through the insights and perspectives
of nine key healthcare stakeholders. The results found big data in healthcare remains poorly
defined – relying almost exclusively on axioms to explain its purpose, provenance, and meaning.
Dr. Myles Rennaker, director of a governmental agency admits, “Nobody ever defined for me.”
While Gartner’s widely-publicized (updated from 3) “4V’s” of High Volume, High Velocity,
High Varity and High Veracity is entrenched into the lexicon of healthcare organizations, Dr.
John Boyken, associate dean at a major medical school adds, “It’s a popular term that means a
lot of different things to a lot of different people.” Buzzwords are deeply-rooted as important
descriptors of big data. They provide sorely needed context to a potentially transformative
organizational asset. Nonetheless, Dr. Rennaker concludes healthcare standard’s organizations
must “clarify and demystify” big data in healthcare.
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Findings from this qualitative study also uncovered a critical dimension of big data that
perilously has been overlooked, or dismissed, in the many well-intended offers to “characterize”
big data in healthcare: the humanistic dimension of big data in healthcare. The humanistic
dimension of big data emphasizes the cognitive prowess and contributions of the human mind,
the extraordinary complexity of the human body as a source of big data, and the lost narratives
and relationships forged between people. And as a government stakeholder shared after reading
the executive summary on the study, “I think you have articulated the attributes that make
healthcare different. This paper represents a contribution to resetting expectations more in line
with reality, which can facilitate more effective use of computers and large databases to
contribute to research, diagnosis, treatment, and quality measurement.”

The widespread integration of vast amounts of genomics data, environmental data, and
new sources and diversity of data generated by wearable devices and sensors with traditional
transactional healthcare datasets requires improved statistical, computational methods, and
visualization tools (Shaw, 2014). The healthcare industry is at the threshold of such widespread
big data integration, fueled by the Triple Aim of improving the experience of care, improving the
health of populations, and reducing per capita costs of health. Such a vision is why the
interdisciplinary fields of information science and knowledge management play a crucial role in
the delivery of 21st Century medicine.

Health and healthcare data provenance include metadata and Meaningful Use attribution
data, not to mention public health surveillance data and global health data. With the never
ending possibilities of adding to healthcare data provenance, there was near unanimous
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consensus that big data in healthcare requires a common ontology for healthcare organizations to
effectively utilize this “natural resource.” With truly massive amounts of heterogeneous big data
being collected now in disparate databases, there is a concrete need for standards advisory
organizations like the National Committee on Vital and Health Statistics (NCVHS) and the
National Institute of Standards (NIST) in partnership with private sector companies and federal
organizations to recommend a consensus-based definition and ontology of big data in healthcare.
Big data generation and integration in healthcare is best served by defining its provenance,
privacy and precision, and purpose (4”P’s”). Study participants concluded governance of big
data in healthcare will allow healthcare organizations to not only “effectively deal with the data
tsunami,” but generate and share sought after knowledge and wisdom for healthcare intelligence
across the healthcare information value chain.

Big data in healthcare is not customarily discussed in qualitative terms. While not
intended to be generalizable, this phenomenological research uncovered foundational insights
and perspectives capable of augmentation with basic research in disciplines to include social
network analysis and health policy development. For example, a phenomenology study using
narrative can inform policy makers and researcher which barriers impede the flow of information
between key healthcare stakeholders and how healthcare stakeholders influence the fidelity of
information that is shared within networks? The findings from this rigorous qualitative study
that uncovered the “know about” big data can be used as the foundation to conduct further mixed
methods research hypotheses that explores the “know that” about big data. Such a study using
regression or path analysis can then generalize the themes and subunits of meaning found in this
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study. Furthermore, these findings can also provide standards advisory organizations with
experiential insights and knowledge about defining a big data definition germane to health and
healthcare.

Finally, derived from the nine key healthcare stakeholder narratives, I offer the following
agile “definition” of big data, which could serve as a spring board for a consensus-based
framework for big data in any industry:
“Big data” is both an organizational philosophy and strategy, enabled by
information science discipline, to purposefully collect, link and analyze a variety
of heterogeneous data resources and data ontologies, requiring the confluence of
people and computers to generate precise information displayed through
advanced visualization tools.
Lessons Learned
There were many valuable lessons learned from conducting this phenomenological study.
First, among the many qualitative methods available to me to conduct this important
research, a phenomenological study using narrative was appropriately chosen to answer the
research question. This research is an important foundational qualitative study to fully
understanding the meaning about big data in healthcare. The experiential knowledge of key
healthcare leaders provided timely, thick descriptions the big data phenomena in healthcare.
Perhaps a mixed methods study design would add further rigor to the findings in this study.
Using modern quantitative data analysis methods adds tremendous insight and value (Shaw,
2014). Weber (1990) points out that the “best content-analytic studies use both qualitative and
quantitative operations” (p. 2). Future research using a mixed methods approach would certainly
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yield new insights and rigor to the research topic, particularly as big data and information sharing
practices are explored.
Second, interviewing patients, caregivers, and other healthcare consumers would have
been ideal – achieving an unparalleled richness and truth about healthcare consumer’s views.
The consumer advocates provided outstanding narratives; however, the voice of the patient is
rarely integrated into policymaking. I have developed a passion for capturing the narratives of
healthcare consumers and look forward to pursuing such work in future academic and
professional endeavors.
Finally, the phrase “large data sets” was often found in the literature but was not included
in this study so to maintain consistency with the study term, “big data.” In retrospect, including
“large data sets” might have added additional sources of scholarly literature to the study. Several
study participants mentioned, “Managing large data sets of implementing analytics.”
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CHAPTER VIII. CONCLUSION

Within and across each of the three key healthcare stakeholder classes, big data in
healthcare remains a misunderstood phenomenon. Unfortunately, the absence of a consensusbased, industry-wide definition of big data enables buzzwords to maintain a prominent and
important descriptor of the phenomena. While key healthcare stakeholders accentuated a keen
awareness of big data, most lacked a concise understanding of its meaning and relied on either
Gartner’s 4 V’s characteristics of High Volume, High Variety, High Velocity, and High Veracity
as a definition or conceding to not understanding what it really means. One consumer
stakeholder frankly admitted:
I think the cause of big data would be better served by characterizing it more
clearly for a lot of us if they want to be able to move forward. People can be
afraid of it. So between not really understanding what’s meant by it, whatever it
is, it needs to be clarified and demystified I think, mainly clarified I’d say because
I’m not sure what the hell they’re talking about (Consumer).

Big data is employed extensively in other industries in which a multitude of lessons
learned can be applied. However, there persists a shortsighted supposition that big data in
healthcare is the same as or even nearly identical to big data in industries that define their
products. Stakeholders agree that the human dimension of big data is what makes big data in
healthcare unique from every other industry sector – from human’s cognitive ability to recognize
patterns to our complex physiology and genetic makeup. A common unit of analysis in
healthcare is a human who’s phenotypic and microbiomic makeup is unique from one individual
to the next.
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Information science is an interdisciplinary field that is a fundamental core to delivering
evidence-based medicine and healthcare intelligence. The information science framework
includes the 3 ”C’s” of big data collection, classification, and curation as well as linking and
creatively visualizing big data sets (Shaw, 2014) over its lifecycle. The information science field
enables the transformation of “big data” into “smart data,” which satisfies stakeholders thirst for
precision and trust, to be used for a variety of healthcare intelligence uses. The reformed
healthcare industry which demands exceptional value for care delivered is in the midst of an
emerging health information economy which requires a new big data governance framework
where health information technology interoperability, metadata provenance, usage policies, and
common standards will allow big data to be analyzed and shared across a connected, “many-tomany” healthcare information value chain.
In summary, this research provided four main categories of meaning and four takeaways
for key healthcare stakeholders to consider:
1. Without a consensus-based “framework” of big data in healthcare, ‘buzzwords’ and slogans
will continue to play an important role in describing big data’s meaning in healthcare.
2. There is a dual ‘humanistic dimension’ to big data in healthcare that takes into account (1)
people’s cognitive contributions and (2) the uniqueness of human data as a unit of analysis.
3. The ability to link and visualize genomic, environmental, and other heterogeneous sources of
complex data positions the disciplines of information science and knowledge management at
the center of the delivery of healthcare and medicine.
4. Data stewardship, modern and refined privacy rules, and a set of common standards are
required for all healthcare stakeholders to realize the benefits of big data in healthcare.
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Finally, medicine is not only rooted in information science. It is a confluence of many
other sciences and arts, including the medical humanities, which include capturing patient
narratives and their unique ‘stories’ in an ethical manner. Such big data need not sit stagnant in
electronic health records, but be used as a credible source of ‘big data’ that generates knowledge
about personalized healthcare. This is the disruptive innovation in a reformed, patient-centered
healthcare system that healthcare policymakers must seriously employ as a credible data source
in the development of healthcare policy. As one provider stakeholder fittingly summed up big
data in healthcare:
Big data doesn’t mean unstructured data. You always create data for a purpose,
right. That’s the human creation. It always has purpose, you have to understand
the purpose if it’s going to be effective.
And then everything else is just a tool.
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APPENDIX A. STUDY DESIGN

Phenomenological Study using Narratives
Phenomenology is a philosophy that had its beginnings in the early years of the 20th
Century and became explicitly aware of itself in 1913 (Husserl, 1970). Phenomenology became
popular in the social and health sciences, especially in sociology (Borgatta & Borgatta, 1992),
psychology (A. Giorgi, 1985), and education (M Van Manen, 1980). While phenomenology has
a rather ambiguous history, as late as the 1970’s, its popularity in the social and health sciences
has potential applicability to current healthcare issues, including the persistent phenomena of
healthcare disparities, social epidemiology of social networks and population health.
Phenomenological research tends to converge with qualitative research strategies (Amedeo
Giorgi, 2009) in which narratives are used as data (Clandinin, 2013).
Phenomenological and narrative-based methodologies have a modest history in public
policy. These methodologies embrace an assortment of epistemologies ranging from
interpretative methods to empirically-oriented narrative policy frameworks. While narratives are
indeed used in the exploration and practice of policy, my practical experience in healthcare
policy development lead me to believe general lay person narratives offered in the policymaking
context are frequently treated as purely persuasive mechanisms, not as part of the body of
evidence (Steiner, 2005) relevant to phenomena, policy-making or public administration (Borins,
2012). A Cornell University e-Rulemaking Initiative (Epstein, Heidt, & Farina, 2013) perhaps
frames the void of multidisciplinary collaboration between the general lay person and
government policy-makers best:
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Given the disparity in power between government decision-makers and the public,
ways of arguing for a particular policy position and perceptions of valid evidence
constitute important boundary objects that make many civic engagement efforts
ineffectual. Members of the lay public largely do not have the skills and the
culture necessary to engage in formal argumentation based on empirical data.
Yet, they possess the unique situated knowledge of living with existing policy or
proposed policy changes. Helping the two communities to establish a shared
repertoire may help in creating better policy solutions (Epstein et al, 2013, p.20).

Epstein et al (2013) also provides a coherent perspective for capturing the narratives of
both policymakers and the general public with the creation of a narrative framework that
embraces the “value of narratives as input in the policymaking process” (p. 1). In today’s modern
healthcare delivery system, there remains a dearth of phenomenological studies encompassing
narrative (Clandinin, 2013; Amedeo Giorgi, 2009; M Van Manen, 1980). Scholarly evidence
supports my decision to approach the inquiry of big data in healthcare through semi-structured
interviews with ten leaders from three key healthcare stakeholder classes: government, providers,
and consumers. A narrative describes the lived experience of a single individual; a
phenomenological study describes the meaning for several individuals of their lived experiences
of a concept or a phenomenon. Phenomenologists focus on describing what all participants have
in common as they experience a phenomenon. The basic purpose of phenomenology is to reduce
individual experiences with a phenomenon to a description of the universal essence (M Van
Manen, 1980). The following (Table 9) provides a comparative summary of potential study
design options considered to conduct this study.
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CHARACTERISTICS

NARRATIVE
RESEARCH

PHENOMENOLOGY

CASE STUDY

(MOUSTAKAS, 1994)

(STAKE, 1995)

(DENZIN & LINCOLN,
2002)

Focus

Exploring the life
of an individual

Understanding the
essence of the
experience

Type of
Problem Best
Suited for
Design
Discipline
Background

Needing to tell
stories of
Individual
experiences
Drawing from the
humanities
including
anthropology,
literature, history,
psychology, and
sociology
Studying one or
more individuals

Needing to describe the
essence of a lived
phenomenon

Unit of
Analysis

Data Collection
Forms

Data Analysis
Strategies

Using primarily
interviews and
Documents

Drawing from
philosophy,
psychology, and
Education

Studying several
individuals that have
shared the
Experience

Using primarily
interviews with
individuals, although
documents,
observations, and
art may also be
considered
Analyzing data for Analyzing data for
stories,
significant
“restorying”
statements, meaning
stories, developing units, textural and
themes, often using structural
a chronology
description, description
of the “essence”

Developing an indepth description
and analysis of a
case or multiple
cases
Providing an indepth
understanding
of a case or cases
Drawing from
psychology, law,
political science,
Medicine

Studying an event,
a
program, an
activity,
more than one
individual
Using multiple
sources, such as
interviews,
observations,
documents,
artifacts
Analyzing data
through
description of the
case and themes of
the case as well as
cross-case themes

Table 9. Comparative summary of narrative inquiry, narrative research, phenomenology and
case study
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Either of the study designs evaluated in Table 9 was adequate to conduct this research
study. Healthcare has historically used a shallow toolbox of research practices to elicit
knowledge and insights. Experimental (e.g., randomized trials) and quasi-experimental designs
have been overused in clinical practice, in part, because the science (and art) of medicine is
grounded in developing a credible evidence-base that informs clinicians and patients. Evidencebased medicine is defined as the conscientious, explicit and judicious use of current best
evidence in making decisions about the care of individual patients (Sackett, 1997). Evidencebased medicine is also founded on the principle that scientific inquiry is superior to expert
opinion and testimonials. It is not often narrative is used to inform decisions in healthcare –
making this phenomenological study a timely scholarly contribution. The following are examples
of a phenomenological study encompassing narrative with a similarly-sized study population.
In Gabrielson’s (2009) dissertation, a qualitative study using narrative analysis of
interviews with ten older lesbians (aged 55 and over) who made a financial commitment to live
in a continuous care retirement center (CCRC) specializing in lesbian, gay, bisexual and
transgender (LGBT) care was conducted. The specific aims of the study were to:


Describe what has impacted older lesbians' decisions to live in an LGBT-specific CCRC;



Describe factors that both positively and negatively impact older lesbians’ perceptions of
elder care (Gabrielson, 2009).
The study combined two qualitative strategies (across-case, thematic analysis and

narrative analysis) and used a convenience sample.
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Another comparable study in phenomenology using narrative was conducted by Baily
and Tilly (2002) in which their study was a constructivist approach to narrative in which ten
stories about death, physical and emotional vulnerability from three key informant groups:
patients, caregivers and nurses were analyzed. Bailey and Tilly (2002) suggest that the events
were not recounted to convey objective reality but to convey meaning, concluding that these
stories were reconstructed in a way to convey their perspective of an event, rather than
decontextualized truths (Bailey & Tilley, 2002).
An important depth-related study that provided a framework for the analysis of big data
was conducted by Halevi and Moed (2012) where they explored the term big data as it evolved
in the peer-reviewed literature. They sought to understand big data as a topic of study and the
scientific problems, methodologies and solutions that researchers focused on in relation to it.
Through a modified systematic review of literature in Scopus, an abstract and citation database
of peer-reviewed literature (http://www.info.sciverse.com/scopus), Halevi and Moed (2012)
uncovered three important themes from their research:


The first appearance of term big data in scholarly literature appears in a 1970 article on
atmospheric and oceanic soundings;13



Early papers (1970 until 2000) were led by computer engineering, building materials,
electric generators, electrical engineering, telecommunication equipment, cellular
telephone systems and electronics disciplines; and,

This is an important finding, as many sources of ‘grey literature’ credit the first references to the term ‘big data’
circa 2000.
13
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From 2000 onwards, the field is led by computer science followed by engineering and
mathematics disciplines (Halevi & Moed, 2012).

These findings are significant. It suggests a strong correlation between the rise of big data in
direct parallel to advances in technology, science and mathematics. Intuitively, with the advent
of HIT in healthcare, there has been a direct upsurge in the notion of big data, too, along with the
renaissance of the data scientist.
Worldview Paradigm
At the foundation of any research project are epistemologies, or philosophical
worldviews (Creswell, 2009) which include postpositive, social construction,
advocacy/participatory and pragmatism. These types of worldviews influence the type of
research design (qualitative, quantitative, or mixed methods) the researcher selects as the most
effective method to study the intended topic (Table 10).
FOUR WORLDVIEWS
Postpositivism









Constructivism

Determination
Reductionism
Empirical Observation and
Measurement
Theory Verification
Advocacy/Participatory






Political
Empowerment
Collaborative
Change-Oriented






Understanding
Multiple Participant Meaning
Social and Historical Construction
Theory Generation
Pragmatism
Consequences of Action
Problem-Centered
Pluralistic
Real-World Practice Oriented

Table 10. Four Philosophical Worldviews
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As data is gathered and synthesized, assumptions are formed to test claims or hypotheses.
Depending on the type of research conducted, a researcher can begin (and end) with either
philosophical worldview that presents the best fit to the intended course of study. Theoretically, a
researcher, as well, could seamlessly traverse each of the four ontologies described by Creswell
(2009):


Postpositivism worldview, which is considered the traditional form of learning and is
grounded in measurement of observations and outcomes;



Constructivism worldview, where researchers seek to understand the world in which
they work and live by collecting data personally, interpreting the results and forming
conclusions;



Advocacy/Participatory worldview, which holds that politics are intertwined in the
research and that there is a political or advocacy action agenda for change; and,



Pragmatism worldview, which holds that there is no singular system or philosophy
that researchers are committed to and employ mixed methods of study and multiple
methods that happen to work at that time (Creswell, 2009, p. 6).

Early in my professional and academic career, my philosophical position manifested from
having worked in diverse healthcare settings, including federal and state government, academia
and private sector managed care organizations which require a practical and academic
perspective for which to understand the work. After contemplating and absorbing each of these
worldview beliefs for at least two academic school years, it is clear that my epistemological
position about the phenomena of big data in healthcare can be constructed as follows: a) data,
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information and knowledge are contained within the perspectives of people that are experienced
in healthcare and big data, either as a policymaker, provider or consumer; and b) my academic
and professional experience is unique and allowed me to collaboratively engage with the study
participants in collecting and constructing meaning about big data in healthcare.
Denzin and Lincoln (2002) postulate a relevant vignette which undoubtedly influences
my study design approach:
Constructivism - Knowledge consists of those constructions about which there is
relative consensus (or at least some movement toward consensus) among those
competent (and, in the case of more arcane material, trusted) to interpret the
substance of the construction. Multiple "knowledges" can coexist when equally
competent (or trusted) interpreters disagree, and/or depending on social,
political, cultural, economic, ethnic, and gender factors that differentiate the
interpreters. These constructions are subject to continuous revision, with changes
most likely to occur when relatively different constructions are brought into
juxtaposition in a dialectical context (p. 113).
By virtue of conducting a phenomenological study, which has a very deep history in
philosophy (Groenewald, 2004), my philosophical grounding in constructivism was reinforced.
This study is about discovery of important categories of meaning about big data in
healthcare through the experiential knowledge of nine key healthcare stakeholders. By listening
to, writing, describing and interpreting text of an individual’s “lived experience,” I also
successfully elicited original, first-hand data about rich social, cultural, and institutional
narratives (Clandinin, 2013) that are potentially lost in a quantitative approach. Make no mistake,
Amedeo Giorgi (2009) was clear that “a completely full experiment requires both aspects” (p.
39) of quantitative and qualitative approaches. I did not consider a mixed method analytical
technique, drawing on my training as an epidemiologist, Leinweber (2011) points out that the
“best content-analytic studies use both qualitative and quantitative operations” (p. 2). However,

207
researching the qualitative aspects of the healthcare big data phenomena yielded a timely and
much richer description about the phenomena. Phenomenology using narratives is appropriate
and timely for the phenomena under study.
Interview Procedures
Each study participant was given the list of the interview questions as part of the
Interview Guide (Appendix C) at least one week prior to the scheduled initial interview. While
there was no formal preparation required, sending the questions ahead of time allowed each
study participant to think through a sequence of events and topics that were possibly forgotten to
memory. An executive summary no longer than three pages was sent to each study participant in
a PDF format.
While the study topic was positively received by potential study participants and industry
leaders, a moderate-level risk loomed: potential candidates who verbally and informally agreed
to participate in this study could recuse themselves for a number of factors, including, schedules,
new commitments, time-lapsed between initial contact and interview, and the end of the current
federal fiscal year (September 30, 2013). To mitigate this risk, I kept potential study participants
informed of the progress of the study’s development through email. This was important because
at the onset of my data collection period, the federal government historically shut down its
operations between October 1 and October 16, 2013.
Of the study participants selected, six were geographically located in the Mid-Atlantic
region (Figure 5) of the United States because of the density of federal healthcare agencies and
integrated delivery systems. The region is also a hub for national patient advocacy organizations.
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The remaining three study participants were selected from the Midwest and Pacific Coast
regions.
After ten study participants were selected from the purposive sample, each signed and
returned the original copy of the Participant Study Consent Form (Appendix B). A one-hour
interview was subsequently scheduled. No potential study participant declined verbally or by
email.

Figure 5. Geographic regional sampling frame from which purposive sample will be drawn
(source: Internet: Google Images www.google.images.com)
Semi – Structured Interviews
A semi-structured interview has a freewheeling (Bernard, 2006) quality – the flow of the
interview, rather than the order in the interview guide (Bailey & Tilley, 2002) which provides
explicit directions about how the interview will be conducted, guides the healthcare “stakeholder
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– researcher” collaboration. A copy of the Interview Guide that provided clear instructions to
guide this study is in Appendix C.
Each initial interview lasted approximately 43 to 60 minutes, with one interview lasting
one hour and 16 minutes. Five interviews were held in the study participant’s place of work,
three were held over the phone, and two were held through Skype. Each study participant
conducted their interview from their place of work with the exception of two who took the
interviews from their homes.
The semi-structured interviews served as the primary data collection method; my written
field notes were a secondary source of data along with additional supplemental data. Four of the
participants provided additional sources of data, including Microsoft PowerPoint slides from
previous presentations on big data, a book co-authored by a study participant, and a URL to a
personal website.
Study participants responded to 11 open-ended questions and one yes-no question that
elicited further elaboration. I solely conducted each interview and recorded the “conversation”
on an Apple iPhone 5S. The data were immediately loaded into a secure password-protected data
management account and uploaded for transcription and analysis. I augmented the recordings
with personal field notes kept in a dedicated journal. Follow up interviews occurred face-to-face
in the study participant’s place of work, via Skype and on the phone. The intent was to maintain
the most comfortable setting for study participants to share their in-depth narratives about big
data in healthcare. No other research interviewers were used in this study. The interview guide
was about the most structured part of the interviews.
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Bracketing
For a major federal project, I conducted twenty-five semi-structured interviews with
middle to senior-level managers in a large healthcare agency to chronicle and synthesize their
requirements for and insights into an enterprise-wide portfolio management initiative. I
developed a study guide to help facilitate the interviews; however, this elite group of federal staff
relied on my ability to navigate an informal conversation, keep them engaged and respect their
limited time.
During interviews, I maintained a collaborative rather than an objective or neutral
relationship with each study participant. One of the lessons learned from the aforementioned
experience was to engage in an informal conversation with lots of flexibility, but maintain a
degree of structure bound by the interview guide. From this in-depth, six-month long project, I
also learned that semi-structured interviewing works very well in projects where researchers
engage with high-level bureaucrats and elite members of a community—people who are
accustomed to efficient use of their time (Bernard, 2006).
I have reflected a lot on my role during this research study. My research has uncovered
the fact that there are a couple of prominent ideologies on the level of involvement of the
researcher. Dahlberg’s (2006) notion of ‘bridling’ provided a reference that guided my
interactions with each study participant. Bracketing, or putting aside my experiences beliefs and
opinions, is a commonly used approach in phenomenology studies. It was very difficult to simply
set aside my presuppositions, opinions and ideas about a topic I am very close to. However, to
get to the “truth” of the story, I successfully set aside my personal knowledge and ideologies on
big data in healthcare and remained conscious of each study participant’s lived experience,
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employing my excellent listening skills. There were three aspects of bridling that guided my
presupposition as described by Bremer (2009):


Like “bracketing,” bridling is “the restraining of one’s pre-understanding in the form of
personal beliefs, theories, and other assumptions that otherwise would mislead the
understanding of meaning and thus limit the research options” (pp. 129 – 130).



It is also about the “understanding as a whole” not just the “pre-understanding”-this is done
so as to not “understand too quickly, too carelessly” (p. 130). It is an “open and alert attitude
of activity waiting for the phenomenon to show up and display itself within the relationship”
(p. 130); and,



It is forward looking rather than backward looking, allowing “the phenomenon to present
itself” (p. 130)(Bremer, Dahlberg, & Sandman, 2009).
Data Management
There were many types of data that required management: documents, interview

transcripts, field notes, websites and books. During the first semester of the doctoral program, I
began ‘memoing’(Miles & Huberman, 1994), or journaling. Journaling is a process of
maintaining a written record of my experiences, activities, thoughts, and ideas on regular basis. It
is a practice that I maintained throughout my studies and research. I used Evernote as the
primary electronic document management system to manage and secure websites and other
documents except the raw transcripts. As a supplement to the electronic media, I maintained a
dedicated written journal to document reflections and thoughts about this research process.
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All interview audio files were stored and managed in a dedicated, secure, passwordprotected Apple iTunes account which I only had access. Six (6) months after the date of the
final study analysis, all iTunes audio files associated with this research study will be destroyed
and not be available for use in further research, articles or publications.
Transcription


Only after permission was granted in writing and verbally approved by each study
participant, each interview was recorded using an Apple iPhone 5s. I took hand-written field
notes to supplement each recording. Field notes were kept in a confidential journal;



After recording each interview, the audio file was converted into a written transcript through
a technique called “parroting:”
o Download the audio file to an Apple iTunes secure cloud platform using a Mac Air laptop;
o Through Dragon NaturallySpeaking 12 Premium Student/Teacher edition software, a
recording of the interview was heard through the Dragon headset;
o No later than one day after each interviews I listened to the recorded text;
o For quality control, the audio file was re-checked against transcription.



I used Microsoft Word as the word processor to manage text data recorded from each audio
interview. A password protected file for each interview was created to ensure privacy and
eventually merged for analysis.



Files were saved based on the coding scheme in Table 13. To maintain confidentiality, no
study participant names were associated with any file. I assigned a web-generated
pseudonym to each participant. Rather than use an impersonal identification code, I chose to
maintain authenticity of narratives realism by assigning traditional names.
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Timeframe
All data collected from the initial semi-structured interviews and subsequent follow up
interviews were conducted between September 23, 2013 and December 10, 2013.

Data Analysis Procedures
For this research study, I employed a commonly used content analysis framework: a
general inductive approach to qualitative analysis (Elo & Kyngäs, 2008; D. Thomas, 2003;
Zhang & Wildemuth, 2009)14. A general inductive approach to qualitative content analysis is a
valuable alternative to more traditional methods when attempting to identify important themes or
categories within a body of text (Zhang & Wildemuth, 2009).The technique is drawn from a
variety of related techniques used in exploratory qualitative research, qualitative content analysis
and constructivist grounded theory (Pope, Ziebland, & Mays, 2000) which if a theory were to be
used is the closest theory that relates to this research study.15 Thomas (2003) purports that the
primary purpose of the inductive approach is “to allow research findings to emerge from the
frequent, dominant or significant themes inherent in raw interview data, without the restraints
imposed by structured methodologies” (p. 2). I chose this framework because the general
inductive approach is frequently reported in health and social science research (D. R. Thomas,
2006; D. Thomas, 2003) and information & library sciences (Zhang & Wildemuth, 2009) and
has a close counterpart, quantitative content analysis.

14

15

David R. Thomas is professor at the School of Population Health, University of Auckland

This is a phenomenological study. Dewey’s Theory of Experience (1938) is most often cited as a philosophical
underpinning of narrative inquiry.
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Qualitative data analysis involves searching for emerging themes, first within an
interview and then across a series of interviews. The search for emerging themes is common
practice in qualitative research and involves the interplay between data and the emerging themes
(Tan & Hunter, 2003). There is no one method to analyze narrative data, and arguably, there are
a host of appropriate analytical methods for a qualitative study in information studies (Table 11).

Trustworthiness
Though as novice researcher and rising scholar-practitioner, my personal goal was to
conduct an ethical high quality research study on big data in healthcare. Qualitative researchers,
who frame their studies in an interpretive paradigm, think in terms of trustworthiness as opposed
to the conventional, positivistic criteria of internal and external validity, reliability, and
objectivity (Denzin & Lincoln, 2002; Guba & Lincoln, 1985). To ensure trustworthiness, I relied
on two methods: triangulation of stakeholder participation of three key healthcare stakeholder
classes and stakeholder checks, which were important to ensure I maintained the essence of each
stakeholder’s narrative. Stakeholder checks were also an invaluable method to capture additional
new information from study participants post initial interview. Many of the study participants
provided additional data and clarified inaudible or erroneous interpretations of their words.
My objective was to not merely connect “thick descriptions” of narrative, but to create a
trusted, meaningful account about big data in healthcare through the insights of those who know
the subject best.
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Study Limitations
This study posed three limitations that could have potentially impacted this study. The
first limitation was the construct of a phenomenological encompassing narrative study design.
Small qualitative studies yield very limited information about a phenomenon from a limited
sampling frame. The study participants selected from the purposive sampling strategy produced
credible and reliable original data. Second, I had no expectations of achieving saturation of
themes that were generalizable to the entire healthcare ecosystem. This study focused on three
key healthcare stakeholder classes out of many that constitute the healthcare ecosystem. “Key”
healthcare stakeholders could be defined differently by other researchers. I chose not to poll
other healthcare experts to validate if the three classes identified in this study as “key.” Third,
patient privacy is protected by federal laws that would jeopardize this study. Patient privacy is
not a risk related to this study as it has been mitigated by purposively selecting responsible
consumer advocates who are well positioned to assist patients in decision making about their
health issues (Petronio, Sargent, Andea, Reganis, & Cichocki, 2004).
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GENERAL
INDUCTIVE
APPROACH

GROUNDED
THEORY
(CHARMAZ, 2006)

(THOMAS 2003)

Study Aim
&
Research
Question

Sampling &
Methods

Analysis

INTERPRETATIVE
PHENOMENOLOG
ICAL
ANALYSIS (IPA)

DISCOURSE
ANALYSIS
(POTTER, 1996)

(SMITH ET AL., 2009)

To examine
topics and
themes, as
well as the
inferences drawn
from them, in the
data and to
generate theory
Samples usually
consist of selected
texts which can
inform the
research
questions being
investigated.

To generate
theory from
empirical data
(e.g. stigma in
mental health)

To understand
individual in-depth
experience; rooted
in psychology

To capture
nuances of text or
public discourse
(e.g.,
understanding
political theory)

Range of
perspectives
and stay true to
research
question;
unstructured
questionnaire

Homogenous sample
and stay true to
participants’ stories;
unstructured
questionnaire

Documents,
speeches,
newspapers, mass
media

Purposive sampling
Purposive
sampling

Theoretical
sampling

Purposive/
Theoretical
sampling

Data-driven
Constant
comparison and
iterative
approach

Identification of
descriptive and
interpretative themes
that actively engages
the researcher and
participants

Detailed,
thorough analysis
of discourses –
speeches, written
text,
conversations

Potential ‘bias’
is managed

Paramount;
importance of
reflexivity

High level of
interpretation or
abstraction
expected

Identification of
descriptive and
interpretative
themes that
actively engages
the researcher and
participants
Researcher’s Immerse in the
Position
data and allow
themes to emerge
from the data

Table 11. Comparison of common qualitative data analysis methods
Some of the assumptions of a general inductive approach are described below:
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Data analysis was determined by both the research objectives (deductive) and multiple
readings and interpretations of the raw data (inductive).



The primary mode of analysis was the development of categories from the raw data into a
model or framework that captures key themes and processes judged to be important.



The research findings result from multiple interpretations made from the raw data by the
researcher who codes the data. Inevitably, I independently made decisions about what was
more important and less important in the data.



Trustworthiness of findings was assessed (a) triangulation within across key healthcare
stakeholders and (b) feedback from participants in the research (D. R. Thomas, 2006; D.
Thomas, 2003; Zhang & Wildemuth, 2009).

I did consider four alternative approaches commonly used in the social sciences: general
inductive approach, grounded theory, Interpretative Phenomenological Analysis (IPA) and
discourse analysis. Because of the time it took to develop an adequate working knowledge of
qualitative content analysis, I chose a credible data analysis procedure that allowed me
systematically apply important categories of meaning necessary to ‘restory’ study participant
narratives.

Presentation of Findings and Conclusions
The framework of a general inductive approach provided a vetted approach to presenting
research study findings. I must note that while this data analysis approach was a good starting
point, the final presentation of the findings is undetermined. In the case of a general inductive
approach to content analysis, the coding process played a central part in how data the data was
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reported; I am thankful for NVIVO 10. The general inductive approach did not produce counts
and statistical significance; instead, it effectively uncovered patterns, themes, and categories
important to a social reality. I let the themes emerge from the coding scheme before I defined
how the data was to be presented. While I visualized many, many approaches to presenting the
data, with the guidance of my committee, the study’s finding as they are presented felt like the
most appropriate way to present these important ‘stories’ on the phenomena of big data in
healthcare. So that study is replicable, I monitored and reported analytical procedures and
processes as completely and truthfully as possible (Patton, 2005). Where possible, I included
tables, graphs, and charts (Miles & Huberman, 1994), and did not deviate from the true objective
of completing a qualitative phenomenological study.

I attempted to maintain a balance between both interpretation and description of themes,
and important categories of meaning. Description gives readers background and context (Denzin
& Lincoln, 2002). An interesting and readable report provides sufficient description to allow the
reader to understand the basis for an interpretation, and sufficient interpretation to allow the
reader to understand the description (Patton, 2005).

My curriculum vita (CV) is included at the end of this dissertation.
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APPENDIX B. STUDY PARTICIPANT CONSENT FORM

SCHOOL OF INFORMATION STUDIES
343 Hinds Hall Syracuse, NY 13210

An Epidemiology of Big Data

My name is John Young and I am a professional doctorate student at Syracuse
University, School of Information Studies. I am inviting you to participate in a research study.
Involvement in the study is simple, voluntary and with very little risk, so you may choose to
participate or not. This document will explain the study to you and please feel free to ask
questions about the research if you have any. I will be happy to explain anything in detail if you
wish.
I am interested in learning more about the important categories of meaning about big data
in healthcare – through the experiences of ten leaders representing three key healthcare
stakeholder classes: government, providers and consumers. You will be asked to provide your
insights by participating in a face-to-face interview at your place of work. Interviews will take
approximately up to two hours of your time, beginning with an initial one hour interview. A
subsequent follow-up interview either face-to-face or by phone will be used to validate and
enhance your narrative. Your participation will be a contribution towards providing new
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knowledge about important categories of meaning about big data in healthcare through an
intertwined ‘story’ of ten key healthcare stakeholders.
Your privacy is important and your responses will remain confidential. I will assign a
unique number to your responses, and only I and my faculty advisor will have the key to indicate
which number belongs to which participant. In any articles I write or any presentations that I
make, I will use a made-up name for you and I will not reveal details or I will change details
about where you work.
I would like to audio record this face-to-face interview using an Apple iPhone 5 so that I
can use it for reference while proceeding with this study. I will be the only one who will hear the
audio recordings, which will be transcribed by me. I will not record this interview without your
permission. If you do grant permission for this conversation to be recorded, you have the right to
end the interview at any time.
This project will be completed by February 15, 2014. All interview recordings will be
stored in a secure, password protected Apple iTunes account that I will only have access to until
six (6) months after that date. The audio files will then be destroyed. Your study data will be kept
as confidential as possible, with the exception of certain information we must report for legal or
ethical reasons.
Contact Information:
If you have any questions, concerns, complaints about the research, contact my faculty advisor
and professor, Dr. Jian Qin at (315) 443 - 5642. If you have any questions about your rights as a
research participant, you have questions, concerns, or complaints that you wish to address to
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someone other than the investigator, if you cannot reach the investigator, contact the Syracuse
University Institutional Review Board at 315-443-3013.
All of my questions have been answered, I am 18 years of age or older, and I wish to
participate in this research study. I have received a copy of this consent form (please keep a copy
of this consent form for your records).
___ I agree to be audio recorded.
___ I do not agree to be audio recorded.
_________________________________________
Signature of participant

_________________________
Date

_______________________________________
Printed name of participant
_________________________________________
Signature of researcher
_________________________________________
Printed name of researcher

_________________________
Date
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APPENDIX C. INTERVIEW GUIDE

SCHOOL OF INFORMATION STUDIES
343 Hinds Hall Syracuse, NY 13210

An Epidemiology of Big Data
Interview Guide
Script:
Thank you for inviting me to your office and agreeing to participate in this research
study. My name is John Young and I am a graduate student in the doctorate of professional
studies – information management program at Syracuse University, School of Information
Studies in Syracuse, NY. This initial interview will take about 60 minutes and will include 11
questions regarding your experiences and insights about big data in healthcare. I would like
your permission to audio record this interview, so I may accurately document the information
you convey. I will also keep hand-written notes to supplement the audio recording. I will
schedule another follow-up face-to-face or telephone interview to check if you have additional
insights to share and to ensure my draft transcription accurately reflects your narrative. If at
any time during the interview you wish to discontinue the use of the recorder or the interview
itself, please feel free to let me know. Your privacy is important; all of your responses will
remain confidential.

Your confidential responses will be used to contribute to new knowledge about themes,
challenges and meaning about big data in healthcare using a narrative-based data collection
method. A coherent ‘story’ from three key healthcare stakeholder classes: government,
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providers, and consumers will be the outcome of the study. The purpose of this study is to
discovery important categories of meaning about big data in healthcare.

At this time I would like to remind you of your written consent to participate in this study.
I am the responsible researcher for this research project: An Epidemiology of Big Data. You and
I have both signed and dated each copy, certifying that we agree to begin this interview. You
will receive one copy and I will keep the other under lock and key, separate from your reported
responses. Thank you.

Your participation in this interview is completely voluntary. If at any time you need to
stop to take a break, please let me know. You may also withdraw your participation at any time
without consequence. Do you have any questions or concerns before we begin? Then with your
permission we will begin the interview.

A phenomenological study encompassing narrative captures a holistic account of
people’s experiences related to a phenomenon. The objective of this phase of the research is to
capture study participant’s insights and perspectives about big data in healthcare in their own
words. The following questions are guide for the interview to ensure I have collected the
intended information. The trustworthiness and credibility of this study relies on study
participant’s to talk openly and objectively about various aspects of big data in their daily
routine and within their healthcare organization. There are no right (or wrong) answers and no
preparation beyond your subject matter knowledge and experience is required.
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DESCRIPTION

RATIONALE

IQ1

What does big data mean to you?
Your organization? What about big
data in healthcare specifically? How
did you arrive to this conclusion?

IQ2

Describe some of the important
professional and academic
experiences that prepared you for
your current position. Please
emphasize any academic training or
practical preparation.

I am looking for categories of
meaning derived from
experiential knowledge which
could inform a cohesive
definition of big data.
I am seeking to understand
how study participant evolved
professionally which could
provide insight into
professional development of
big data in healthcare.

IQ3

What makes ‘big data’ different from Big data is a “buzzword” that
‘data?’ Are there certain attributes?
is poorly defined.
This is the only ‘yes’ or ‘no’
question, but please elaborate: Is
medicine an information science?

IQ4

Describe the drivers and influencers
that impact ’big data’ in healthcare?

IQ5

Describe the ‘big data’ sources (e.g.,
data sets) you use. How do you get
access to these data sources? Does
someone else manage access to and
analysis/interpretation of ‘big data?’

IQ6

Describe the organizational
challenges of making data driven.
Can ‘big data’ help address these
challenges?

IQ7

Describe what ‘big data’ you share?
How do you share it? With whom do

Big data has been slow to
catch on in healthcare. IQ3
provides professional and
organizational insights into
drivers and influencers of big
data
Big data requires computing
platforms and analytics that
are not customarily available
on a desktop. Provides content
and context into the
capabilities, support, tools
needed to manage and use big
data.
These challenges might
provide insight into why big
data has been slow to evolve
in healthcare.
My thought here is by
understanding
multidisciplinary perspectives

SOURCE
(Dumbill, 2013;
Villars et al.,
2011)

(Borgman, 2012)

(Borangiu &
Purcărea, 2008;
Davenport et al.,
2012; Rooney,
2012; Sackett et
al., 1996; Smith,
1996)
(Bollier &
Firestone, 2010;
L. R. Burns et al.,
2002; Sullivan,
2011)
(Anderson, 2004;
Davenport &
Patil, 2012;
Eysenbach, 2008;
Pryor & Donnelly,
2009; Rhoads &
Ferrara)
(Porter &
Teisberg, 2006;
Weisbrod, 1991)
(Theodor
Borangiu &
Victor Purcarea,
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you share your ‘big data?’

IQ8

Describe any uses, unintended
consequences, or reuses of big data.
Should big data be repurposed for
secondary use by each of the three
stakeholder classes? Please
Elaborate.

IQ9

Describe your vision of a future state
of big data in healthcare. What are
your hopes for big data?

IQ10

Metaphors and symbols are
prevalent in healthcare. Can you
describe any big data metaphors or
symbols that resonate with you or
your organization? Why?
Please elaborate on any points about
big data not covered in these
questions that make sense for you
and add other points that are unique
to you and your organization.

IQ11

about big data, this study
could be a small step towards
informing further studies in
health data sharing policy.
Here, I am hoping to capture
data on any unintended
consequences of big data and
whether data prepared for
government can be used for
consumers.

2008; Gorman,
1995; Porter &
Teisberg, 2006)

Provides content and
framework for current gaps
between “as is” and “to be”
big data.
Metaphors like “data deluge”,
the new oil,” and “data
tsunami” all attempt to
describe big data and highlight
the challenges of doing so.
Always end with an openended question in the event I
missed something.

(Borangiu &
Purcărea, 2008;
Feldman et al.,
2012)
(Burns, 2011)

(Borgman, 2012;
Kerr, Norris, &
Stockdale, 2007)

(Borins, 2012;
Boyce & Neale,
2006; Ryan &
Bernard, 2003)

Table 12. Semi-Structured Interview Questions and Rationale
Script continuedThis concludes the initial interview. I will follow up with next steps about the follow up
interview. Thank you very much for taking time from you busy schedule to participate in this
research study.
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APPENDIX D. IRB DETERMINATION OF EXEMPTION

227
APPENDIX E. INTERVIEW DATA EXPLICATION SCHEME

STEP

ACTIVITY

Step 1

Prepare the Data

Step 2

Close Reading (and
Rereading) of the text.

Step 3

Develop Categories
and a Coding Scheme

Step 4

Overlapping Coding
and Un-coded Text

Step 5

Code All the Text and
Continuing Revision
and Refinement of
Category System

Step 6

Draw Conclusions
from the Coded Data

DESCRIPTION
After transcription from audio to text, I formatted the raw
data files into a common format (e.g., font size, margins,
questions or interviewer comments highlighted). I printed
and made backups of each raw data file and kept hard copies
each interview in a single binder.
The raw text files were read in detail to become familiar with
the content and gain an understanding of the categories of
meaning or “themes” and details in the text.
Categories and a coding scheme were derived primarily from
the semi-structured interview data. Other data sources
including scholarly and grey literature, study participant
supporting materials, (e.g., books, resumes) were also
analyzed. This study did not require a theoretical framework;
categories were inductively generated from the interview
data.
Among the commonly assumed rules that underlie qualitative
coding, two are different from the rules typically used in
quantitative coding: (a) segmentation of text was coded into
more than one category and (b) a considerable amount of the
text was not assigned to any category.
Within each category, I searched for subunits of meaning and
included contradictory points of view and new insights. I
select appropriate quotes that conveyed the core theme or
essence of a category. The categories were often combined
and linked when the meanings are similar.
This step involved making sense of the themes or categories
identified, and their properties. I began making inferences
and presented the reconstructions of categories of meaning
derived from the data, including exploring different
dimensions of categories, identifying relationships between
categories, uncovering patterns within and across healthcare
stakeholder classes, and testing categories against the full
range of data.

Table 13. Coding Scheme: A General Inductive Approach
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